Compositions for use in a substance delivery system

A composition of fatty acids and aromatic carboxylic acids in non-combustible systems replicates the flavor and aroma of cigarettes, addressing the shortfall in existing alternatives and improving user satisfaction.

WO2026234397A2PCT designated stage Publication Date: 2026-11-12NICOVENTURES TRADING LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/GB2026/050800
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-11
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing non-combustible smoking alternatives fail to fully replicate the flavor dimensions of a traditional cigarette experience, particularly the aroma, which is critical for consumer satisfaction.

Method used

A composition comprising specific combinations of fatty acids and aromatic carboxylic acids, tailored to provide a tobacco aroma that simulates the flavor of a cigarette when used in non-combustible substance delivery systems, such as heat-not-burn devices or vaping devices.

Benefits of technology

The composition effectively replicates the flavor and aroma of a cigarette, enhancing the user experience in non-combustible systems and making them more appealing to consumers who prefer the traditional smoking experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000112_0001
    Figure IMGF000112_0001
  • Figure IMGF000114_0001
    Figure IMGF000114_0001
  • Figure IMGF000114_0002
    Figure IMGF000114_0002
Patent Text Reader

Abstract

The present invention relates to a composition for use in a non-combustible substance delivery system to provide a tobacco aroma, the composition comprising a combination of fatty acids selected from the following groups: (a) one C14 to C18 saturated fatty acid and one C16 to C20 unsaturated fatty acids; (b) three C3 to C18 saturated fatty acids; or (c) at least three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid; wherein the composition has a pH of about 4 to about 7.6.
Need to check novelty before this filing date? Find Prior Art

Description

COMPOSITIONS FOR USE IN A SUBSTANCE DELIVERY SYSTEMTechnical Field

[0001] The present disclosure relates to a composition for use in a substance delivery system to provide a tobacco aroma and a method of forming the composition. The substance delivery system is a non-combustible substance delivery system. The tobacco aroma provided by the composition is advantageous in contributing to a factory-made cigarette (FMC)-like experience when the composition is employed in a substance delivery system, such as a non-combustible aerosol provision device. Also provided is a consumable for use in a non-combustible substance delivery system, the consumable comprising the composition, and a substance delivery system which is a non-combustible aerosol provision system, or an aerosol-free delivery system.Background

[0002] Smoking articles such as cigarettes, cigars, and the like, burn tobacco during use to create tobacco smoke. Alternatives to these types of articles release an inhalable aerosol or vapour by releasing compounds from a substrate material by heating without burning. These may be referred to as non-combustible smoking articles, aerosol-generating assemblies, or non-combustible aerosol provision systems. One example of such a product is a heating device which releases compounds by heating, but not burning, a solid aerosolisable material. This solid aerosolisable material may, in some cases, contain a tobacco material. The heating volatilises at least one component of the material, typically forming an inhalable aerosol. These products may be referred to as heat-not-burn devices, tobacco heating devices or tobacco heating products. Various different arrangements for volatilising at least one component of the solid aerosolisable material are known.

[0003] As another example, there are e-cigarette / tobacco heating product hybrid devices, also known as electronic tobacco hybrid devices. These hybrid devices contain a liquid source, which may or may not contain nicotine, which is vaporised by heating to produce an inhalable vapour or aerosol. The device additionally contains a solid aerosolisable material, which may or may not contain a tobacco material, and components of this material are entrained in the inhalable vapour or aerosol to produce the inhaled medium. A further alternative is vapour products which are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, commonly known as vapour.

[0004] The compositions used in heated products and vaping platforms, can also be used in oral products which are consumed by the user.Summary

[0005] In accordance with some aspects of the invention described herein, there is provided a composition for use in a substance delivery system to provide a tobacco aroma, the composition comprising a combination of fatty acids selected from the following groups:a. one C14 to C18 saturated fatty acid and one C16 to C20 unsaturated fatty acids;b. three C3 to C18 saturated fatty acids; orc. at least three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid;wherein the composition has a pH of about 4 to about 7.6.

[0006] It will be understood that the substance delivery system in which the consumable may be used is not a combustible substance delivery system (e.g. a cigarette). Hence, the term “substance delivery system” in the present disclosure means non-combustible substance delivery system.

[0007] In some examples, the composition further comprises acetic acid, C7 to C24 aromatic carboxylic acids and combinations thereof. In some examples, the composition further comprises a combination of acetic acid and C7 to C24 aromatic carboxylic acids.

[0008] In some examples, the composition comprises no more than ten aromatic acids. In some examples, the composition comprises no more than nine aromatic acids. In some examples, the composition comprises no more than eight aromatic acids. In some examples, the composition comprises no more than seven aromatic acids. In some examples, the composition comprises no more than six aromatic acids. In some examples, the composition comprises no more than five aromatic acids. In some examples, the composition comprises no more than four aromatic acids. In some examples, the composition comprises no more than three aromatic acids. In some examples, the composition comprises no more than two aromatic acids.

[0009] In some examples, the composition comprises a combination of fatty acids consisting of three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid.

[0010] In some examples, the composition comprises a combination of fatty acids consisting of three C3 to C18 unsaturated fatty acids and nine C3 to C18 saturated fatty acids.

[0011] In some examples, the composition comprises no more than ten unsaturated fatty acids. In some examples, the composition comprises no more than nine unsaturated fattyacids. In some examples, the composition comprises no more than eight unsaturated fatty acids. In some examples, the composition comprises no more than seven unsaturated fatty acids. In some examples, the composition comprises no more than six unsaturated fatty acids. In some examples, the composition comprises no more than five unsaturated fatty acids. In some examples, the composition comprises no more than four unsaturated fatty acids. In some examples, the composition comprises no more than three unsaturated fatty acids. In some examples, the composition comprises no more than two unsaturated fatty acids.

[0012] In some examples, the composition comprises unsaturated fatty acids, if present, in an amount of 1 pg / g to about 400 pg / g. In some examples, the composition comprises unsaturated fatty acids, if present, in an amount of from about 10 pg / g to about 200 pg / g.

[0013] In some examples, the composition comprises saturated fatty acids in an amount of from about 1 pg / g to about 500 pg / g. In some examples, the composition comprises saturated fatty acids in an amount of from about 10 pg / g to about 400 pg / g.

[0014] In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 2.0: 1.0 to about 1.0:2.5. In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 1.0:1.0 to about 1.0:2.2. In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 1.0: 1.7 to about 1.0 to 2.2.

[0015] In accordance with some aspects described herein, there is provided a composition for a substance delivery system to provide a tobacco aroma, wherein the composition comprises one or more reaction products of two or more reactants, the reaction products being selected from:a. esters, the esters being an esterification reaction product of organic acid and alcohol reactants; and / orb. esters and / or alcohols, the esters and / or alcohols being a transesterification reaction product of ester and alcohol reactants;c. alcohols and / or acids, the alcohols and / or acids being a hydrolysis reaction product of ester and water reactants;d. acetals, the acetals being the acetalisation reaction product of aldehyde and alcohol reactants;e. acetals, the acetals being the acetalisation reaction product of ketone and alcohol reactants;or combinations of the reaction products.

[0016] In some examples, the organic acid reactants are selected from C2 to C24 carboxylic acids and combinations thereof.

[0017] In some examples, the alcohol reactants are selected from terpene alcohols, C7 to C18 aromatic alcohols, phenol or C7 to C18 substituted phenols and combinations thereof. In some examples, the C7 to C18 substituted phenols are monophenols.

[0018] In some examples, the alcohol reactants are primary alcohols, polyhydric alcohols or combinations thereof. In some examples, the primary alcohols are selected from ethanol, methanol or combinations thereof and the polyhydric alcohols are selected from glycerol, propylene glycol or combinations thereof.

[0019] In some examples, the ester reactants are selected from C3 to C24 aliphatic esters, C8 to C18 aromatic esters and combinations thereof.

[0020] In some examples, the aldehyde reactants are selected from C3 to C24 aliphatic, and aromatic aldehydes and combinations thereof.

[0021] In some examples, the ketone reactants are selected from C3 to C24 aliphatic and aromatic ketones, and combinations thereof.

[0022] In some examples, the composition has a pH of less than 7. In some examples, the composition has a pH of about 4 to about 5.

[0023] In some examples, the composition is obtained by extracting one or more reactants or compounds from a tobacco source.

[0024] In accordance with some aspects described herein, there is provided a method for forming the composition as defined herein, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the reactants or compounds from the tobacco into the solvent.

[0025] In accordance with some aspects described herein, there is provided a consumable comprising the composition as defined herein, and a substrate material. In some examples, the substrate material comprises a carrier material, a porous material, or a combination thereof.

[0026] In accordance with some aspects described herein, there is provided a container or package containing the composition as defined herein. In some examples, the container or package is a pouched oral product comprising a saliva permeable pouch, or a cartridge for an aerosol provision system.

[0027] In accordance with some aspects described herein, there is provided a substance delivery system comprising the consumable, or the container or package as defined herein. In some examples, the system is a combustible aerosol provision system, a non-combustible aerosol provision system, or an aerosol-free delivery system.

[0028] In accordance with some aspects described herein, there is provided an aerosolisable formulation comprising: (a) a carrier; and (b) a composition as defined herein.

[0029] In accordance with some aspects described herein, there is provided an aerosolised formulation comprising: (a) a carrier; and (b) a composition as defined herein.

[0030] These and other features, aspects and advantages of the disclosure will be apparent from the following detailed description and drawings. The invention includes any combination of two, three, four, or more of the above-noted examples as well as combinations of any two, three, four, or more features or elements set forth in this disclosure, regardless of whether such features or elements are expressly combined in a specific example description herein. This disclosure is intended to be read holistically such that any separable features or elements of the disclosed invention, in any of its various aspects and examples, should be viewed as intended to be combinable unless the context clearly dictates otherwise.Brief Description of the Figures

[0031] Having thus described aspects of the disclosure in the foregoing general terms, reference will now be made to the accompanying figures. The figures are exemplary only and should not be construed as limiting the disclosure.Figure 1 is a mass spectra of a consumable prepared using a pre-formulated levulinic acid / glycerol product.Figure 2 is a mass spectra of a consumable prepared using a pre-formulated levulinic acid / glycerol / propylene glycol product.Figure 3 is a mass spectra of a consumable prepared using a pre-formulated levulinic acid / glycerol product at point of formulation (i.e. T=0hr).Figure 4 is a mass spectra of a consumable prepared using a pre-formulated levulinic acid / glycerol product after storage (i.e. T=18hr).Figure 5 is a mass spectra of consumable prepared using a single step manufacturing process.Figure 6 is a chromatogram of a consumable prepared using a pre-formulated 4-formylbenzoic acid I glycerol product at point of formulation (i.e. T=0hr).Figure 7 is a chromatogram of a consumable prepared using a pre-formulated 4-formylbenzoic acid I glycerol product after storage (i.e. T=2hr).Figure 8 is a chromatogram of a consumable prepared using a pre-formulated 4-formylbenzoic acid I glycerol product after storage (i.e. T=20hr).Figure 9 is a chromatogram of a consumable prepared using a pre-formulated glyoxylic acid I glycerol product after storage (i.e. T=2hr).Figure 10 is a chromatogram of a consumable prepared using a pre-formulated pyruvic acid I glycerol product at point of formulation (i.e. T=0hr).Figure 11 is a chromatogram of a consumable prepared using a pre-formulated pyruvic acid I glycerol product after storage (i.e. T=20hr).Figure 12 is a chromatogram of a consumable prepared using a pre-formulated pyruvic acid I 2-methyl 1,3 propanediol product at point of formulation (i.e. T=0hr).Figure 13 is a chromatogram of a consumable prepared using a pre-formulated pyruvic acid I 2-methyl 1,3 propanediol product after storage (i.e. T=20hr).Figure 14 is a chromatogram of a consumable prepared using a pre-formulated a-ketoglutaric acid 12-methyl 1 ,3 propanediol product at point of formulation (i.e. T=0hr).Figure 15 is a chromatogram of a consumable prepared using a pre-formulated a-ketoglutaric acid 12-methyl 1,3 propanediol product after storage (i.e. T=20hr).Figure 16 demonstrates location of irritation across samples 1-3 tested in Example 7.Figure 17 demonstrates location of irritation across samples 4-6 tested in Example 7.Detailed Description

[0032] It is to be understood that this disclosure is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, andmaterials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular examples only and is not intended to be limiting since the scope will be limited only by the appended claims and equivalents thereof.

[0033] As used in this specification and the claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Reference to "dry % by weight" or "dry weight basis" refers to weight on the basis of dry ingredients (i.e., all ingredients except water or carrier). Reference to "wet weight" refers to the weight of the formulation or composition including water or carrier. Unless otherwise indicated, reference to "% by weight" (or “% by weight”) of formulation or composition reflects the total wet weight of the formulation or composition (i.e., including water / carrier). Unless otherwise indicated, all % values are calculated on a weight basis, and are provided with reference to the total weight of the product in which the substance is present.

[0034] In this specification, unless otherwise stated, the term "about" modifying the quantity of an ingredient in the formulation or employed in the methods refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the formulation, or to carry out the methods; and the like. The term “about” also encompasses amounts that differ due to different equilibrium conditions for a formulation or composition resulting from a particular initial mixture. Whether or not modified by the term "about", the claims include equivalents to the quantities.

[0035] The ranges provided herein relate to preferred amounts of each of the compound groups. Each of these ranges may be taken alone or combined with one or more other compound group range(s) to provide a preferred example of the invention.

[0036] As used herein, “substantially free” means no more than trace amounts, i.e. the amount of the substance(s) concerned is negligible. In some examples, “substantially free” means no more than 1 ppm of the substance(s) concerned.

[0037] In all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers and tautomers of the compounds disclosed herein. A person skilled in the art will recognise compounds that possess optical properties (one or more chiral carbon atoms) or tautomeric characteristics. The corresponding enantiomers and / or tautomers may be isolated / prepared by methods known in the art. Some of the compounds disclosed herein may exist as stereoisomers and / or geometric isomers - e.g. they may possess one or more asymmetric and / or geometric centres and so may exist in two or more stereoisomeric and / orgeometric forms. The present disclosure contemplates the use of all the individual stereoisomers and geometric isomers of those compounds, and mixtures thereof. The terms used in the claims encompass these forms.

[0038] As used herein, an alkyl group can be a substituted or unsubstituted, linear or branched chain saturated radical. Examples of alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, hexadecyl, heptadecyl, octadecyl, nondecyl, eicosyl, and isomeric forms thereof. Cycloalkyl groups are derived from cycloalkanes by removal of a hydrogen atom from a ring carbon atom; they include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, 2-methylcyclopentyl, 2,3-dimethyl-cyclobutyl, 4-methylcyclobutyl, 3-cyclopentyl propyl, and the like.

[0039] As used herein, an alkenyl group can be a substituted or unsubstituted, linear, branched or cyclic unsaturated radical. An alkenyl group thus contains one or more carboncarbon double bonds. Examples of alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, dodecenyl, hexadecenyl, heptadecenyl, octadecenyl, nondecenyl, eicosenyl, and isomeric forms thereof. Cycloalkenyl groups include cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, and the like, and isomeric forms thereof.

[0040] As used herein, an aromatic group is a substituted or unsubstituted group derived from arenes by removal of a hydrogen atom from a ring carbon atom. Aryl groups include phenyl, tolyl, xylyl, naphthyl, biphenylyl, and the like.

[0041] A cigarette, also known as a factory-made cigarette or ‘FMC’, gives rise to a cigarettelike or FMC-like experience when smoked by a consumer. Such an experience can have various dimensions, including sense, taste and flavour dimensions. By the ‘sense’ of a cigarette, is meant the overall feel of smoking a cigarette which includes attributes such as impact, irritation, harshness, mouth drying, and mouth coating or mouthfeel. By the “taste” of a cigarette is meant the overall taste of smoking a cigarette including tastes such as hay-like, bread-like, smoky, tannin, resinous, musk, etc., and by the “flavour” of a cigarette is meant the overall flavour of smoking cigarette including flavours such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc.

[0042] As noted above, there are several alternative means by which a consumer can replicate the smoking experience. These include e-cigarettes and tobacco heating devices which provide the consumer with an inhalable aerosol. One potential drawback with such devices is, however, that they may fail to completely replicate one or more of the dimensions associated with the FMC-like experience. One dimension that is particularly critical forconsumers is “flavour”. With an inhalable aerosol, flavour is delivered primarily via aroma. Hence, when a consumer is seeking an “FMC-like experience” with a heating device (whether with a solid, liquid, gel or hybrid aerosolisable formulation(s)), it is desirable for the aroma to replicate that of smoking a cigarette, i.e. for the aroma to be tobacco-like and deliver a richness and complexity comparable to smoking a cigarette.

[0043] The present disclosure relates to a combination of ingredients which can be used in a consumable for a non-combustible substance delivery system to replicate the ‘FMC’ flavour. In particular, the inventors have identified a range of compounds (also called chemical markers) responsible for various flavour dimensions of smoking a cigarette, such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc., and identified a combination of such compounds which is particularly beneficial for delivering the desired ‘FMC-like’ flavour experience when employed in a non-combustible substance delivery system. These compounds were identified by preparing and analysing a range of different tobacco extracts, as well as using machine learning and / or human sensory assessment of such extracts. More information on the analysis is set out herein.

[0044] The compounds of the present disclosure can advantageously be used to prepare a composition for inclusion in a consumable for a substance delivery system, including a composition which can be used with or without a plant material (e.g. a tobacco extract) in order to replicate the ‘FMC’ flavour experience. Furthermore, the levels of the compounds can be adjusted in order to tailor the flavour intensity and / or focus to consumer preference or, when present, the substrate material (for example, the tobacco-type from which the tobacco extract included with the compounds in some examples was derived).

[0045] In total, the inventors identified over 300 compounds across 9 different tobacco extracts, the extracts being obtained by a variety of different extraction methods and from various tobacco sources (e.g. Virginia, Oriental, Burley, Dark and combinations thereof). These compounds were classified into groups, the groups associated with a contribution to the flavour profile of a cigarette, and commonalities across the extracts thereby identified including the range of concentrations for the identified compound groups. With this assessment, the inventors identified key chemical classes associated with replicating an FMC-like flavour experience. This assessment was then supplemented using machine learning and human sensory assessment as described herein.

[0046] The present disclosure is particularly focussed on a combination of fatty acid compounds able to provide a FMC-like flavour experience which are (a) one C14 to C18 saturated fatty acid and one C16 to C20 unsaturated fatty acids; (b) three C3 to C18 saturatedfatty acids; (c) at least three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid.

[0047] The inventors have therefore found a combination of chemical markers that are able to provide a tobacco aroma when used in a substance delivery system, without the need to smoke or burn a cigarette. This includes the ability to combine the combination of chemical markers with a substrate material, such as a tobacco or other plant extract, and thereby improve the ‘FMC-like’ flavour profile provided by the substrate material when used in a substance delivery system. Furthermore, it is possible to create a composition for use in an aerosol-free delivery system, such as an oral product which is placed in the oral cavity of the consumer.

[0048] The composition of the present disclosure may therefore allow for a more user-friendly and improved cigarette-like experience to be created. This has many benefits; many consumers who smoke traditional cigarettes may previously have been reluctant or unwilling to use non-combustible aerosol provision devices, e.g. heat-not-burn, hybrid or vapour devices, or oral compositions, because the experience of using these devices or compositions may differ from the experience of burning and smoking a cigarette. The composition of the present disclosure may, however, allow for consumers to get the same or similar experience to smoking a cigarette when using oral compositions and / or non-combustible aerosol provision systems. For example, when using the composition of the present disclosure in a non-combustible aerosol provision system, a more ‘cigarette-like’ experience and / or aerosol can be created compared to using a previously-known or commercially available composition for use in such devices.

[0049] As well as being used in a non-combustible substance delivery system, the composition of the present disclosure is not raw tobacco. As used herein, the term “raw tobacco” refers to any part of a plant of the Nicotiana species (e.g. leaf or stem) that has been harvested from the ground but not otherwise subjected to any processing steps.

[0050] For ease of reference, these and further aspects of the present invention are now discussed under appropriate section headings. However, the teachings under each section are not necessarily limited to each particular section. In other words, particular sections of the description are not to be read in isolation from other sections.Composition for use in a substance delivery system

[0051] There is provided herein a composition for use in a substance delivery system to provide a tobacco aroma. By the term “tobacco aroma” is meant an aroma that simulates the aroma from burning or smoking a cigarette containing tobacco. This aroma results from variousvolatile compounds naturally-present in the tobacco and / or produced during curing, aging and / or processing of the tobacco leaves. Many of the compounds present in the composition of the present disclosure thus have a boiling point of less than 250°C and / or a molecular weight of about 50 to about 500 g / mol. The molecular weight is the ratio of the mass of a molecule to the unified atomic mass unit (as defined in the IIIPAC Gold Book); it is also referred to in the art as the relative molar mass. Hence, the compounds present in the composition of the present disclosure have the potential to be aerosolised when the composition is used in a substance delivery system which is a non-combustible aerosol provision system or device, such as a heat-not-burn or vaping device or system.

[0052] Without wishing to be bound by theory, it is believed that the presence of (a) one C14 to C18 saturated fatty acid and one C16 to C20 unsaturated fatty acids; (b) three C3 to C18 saturated fatty acids; (c) at least three 03 to 018 saturated fatty acids and at least one 03 to 018 unsaturated fatty acid contributes a creamy / sweet / green / savoury / spicy / fruity flavour / aroma. These components may be supplemented acetic acid, 07 to 024 aromatic carboxylic acids and combinations thereof. The additional compounds are typically associated with creamy flavour / aroma (aromatic carboxylic acids) and spicy flavour / aroma (acetic acid). Hence, by formulating a composition according to the present disclosure, it is possible to formulate a composition which is able to simulate a cigarette-like flavour / aroma experience.

[0053] This composition may be used in a substance delivery system with or without a plant (e.g. tobacco) material. When used in combination with a tobacco material such as a tobacco extract, the extract may first be analysed for the presence of one or more of the compounds, and then supplemented with additional compounds as disclosed herein in order to improve the FMC-like flavour experience obtained when used in a substance delivery system. That is, one or more of the compounds disclosed herein may be added to a tobacco extract, the tobacco extract optionally already containing one or more of the compounds defined herein. It is also possible to add further compounds to the compositions which may be absent from a tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract. These compounds are discussed further below and termed the ‘smoke markers’. This may, in some examples, further improve the cigarette-like experience provided by the composition of the present disclosure when used in a substance delivery system.Fatty Acids

[0054] In accordance with some aspects of the invention described herein, the fatty acids may be selected from the group comprising of: decanoic acid; dodecanoic acid; tetradecanoic acid; n-hexadecanoic acid; palmitic acid; octadecanoic acid; stearic acid; propanoic acid; lactic acid; butanoic acid, 4-hydroxy-; butanoic acid, 2-methyl-; butanoic acid, 3-methyl-; isovalericacid; valeric acid; tiglic acid; pentanoic acid, 4-oxo-; pentanoic acid, 3-methyl-; pentanoic acid, 4-methyl-; hexanoic acid, 2-methyl-; octanoic acid; pelargonic acid; pentadecanoic acid; linolenic acid; linoleic acid; 13-hydroperoxylinoleic acid (e.g. 13-L-hydroperoxylinoleic acid); elaidic acid; fumaric acid; 2-butenoic acid (e.g. 2-butenoic acid, (E)-).

[0055] In some examples, the C3 to C18 saturated fatty acids may be selected from the group comprising of: decanoic acid; dodecanoic acid; tetradecanoic acid; n-hexadecanoic acid; palmitic acid; octadecanoic acid; stearic acid; propanoic acid; lactic acid; butanoic acid, 4-hydroxy-; butanoic acid, 2-methyl-; butanoic acid, 3-methyl-; isovaleric acid; valeric acid; tiglic acid; pentanoic acid, 4-oxo-; pentanoic acid, 3-methyl-; pentanoic acid, 4-methyl-; hexanoic acid, 2-methyl-; octanoic acid; pelargonic acid. In some examples, the C14 to C18 saturated fatty acids may be selected from the group comprising of: tetradecanoic acid; n-hexadecanoic acid; palmitic acid; octadecanoic acid; stearic acid.

[0056] In some examples, the C3 to C18 saturated fatty acids may be selected from the group comprising of: isovaleric acid; valeric acid; lactic acid; 2-methylvaleric acid; butyric acid; isobutyric acid; 2-methyl butyric acid; levulinic acid; 3-methyl pentanoic acid; and heptanoic acid.

[0057] In some examples, the C3 to C18 unsaturated fatty acids may be selected from the group comprising of: pentadecanoic acid; linolenic acid; linoleic acid; 13-hydroperoxylinoleic acid; elaidic acid; 2-butenoic acid. In some examples, the C16 to C20 unsaturated fatty acids may be selected from the group comprising of: linolenic acid; linoleic acid; 13-hydroperoxylinoleic acid; elaidic acid.

[0058] In some examples, the composition comprises a combination of fatty acids consisting of three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid. In some examples, the composition comprises a combination of fatty acids consisting of three C3 to C18 unsaturated fatty acids and nine C3 to C18 saturated fatty acids.

[0059] In some examples, the composition comprises no more than four unsaturated fatty acids.

[0060] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid; 3-methylvaleric acid; and linolenic acid.

[0061] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid, valeric acid and linolenic acid.

[0062] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid.

[0063] In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid.

[0064] In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid.

[0065] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid.

[0066] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; linolenic acid; palmitic acid; pelargonic acid; pentadecanoic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid.

[0067] In some examples, one or more fatty acid may be independently present in an amount of about 0.1 pg / g to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 10% w / w for the composition, means that each fatty acid may be present in the consumable from about 0.00001 wt% to about 0.05 wt%, based on the total weight of the consumable.

[0068] In some examples, one or more fatty acid may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 140 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 120 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 100pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 80 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 60 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 40 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 20 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 10 pg / g. In some examples, one or more fatty acid may be independently present in an amount of from about 1 to about 5 pg / g.

[0069] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 140 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 120 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 100 pg / g.

[0070] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 100 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 80 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 60 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 40 pg / g.

[0071] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 140 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 120 pg / g. n some examples, thecomposition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 100 pg / g.

[0072] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 80 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 60 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 40 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 20 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 10 pg / g.

[0073] In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 140 pg / g.In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 120 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of palmitic acid and linolenic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 100 pg / g.

[0074] In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 140 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 120 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 100 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 80 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid,palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 60 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of valeric acid, linolenic acid, palmitic acid and 3-methylvaleric acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 40 pg / g.

[0075] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 180 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 160 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; valeric acid; linolenic acid; palmitic acid; pentadecanoic acid; stearic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 140 pg / g.

[0076] In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; linolenic acid; palmitic acid; pelargonic acid; pentadecanoic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.1 to about 400 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; linolenic acid; palmitic acid; pelargonic acid; pentadecanoic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 0.5 to about 300 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; linolenic acid; palmitic acid; pelargonic acid; pentadecanoic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 250 pg / g. In some examples, the composition comprises a combination of fatty acids consisting of butanoic acid, 2-methyl-; 3-methylvaleric acid; linolenic acid; palmitic acid; pelargonic acid; pentadecanoic acid; tetradecanoic acid; butanoic acid, 4-hydroxy-; lactic acid; n-hexadecanoic acid; octadecanoic acid; and elaidic acid, where one or more of the fatty acids may be independently present in an amount of from about 1 to about 200 pg / g.

[0077] In some examples, the total amount of the fatty acids (either saturated and / or unsaturated fatty acids) may be about 10 to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.001 wt% to about 0.05 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable.

[0078] In some examples, the total amount of fatty acid is from about 10 pg / g to about 5000 pg / g. In some examples, the total amount of fatty acid is from about 10 pg / g to about 4000 pg / g. In some examples, the total amount of fatty acid is from about 10 pg / g to about 3000 pg / g. In some examples, the total amount of fatty acid is from about 10 pg / g to about 2000 pg / g. In some examples, the total amount of fatty acid is from about 10 pg / g to about 1000 pg / g. In some examples, the total amount of fatty acid is from about 10 pg / g to about 500 pg / g.

[0079] In some examples, the total amount of saturated fatty acid is from about 1 pg / g to about 3000 pg / g. In some examples, the total amount of saturated fatty acid is from about 1pg / g to about 2000 pg / g. In some examples, the total amount of saturated fatty acid is from about 1 pg / g to about 1000 pg / g. In some examples, the total amount of saturated fatty acid is from about 1 pg / g to about 500 pg / g. In some examples, the total amount of saturated fatty acid is from about 5 pg / g to about 500 pg / g. In some examples, the total amount of saturated fatty acid is from about 10 pg / g to about 500 pg / g.

[0080] In some examples, the total amount of fatty unsaturated fatty acid is from about 1 pg / g to about 3000 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 1 pg / g to about 2000 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 1 pg / g to about 1000 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 1 pg / g to about 500 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 1 pg / g to about 400 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 5 pg / g to about 300 pg / g. In some examples, the total amount of unsaturated fatty acid is from about 10 pg / g to about 200 pg / g.

[0081] In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 2.0: 1.0 to about 1.0:2.5. In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 1.0: 1.0 to about 1.0:2.2. In some examples, the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 1.0: 1.7 to about 1.0 to 2.2.

[0082] In some examples, the weight ratio of the acetic acid to C7 to C24 aromatic carboxylic acids, if both present in the composition, is of from about 2.0:1.0 to about 5.0:1.0. In some examples, the weight ratio of the acetic acid to unsaturated fatty acids, if both present in the composition, is of from about 2.0:1.0 to about 0.8:1.0.

[0083] In some examples, the weight ratio of the acetic acid to saturated fatty acids, if both present in the composition, is of from about 1.0: 1.0 to about 1.0:2.5.

[0084] In some examples, the weight ratio of the C7 to C24 aromatic carboxylic acids to unsaturated fatty acids, if both present in the composition, is of from about 1.0: 1.0 to about 1.0:4.0.

[0085] In some examples, the weight ratio of the C7 to C24 aromatic carboxylic acids to saturated fatty acids, if both present in the composition, is of from about 1.0:2.0 to about 1.0:8.0.

[0086] In some examples, the composition has a pH of about 4 to about 7. In some examples, the composition has a pH of about 4 to about 6.5. In some examples, the composition has apH of about 4 to about 6. In some examples, the composition has a pH of about 4 to about 5.5. In some examples, the composition has a pH of about 4 to about 5.

[0087] In some examples, the each C5 to C24 fatty acid has a molecular weight from about 100 g / mol to about 300 g / mol.Additional CompoundsSubstituted Pyrazines and Pyridines

[0088] The composition of the present disclosure includes at least one compound selected from C6 to C18 substituted pyrazines and C6 to C18 substituted pyridines. The carbon atom range “C6 to C18” refers to the compound as a whole, i.e. the substituted pyrazine / pyridine. The substituents of the pyrazine or pyridine moiety are not typically limited. In some examples, the C6 to C18 substituted pyrazines and C6 to C18 substituted pyridines are defined by their molecular weight; the molecular weight of each C6 to C18 substituted pyrazine may be from about 90 g / mol to about 150 g / mol; the molecular weight of each C6 to C18 substituted pyridine may be from about 100 g / mol to about 200 g / mol.

[0089] In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, aryl groups, hydroxyl groups, carboxyl groups, alkoxy groups, sulfhydryl groups, thionyl groups, sulfide groups, and combinations thereof. In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, carboxyl groups (e.g. ketones), hydroxyl groups, alkoxy groups, sulfhydryl groups, and combinations thereof. In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, carboxyl groups (e.g. ketones), alkoxy groups, sulfhydryl groups, and combinations thereof.

[0090] In some examples, the composition includes at least one C6 to C18 substituted pyrazine, wherein the substituents are selected from alkyl groups, alkenyl groups, carboxyl groups (e.g. ketones), alkoxy groups, hydroxyl groups, sulfhydryl groups, and combinations thereof. The alkyl groups are preferably C1 to C6 alkyl groups; the alkenyl groups are preferably C2 to C6 alkenyl groups; and the carboxyl groups are preferably ketones or aldehydes such as C2 to C6 ketones. In some examples, the composition includes at least one C6 to C18 substituted pyrazine, wherein the substituents are selected from alkyl groups, alkenyl groups, and combinations thereof.

[0091] In some examples, the composition includes at least one C6 to C18 substituted pyrazine selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g. 2,3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2,6-dimethyl pyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof.

[0092] In some examples, the composition includes at least two C6 to C18 substituted pyrazines selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g. 2,3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2,6-dimethyl pyrazine; 2-ethylpyrazine; 2-ethenylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2-methyl-3-butyl-pyrazine; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof.

[0093] In some examples, the composition includes at least two C6 to C18 substituted pyrazines selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g. 2,3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2,6-dimethyl pyrazine; 2-ethylpyrazine; 2-ethenylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0094] In some examples, the composition includes at least one C6 to C18 substituted pyrazine selected from 2,3,5-trimethylpyrazine; pyrazine, 2,6-diethyl-;2,3,5,6-tetramethylpyrazine; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0095] In some examples, the composition includes at least two C6 to C18 substituted pyrazines selected from 2,3,5-trimethylpyrazine; pyrazine, 2,6-diethyl-;2,3,5,6-tetramethylpyrazine; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0096] In some examples, the composition includes at least two C6 to C18 substituted pyrazines selected from 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0097] In some examples, the at least one C6 to C18 substituted pyrazine is a methylpyrazine or dimethylpyrazine, e.g. 2-methylpyrazine or 2,5-dimethylpyrazine, or an ethenylpyrazine (e.g. 2-ethenylpyrazine). In some examples, the composition comprises a methyl-pyrazine (e.g. 2-methylpyrazine) or dimethylpyrazine or an ethenylpyrazine, and at least one additional C6 to C18 substituted pyrazine selected from 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0098] In some examples, the composition comprises a methyl-pyrazine (e.g. 2-methylpyrazine), and at least one additional C6 to C18 substituted pyrazine selected from 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; 2-ethyl-6-methylpyrazine; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.

[0099] In some examples, the composition comprises a methyl-pyrazine (e.g. 2-methylpyrazine), and at least one additional C6 to C18 substituted pyrazine selected from 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2,6-dimethylpyrazine; and combinations thereof.[000100] In some examples the composition comprises a dimethyl-pyrazine, and at least one additional C6 to C18 substituted pyrazine selected from 2-ethylpyrazine; 2-ethyl-6-methylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.[000101] In some examples, the composition comprises an ethenyl-pyrazine, and at least one additional C6 to C18 substituted pyrazine selected from 2-ethylpyrazine; 2-ethyl-6-methylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.[000102] In some examples, each C6 to C18 substituted pyrazine is present in the composition an amount from about 0.1 pg / g to about 250 pg / g. In some examples, each C6 to C18 substituted pyrazine is present in the composition in an amount from about 0.1 pg / g to about 50 pg / g. In some examples, each C6 to C18 substituted pyrazine is present in the composition in an amount from about 0.1 pg / g to about 25 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w for the composition, the amount of each C6 to C18 substituted pyrazine maybe about 0.0000005 wt% to about 0.00125 wt%, about 0.0000005 wt% to about 0.00025 wt%, or about 0.0000005 wt% to about 0.000125 wt%, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.0000008 wt% to about 0.002 wt%, about 0.0000008 wt% to about 0.0004 wt%, or about 0.0000008 wt% to about 0.0002 wt%, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.000001 wt% to about 0.0025 wt%, about 0.000001 wt% to about 0.0005 wt%, or about 0.000001 wt% to about 0.00025 wt%, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.0000015 wt% to about 0.00375 wt%, about 0.0000015 wt% to about 0.00075 wt%, or about 0.0000015 wt% to about 0.000375 wt%, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.000002 wt% to about 0.005 wt%, about 0.000002 wt% to about 0.001 wt%, or about 0.000002 wt% to about 0.0005 wt%, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.0000025 wt% to about 0.00625 wt%, about 0.0000025 wt% to about 0.00125 wt%, or about 0.000001 wt% to about 0.000625 wt%, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w for the composition, the amount of each C6 to C18 substituted pyrazine may be about 0.000003 wt% to about 0.0075 wt%, about 0.000003 wt% to about 0.0015 wt%, or about 0.000003 wt% to about 0.00075 wt%, based on the total weight of the consumable.[000103] In some examples, the total amount of C6 to C18 substituted pyrazine in the composition is from about 1 pg / g to about 350 pg / g. In some examples, the total amount of C6 to C18 substituted pyrazine in the composition is from about 1 pg / g to about 100 pg / g. In some examples, the total amount of C6 to C18 substituted pyrazine in the composition is from about 5 pg / g to about 50 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly relative to the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.000005 wt% to about 0.00175 wt%, about 0.000005 wt% to about 0.0005 wt%, or about 0.000025 wt% to about 0.00025 wt%, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.000008 wt% to about 0.0028 wt%, about 0.000008 wt% to about 0.0008 wt%, or about 0.00004 wt% to about 0.0004 wt%, based on the total weight of theconsumable. For example, at an inclusion level of 10% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.00001 wt% to about 0.0035 wt%, about 0.00001 wt% to about 0.001 wt%, or about 0.00005 wt% to about 0.0005 wt%, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.000015 wt% to about 0.00525 wt%, about 0.000015 wt% to about 0.0015 wt%, or about 0.000075 wt% to about 0.00075 wt%, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.000025 wt% to about 0.00875 wt%, about 0.000025 wt% to about 0.0025 wt%, or about 0.000125 wt% to about 0.00125 wt%, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w for the composition, the total amount of C6 to C18 substituted pyrazine may be about 0.00003 wt% to about 0.0105 wt%, about 0.00003 wt% to about 0.003 wt%, or about 0.00015 wt% to about 0.0015 wt%, based on the total weight of the consumable.[000104] In some examples, the composition of the present disclosure includes a C6 to C18 substituted pyridine which is an alkaloid and at least one, preferably at least two, C6 to C18 substituted pyrazines as defined above. In some examples, the composition of the present disclosure includes a C6 to C18 substituted pyridine selected from nicotine, myosmine, cotinine, and combinations thereof, and at least one, preferably at least two, C6 to C18 substituted pyrazines as defined above. In some examples, the composition of the present disclosure includes nicotine and / or cotinine, and at least one, preferably at least two, C6 to C18 substituted pyrazines as defined above.[000105] In some examples, the composition includes a C6 to C18 substituted pyridine which is an alkaloid, and at least one C6 to C18 substituted pyrazine selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g.2,3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof. In preferred examples, the at least one C6 to C18 substituted pyrazine is selected from 2,3,5-trimethylpyrazine; pyrazine, 2,6-diethyl-;2,3,5,6-tetramethylpyrazine; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof. In particularly preferred examples, the at least one C6 to C18 substitutedpyrazine is selected from pyrazine, 2,6-diethyl-; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; 2-ethyl-6-methylpyrazine; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.[000106] In some examples, the composition includes a C6 to C18 substituted pyridine which is an alkaloid, and at least two C6 to C18 substituted pyrazines selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g.2,3,5,6-tetramethylpyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine;, 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof. In preferred examples, the at least two C6 to C18 substituted pyrazines are selected from 2,3,5-trimethylpyrazine; pyrazine, 2,6-diethyl-;2,3,5,6-tetramethylpyrazine; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof. In particularly preferred examples, the at least two C6 to C18 substituted pyrazines are selected from pyrazine, 2,6-diethyl-; 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; 2-ethyl-6-methylpyrazine; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof.[000107] In examples where the C6 to C18 substituted pyridine is an alkaloid, each alkaloid may be present in the composition in an amount of from about 1 pg / g to about 5000 pg / g. In some examples, each alkaloid may be present in the composition in an amount of 1 pg / g to about 4000 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may comprise from about 0.000005 wt% to about 0.025 wt% of each alkaloid. For example, at an inclusion level of 8% w / w of the composition, the consumable may comprise from about 0.000008 wt% to about 0.04 wt% of each alkaloid. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise from about 0.00001 wt% to about 0.05 wt% of each alkaloid. For example, at an inclusion level of 15% w / w of the composition, the consumable may comprise from about 0.000015 wt% to about 0.075 wt% of each alkaloid. For example, at an inclusion level of 20% w / w of the composition, the consumable may comprise from about 0.00002 wt% to about 0.1 wt% of eachalkaloid. For example, at an inclusion level of 25% w / w of the composition, the consumable may comprise from about 0.000025 wt% to about 0.125 wt% of each alkaloid. For example, at an inclusion level of 30% w / w of the composition, the consumable may comprise from about 0.00003 wt% to about 0.15 wt% of each alkaloid.[000108] In some examples, the at least one C6 to C18 substituted pyridine comprises substituents selected from alkyl groups, alkenyl groups, aryl groups, hydroxyl groups, carboxyl groups, alkoxy groups, and combinations thereof. In some examples the C6 to C18 substituted pyridine comprises substituents selected from alkyl groups, alkenyl groups, carboxyl groups (e.g. ketones and / or aldehydes), hydroxyl groups, alkoxy groups, and combinations thereof. In some examples the C6 to C18 substituted pyridine comprises substituents selected from alkyl groups, alkenyl groups, carboxyl groups (e.g. ketones or aldehydes), and combinations thereof. The alkyl groups are preferably C1 to C6 alkyl groups; the alkenyl groups are preferably C2 to C6 alkenyl groups; and the carboxyl groups are preferably ketones or aldehydes such as C2 to C6 ketones.[000109] In some examples, the composition comprises at least one C6 to C18 substituted pyridine which is not an alkaloid. In some examples, this at least one C6 to C18 substituted pyridine is selected from: n-phenylpyridine-3-carboxamide; 1-(5-methylpyridin-3-yl)ethanone; thionicotinic acid; 3-(2,3-dihydro-1h-pyrrol-5-yl)pyridine; 3-[1,2,3,6-tetrahydropyridin-2-yl]pyridine; 3-phenylpyridine; 2-(pyridin-2-ylmethyl)pyridine; 3-methyl-2-phenylpyridine; 1-pyridin-3-ylethanone; 2-(3-pyridinyl)-2-pyrroline; and combinations thereof. In some examples, this at least one C6 to C18 substituted pyridine is selected from: n-phenylpyridine-3-carboxamide; 1-(5-methylpyridin-3-yl)ethanone; thionicotinic acid; 3-phenylpyridine; 2-(pyridin-2-ylmethyl)pyridine; 3-methyl-2-phenylpyridine; 2-(3-pyridinyl)-2-pyrroline; ethyl-pyridine; methyl-pyridine; methyl-ethyl-pyridine; ethenyl-pyridine; acetyl pyridine; 2,6-bis(hydroxymethyl)-3-pyridinol; 1 -propanone, 1-(4-methyl-2-pyridinyl)-; pyridinecarboxaldehyde; and combinations thereof.[000110] In some examples, the composition comprises at least one C6 to C18 substituted pyridine selected from n-phenylpyridine-3-carboxamide; 1-(5-methylpyridin-3-yl)ethanone; thionicotinic acid; 3-(2,3-dihydro-1 h-pyrrol-5-yl)pyridine; 3-[(2s)-1 ,2,3,6-tetrahydropyridin-2-yl]pyridine; 3-phenylpyridine; 2-(pyridin-2-ylmethyl)pyridine; 3-methyl-2-phenylpyridine; 1-pyridin-3-ylethanone; 2-(3-pyridinyl)-2-pyrroline; ethyl-pyridine; methyl-pyridine; methyl-ethyl-pyridine; ethenyl-pyridine; acetyl pyridine; 2,6-bis(hydroxymethyl)-3-pyridinol; 1-propanone, 1-(4-methyl-2-pyridinyl)-; pyridinecarboxaldehyde; and combinations thereof; and a C6 to C18 substituted pyridine which is an alkaloid.[000111] When present, each C6 to C18 substituted pyridine which is not an alkaloid may be present in the composition in an amount of from about 0.1 pg / g to about 300 pg / g. In some examples, the total amount of C6 to C18 substituted pyridines which are not alkaloids may be about 1 pg / g to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may comprise from about 0.0000005 wt% to about 0.0015 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.000005 wt% to about 0.0025 wt%, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may comprise from about 0.0000008 wt% to about 0.0024 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.000008 wt% to about 0.004 wt%, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise from about 0.000001 wt% to about 0.003 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.00001 wt% to about 0.005 wt%, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may comprise from about 0.0000015 wt% to about 0.0045 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.000015 wt% to about 0.0075 wt%, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may comprise from about 0.000002 wt% to about 0.006 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.00002 wt% to about 0.01 wt%, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may comprise from about 0.0000025 wt% to about 0.0075 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.000025 wt% to about 0.0125 wt%, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may comprise from about 0.000003 wt% to about 0.009 wt% of each C6 to C18 substituted pyridine which is not an alkaloid, or the total amount of C6 to C18 substituted pyridine which is not alkaloid is about 0.00003 wt% to about 0.015 wt%, based on the total weight of the consumable.C8 to C18 aromatic esters[000112] The composition of the present disclosure includes at least one C8 to C18 aromatic ester. In some examples, the C8 to C18 aromatic esters may be defined by their molecular weight which may be from about 120 g / mol to about 350 g / mol. In some examples, the C8 to C18 aromatic esters may be selected from benzoates, phenylacetates, acetates, cinnamates, phthalates, pentanoates, isovalerates, acetoxytoluenes, anisates, biphenylcarboxlates, and combinations thereof. These ester compounds may include alkyl groups, alkenyl groups, aryl groups, hydroxyls, halo compounds, alkoxy groups, carboxyl groups, ether groups, and combinations thereof.[000113] In some examples, the C8 to C18 aromatic ester may be selected from methyl benzoate, ethyl benzoate, methyl phenylacetate, ethyl phenylacetate, propyl phenylacetate, methyl cinnamate, ethyl cinnamate, isoamyl cinnamate, isobutyl benzoate, methyl 4-fluoro-3-methoxybenzoate, benzyl pentanoate, phenylethyl isovalerate, 2,5-diacetoxytoluene, 2,6-dimethoxyphenylacetate, methyl biphenyl-4-carboxylate, benzyl benzoate, benzyl acetate, isoeugenol acetate, ethyl anisate,, phenethyl phenylacetate, diethylene glycol dibenzoate, cyclohexyl butyl phthalate, 2-hydroxyethyl benzoate; 2-chloroethyl benzoate; dibutyl phthalate; bis(2-ethylhexyl) benzene-1,3-dicarboxylate; Methyl 3,4,5-trihydroxybenzoate; (3-hydroxyphenyl) benzoate; and combinations thereof.In some examples, the C8 to C18 aromatic ester may be selected from methyl benzoate, ethyl phenylacetate, methyl cinnamate, isobutyl benzoate, methyl 4-fluoro-3-methoxybenxoate, benzyl pentanoate, phenylethyl isovalerate, 2,5-diacetoxytoluene, 2,6-dimethoxyphenylacetate, methyl biphenyl-4-carboxylate, benzyl benzoate, phenethyl phenylacetate, diethylene glycol dibenzoate, cyclohexyl butyl phthalate, 2-hydroxyethyl benzoate; 2-chloroethyl benzoate; dibutyl phthalate; bis(2-ethylhexyl) benzene-1,3-dicarboxylate; Methyl 3,4,5-trihydroxybenzoate; (3-hydroxyphenyl) benzoate; and combinations thereof.In some examples, the C8 to C18 aromatic ester may be selected from methyl benzoate, methyl phenylacetate, ethyl phenylacetate, methyl cinnamate, isoamyl cinnamate,, benzyl pentanoate, benzyl benzoate, cyclohexyl butyl phthalate, dibutyl phthalate, bis(2-ethylhexyl)benzene-1,3-dicarboxylate, methyl 3,4,5-trihydroxybenzoate, and combinations thereof.[000114] In some examples, each C8 to C18 aromatic ester may be present in an amount of about 0.1 pg / g to about 20 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjustedaccordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 5% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.0000005 wt% to about 0.0001 wt%, based on the total weight of the consumable. For example, an inclusion level of 8% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.0000008 wt% to about 0.00016 wt%, based on the total weight of the consumable. For example, an inclusion level of 10% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.000001 wt% to about 0.0002 wt%, based on the total weight of the consumable. For example, an inclusion level of 15% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.0000015 wt% to about 0.0003 wt%, based on the total weight of the consumable. For example, an inclusion level of 20% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.000002 wt% to about 0.0004 wt%, based on the total weight of the consumable. For example, an inclusion level of 25% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.0000025 wt% to about 0.0005 wt%, based on the total weight of the consumable. For example, an inclusion level of 30% w / w for the composition, means that each C8 to C18 aromatic ester may be present in the consumable from about 0.000003 wt% to about 0.0006 wt%, based on the total weight of the consumable.[000115] In some examples, the total amount of C8 to C18 aromatic esters may be from about 1 pg / g to about 50 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.000005 wt% to about 0.00025 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.000008 wt% to about 0.0004 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.00001 wt% to about 0.0005 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.000015 wt% to about 0.00075 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.00002 wt% to about 0.001 wt% of C8 to C18 aromatic esters, based on the total weight of theconsumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.000025 wt% to about 0.00125 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.00003 wt% to about 0.0015 wt% of C8 to C18 aromatic esters, based on the total weight of the consumable.Carboxylic Acids and Anhydrides[000116] The composition of the present disclosure includes at least one C2 to C24 carboxylic acid or anhydride thereof. In some examples, the composition of the present disclosure includes at least one C2 to C24 carboxylic acid. In some examples, the at least one C2 to C24 carboxylic acid is defined by its molecular weight: being from about 60 g / mol to about 300 g / mol.[000117] In some examples, the at least one C2 to C24 carboxylic acid includes benzoic acid, acetic acid, phenylacetic acid, (3,4-dimethoxyphenyl) acetic acid, or a combination thereof. In some examples, the at least one C2 to C24 carboxylic acid includes benzoic acid, acetic acid, phenyl acetic acid, or a combination thereof. In some examples, the at least one C2 to C24 carboxylic acid includes acetic acid, phenylacetic acid, or a combination thereof.[000118] In some examples, the at least one C2 to C24 carboxylic acid includes acetic acid, phenylacetic acid, valeric acid, 2-methylvaleric acid, isovaleric acid, valeric acid, lactic acid, 2-methylvaleric acid, butyric acid, isobutyric acid, 2-methylbutyric acid, levulinic acid, 3-methylpentanoic acid, heptanoic acid or a combination thereof.[000119] In some examples, each C2 to C24 carboxylic acid or anhydride thereof is present in an amount of about 0.1 pg / g to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 5% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.0000005 wt% to about 0.0025 wt%, based on the total weight of the consumable. For example, an inclusion level of 8% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.0000008 wt% to about 0.004 wt%, based on the total weight of the consumable. For example, an inclusion level of 10% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.000001 wt% to about 0.005 wt%, based on the total weight of the consumable. For example, an inclusion level of 15% w / w for the composition, means that each C2 to C24 carboxylic acidmay be present in the consumable from about 0.0000015 wt% to about 0.0075 wt%, based on the total weight of the consumable. For example, an inclusion level of 20% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.000002 wt% to about 0.01 wt%, based on the total weight of the consumable. For example, an inclusion level of 25% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.0000025 wt% to about 0.0125 wt%, based on the total weight of the consumable. For example, an inclusion level of 30% w / w for the composition, means that each C2 to C24 carboxylic acid may be present in the consumable from about 0.000003 wt% to about 0.015 wt%, based on the total weight of the consumable.[000120] In some examples, the at least one C2 to C24 carboxylic acid selected from benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof is present in an amount of about 5 pg / g to about 500 pg / g, and the composition further comprises at least one C5 to C24 fatty acid, optionally at least two C5 to C24 fatty acids. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 5% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.000025 wt% to about 0.0025 wt%, based on the total weight of the consumable. For example, an inclusion level of 8% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.00004 wt% to about 0.004 wt%, based on the total weight of the consumable. For example, an inclusion level of 10% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.00005 wt% to about 0.005 wt%, based on the total weight of the consumable. For example, an inclusion level of 15% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.000075 wt% to about 0.0075 wt%, based on the total weight of the consumable. For example, an inclusion level of 20% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.0001 wt% to about 0.01 wt%, based on the total weight of the consumable. For example, an inclusion level of 25% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may be present in the consumable from about 0.000125 wt% to about 0.0125 wt%, based on the total weight of the consumable. For example, an inclusion level of 30% w / w for the composition, means that benzoic acid, acetic acid, phenylacetic acid, and anhydrides thereof may bepresent in the consumable from about 0.00015 wt% to about 0.015 wt%, based on the total weight of the consumable.[000121] When present, each C5 to C24 fatty acid may be present in the composition in an amount of from about 0.1 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.0000005 wt% to about 0.0015 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.0000008 wt% to about 0.0024 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.000001 wt% to about 0.003 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.0000015 wt% to about 0.0045 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.000002 wt% to about 0.006 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.0000025 wt% to about 0.0075 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.000003 wt% to about 0.009 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable.[000122] In some examples, the total amount of C5 to C24 fatty acid may be about 10 to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.00005 wt% to about 0.0025 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00008 wt% to about 0.004 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.0001 wt% to about 0.005 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable.For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.0075 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0002 wt% to about 0.01 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.00025 wt% to about 0.0125 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.0003 wt% to about 0.015 wt% of each C5 to C24 fatty acid, based on the total weight of the consumable.[000123] In some examples, the total amount of C2 to C24 carboxylic acid and anhydrides thereof may be from about 10 pg / g to about 600 pg / g. In such examples, the total amount of C5 to C24 fatty acid may be about 10 pg / g to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.00005 wt% to about 0.003 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.00005 wt% to about 0.0025 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00008 wt% to about 0.0048 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.00008 wt% to about 0.004 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.0001 wt% to about 0.006 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.0001 wt% to about 0.005 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.009 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.00015 wt% to about 0.0075 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0002 wt% to about 0.012 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.0002 wt% to about 0.01 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.00025 wt% to about 0.015 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.00025 wt% to about 0.0125 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may includeabout 0.0003 wt% to about 0.018 wt% of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 0.0003 wt% to about 0.015 wt%, is C5 to C24 fatty acids, based on the total weight of the consumable. For example, the composition may comprise about 50 to about 500 pg / g of C2 to C24 carboxylic acids and anhydrides thereof, wherein about 60 pg / g to about 450 pg / g is C5 to C24 fatty acids.[000124] In some examples, the weight ratio of C2 to C24 carboxylic acids selected from benzoic acid, acetic acid, phenylacetic acid, and combinations thereof, to C5 to C24 fatty acids as defined above is from about 1:10 to 1:1. In some examples, the weight ratio of C2 to C24 carboxylic acids selected from benzoic acid, acetic acid, phenylacetic acid, and combinations thereof, to C5 to C24 fatty acids selected from 2-methylbutanoic acid, 3-methylvaleric acid, pentanoic acid, 3-methyl-, valeric acid, decanoic acid, dodecanoic acid, octanoic acid, pelargonic acid, tetradecanoic acid, pentadecanoic acid, palmitic acid, stearic acid, 9,12,15-octadecatrienoic acid, linolenic acid, elaidic acid, and combinations thereof, is from about 1:10 to 1:1.Preferred Examples of Compound Groups (a) to (c)[000125] In some examples, the composition includes the following compound groups (a) to (c) in combination with (d) at least five additional compounds selected from at least two of the groups (1) to (3) defined herein:(a) at least one C6 to C18 substituted pyrazine, wherein the substituents are selected from C1-6 alkyl groups, C2-6 alkenyl groups, C2-6 ketones, C1-6 alkoxy groups, hydroxyl groups, sulfhydryl groups, and combinations thereof;(b) at least one C8 to C18 aromatic ester selected from benzoates, phenylacetates, acetates, cinnamates, phthalates, pentanoates, isovalerates, acetoxytoluenes, anisates, biphenylcarboxlates, and combinations thereof; and(c) at least one C5 to C24 fatty acid.[000126] In some examples, the composition includes the following compound groups (a) to (c) in combination with (d) at least five additional compounds selected from at least two of the groups (1) to (3) defined herein:(a) at least two C6 to C18 substituted pyrazines selected from: 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; acetyl pyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; 2,6-dimethylpyrazine; 2-ethenyl-pyrazine; 2-methyl-3-butyl-pyrazine; and combinations thereof; and a C6 to C18 substituted pyridine which is an alkaloid;(b) at least one C8 to C18 aromatic ester selected from: methyl benzoate, ethyl benzoate, methyl phenylacetate, ethyl phenylacetate, methyl cinnamate, isoamyl cinnamate benzyl pentanoate, benzyl benzoate, cyclohexyl butyl phthalate, dibutyl phthalate, bis(2-ethylhexyl)benzene-1,3-dicarboxylate, methyl 3,4,5-trihydroxybenzoate, and combinations thereof;(c) at least one C2 to C24 carboxylic acid selected from: benzoic acid, acetic acid, phenylacetic acid, or one or more C5 to C24 fatty acids optionally selected from 2-methylbutanoic acid; 3-methylvaleric acid; Pentanoic acid, 3-methyl-; valeric acid; decanoic acid; dodecanoic acid; octanoic acid; pelargonic acid; tetradecanoic acid; pentadecanoic acid; palmitic acid; stearic acid; octadecatrienoic acid; linolenic acid; elaidic acid; and combinations thereof.[000127] In some examples, the composition includes the following compound groups (a) to (c) in combination with (d) at least five additional compounds selected from at least two of the groups (1) to (3) defined herein):(a) at least one C6 to C18 substituted pyridine selected from n-phenylpyridine-3-carboxamide; 1-(5-methylpyridin-3-yl)ethanone; thionicotinic acid; 3-(2,3-dihydro-1h-pyrrol-5-yl)pyridine; 3-[1,2,3,6-tetrahydropyridin-2-yl]pyridine; 3-phenylpyridine; 2-(pyridin-2-ylmethyl)pyridine; 3-methyl-2-phenylpyridine; 1-pyridin-3-ylethanone; 2-(3-pyridinyl)-2-pyrroline; and combinations thereof; and a C6 to C18 substituted pyridine which is an alkaloid;(b) at least one C8 to C18 aromatic ester selected from: methyl benzoate methyl phenylacetate, ethyl phenylacetate, methyl cinnamate, isoamyl cinnamate, benzyl pentanoate, benzyl benzoate, cyclohexyl butyl phthalate, dibutyl phthalate, bis(2-ethylhexyl)benzene-1,3-dicarboxylate, methyl 3,4,5-trihydroxybenzoate, and combinations thereof.; and(c) at least one C2 to C24 carboxylic acid selected from: benzoic acid, acetic acid, phenylacetic acid, or a combination thereof, and one or more C5 to C24 fatty acids optionally selected from 2-methylbutanoic acid; 3-methylvaleric acid; Pentanoic acid, 3-methyl-; valeric acid; decanoic acid; dodecanoic acid; octanoic acid; pelargonic acid; tetradecanoic acid; pentadecanoic acid; palmitic acid; stearic acid; octadecatrienoic acid; linolenic acid; elaidic acid; and combinations thereof.[000128] In the above examples, the total amount of C6 to C18 substituted pyrazine in the composition may be from about 1 pg / g to about 350 pg / g; the total amount of C6 to C18 substituted pyridine which is not alkaloid may be from about 1 pg / g to about 500 pg / g; the total amount of C8 to C18 aromatic esters may be from about 1 pg / g to about 50 pg / g; and the total amount of C2 to C24 carboxylic acid or anhydrides thereof is from about 10 pg / g to about 600 pg / g-[000129] When included in a consumable, for example at 5% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.000005 wt% to about 0.00175 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.000005 wt% to about 0.0025 wt%; a total amount of C8 to C18 aromatic ester of from about 0.000005 wt% to about 0.00025 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.00005 wt% to about 0.003 wt%; based on the total weight of the consumable.[000130] When included in a consumable, for example at 8% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.000008 wt% to about 0.0028 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.000008 wt% to about 0.004 wt%; a total amount of C8 to C18 aromatic ester of from about 0.000008 wt% to about 0.0004 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.00008 wt% to about 0.0048 wt%; based on the total weight of the consumable.[000131] When included in a consumable, for example at 10% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.00001 wt% to about 0.0035 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.00001 wt% to about 0.005 wt%; a total amount of C8 to C18 aromatic ester of from about 0.00001 wt% to about 0.0005 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.0001 wt% to about 0.006 wt%; based on the total weight of the consumable.[000132] When included in a consumable, for example at 15% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.000015 wt% to about 0.00525 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.000015 wt% to about 0.0075 wt%; a total amount of C8 to C18 aromatic ester of from about 0.000015 wt% to about 0.00075 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.00015 wt% to about 0.009 wt%; based on the total weight of the consumable.[000133] When included in a consumable, for example at 20% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.00002 wt% to about 0.007 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.00002 wt% to about 0.01 wt%; a total amount of C8 to C18 aromatic ester of from about 0.00002 wt% to about 0.001 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.0002 wt% to about 0.012 wt%; based on the total weight of the consumable.[000134] When included in a consumable, for example at 25% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.000025 wt% to about 0.00875 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.000025 wt% to about 0.0125 wt%; a total amount of C8 to C18 aromatic ester of from about 0.000025 wt% to about 0.00125 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.00025 wt% to about 0.015 wt%; based on the total weight of the consumable.[000135] When included in a consumable, for example at 30% w / w, the consumable may therefore include: a total amount of C6 to C18 substituted pyrazine of from about 0.00003 wt% to about 0.0105 wt%; a total amount of C6 to C18 substituted pyridine which is not alkaloid of from about 0.00003 wt% to about 0.015 wt%; a total amount of C8 to C18 aromatic ester of from about 0.00003 wt% to about 0.0015 wt%, based on the total weight of the consumable; and a total amount of C2 to C24 carboxylic acids or anhydrides thereof, of from about 0.0003 wt% to about 0.018 wt%; based on the total weight of the consumable.Additional Compounds[000136] The composition of the present disclosure includes at least five additional compounds selected from at least two of the three groups (1) to (3). In some examples, the composition includes at least ten of the additional compounds. In some examples, the composition includes at least fifteen of the additional compounds.[000137] The additional compounds are selected from at least two of the following groups (1) to (3); for example: groups (1) and (2), (1) and (3), or (2) and (3). In some examples, the composition includes compounds from each of the three groups. The groups are: (1) C7 to C18 aromatic alcohols; (2) C3 to C24 aliphatic esters; and (3) C4 to C18 lactones. In some examples, the composition further includes at least one compound from (4) phenol and C7 to C18 substituted phenols. Each group will now be discussed but the skilled person will understand that the examples presented for each group may be combined according to the above.Group 1: C7 to C18 aromatic alcohols[000138] In some examples, the composition further comprises at least one C7 to C18 aromatic alcohol. The C7 to C18 aromatic alcohol may be defined by its molecular weight being from about 100 g / mol and about 200 g / mol. In some examples, the at least one aromatic alcohol is a C7 to C18 aromatic alcohol, wherein a benzene ring is substituted by one or more alkyl, alkenyl, and hydroxyl groups, or a combination thereof. In some examples, the at least one aromatic alcohol is selected from benzyl alcohol, phenylethanol, phenylmethylcarbinol, 1-phenylpropane-1 ,2-diol, 1-phenyl-2-butanol, Benzenemethanol, a-dimethyl-, 4-hydroxybenzyl alcohol, Vanillyl alcohol, cinnamyl alcohol, and combinations thereof. In some examples, the at least one aromatic alcohol includes phenylethanol.[000139] In some examples, each C7 to C18 aromatic alcohol is present in the composition in an amount of from about 0.5 pg / g to about 100 pg / g. In some examples, each C7 to C18 aromatic alcohol is present in an amount of from about 0.5 pg / g to about 75 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.0000025 wt% to about 0.0005 wt%, or about 0.0000025 wt% to about 0.000375 wt%, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.000004 wt% to about 0.0008 wt%, or about 0.000004 wt% to about 0.0006 wt%, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.000005 wt% to about 0.001 wt%, or about 0.000005 wt% to about 0.00075 wt%, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.0000075 wt% to about 0.0015 wt%, or about 0.0000075 wt% to about 0.001125 wt%, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.00001 wt% to about 0.002 wt%, or about 0.00001 wt% to about 0.0015 wt%, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.0000125 wt% to about 0.0025 wt%, or about 0.0000125 wt% to about 0.001875 wt%, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, each C7 to C18 aromatic alcohol may be present in the consumable in an amount of about 0.000015 wt% to about 0.003 wt%, or about 0.000015 wt% to about 0.00225 wt%, based on the total weight of the consumable.[000140] In some examples, the total amount of C7 to C18 aromatic alcohol is from about 0.5 pg / g to about 100 pg / g. In some examples, the total amount of C7 to C18 aromatic alcohol is from about 0.5 pg / g to about 75 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will beadjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the total amount of 07 to C18 aromatic alcohol in the consumable may be about 0.0000025 wt% to about 0.0005 wt%, or about 0.0000025 wt% to about 0.000375 wt%, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the total amount of 07 to C18 aromatic alcohol in the consumable may be about 0.000004 wt% to about 0.0008 wt%, or about 0.000004 wt% to about 0.0006 wt%, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the total amount of 07 to C18 aromatic alcohol in the consumable may be about 0.000005 wt% to about 0.001 wt%, or about 0.000005 wt% to about 0.00075 wt%, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the total amount of 07 to C18 aromatic alcohol in the consumable may be about 0.0000075 wt% to about 0.0015 wt%, or about 0.0000075 wt% to about 0.001125 wt%, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the total amount of C7 to C18 aromatic alcohol in the consumable may be about 0.00001 wt% to about 0.002 wt%, or about 0.00001 wt% to about 0.0015 wt%, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the total amount of C7 to C18 aromatic alcohol in the consumable may be about 0.0000125 wt% to about 0.0025 wt%, or about 0.0000125 wt% to about 0.001875 wt%, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the total amount of C7 to C18 aromatic alcohol in the consumable may be about 0.000015 wt% to about 0.003 wt%, or about 0.000015 wt% to about 0.00225 wt%, based on the total weight of the consumable.Group (2): C3 to C24 aliphatic esters[000141] In some examples, the additional compounds include one or more C3 to C24 aliphatic esters. The one or more C3 to C24 aliphatic ester, which may be a fatty acid ester, may be defined by its molecular weight which may be from about 100 g / mol to about 350 g / mol.[000142] The C3 to C24 aliphatic esters may be fatty acid esters such as butyrates, hexanoates, octanoates, decanoates, laurates, tetradecanoates, palmitates, pentadecanoates, linoleates, linolenates, stearates, or a docosahexanoic acid ester. In some examples, the one or more C3 to C24 aliphatic ester may be selected from ethyl butyrate, methyl butyrate, methyl hexanoate, ethyl hexanoate, methyl octanoate, ethyl octanoate, methyl decanoate, ethyl decanoate, methyl laurate, ethyl laurate, methyl tetradecanoate, ethyl tetradecanoate, methyl palmitate, ethyl pentadecanoate, ethyl palmitate, methyl linoleate, ethyl linolenate, ethyl linoleate, ethyl stearate, methyl linolenate, docosahexanoic acid methyl ester,and combinations thereof. In some examples, the additional compounds therefore include one or more C3 to C24 aliphatic esters which are fatty acid esters.[000143] In some examples, each C3 to C24 aliphatic ester, which is preferably a fatty acid ester, may be present in an amount of about 0.5 pg / g to about 150 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 5% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.0000025 wt% to about 0.00075 wt%, based on the total weight of the consumable. For example, an inclusion level of 8% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.000004 wt% to about 0.0012 wt%, based on the total weight of the consumable. For example, an inclusion level of 10% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.000005 wt% to about 0.0015 wt%, based on the total weight of the consumable. For example, an inclusion level of 15% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.0000075 wt% to about 0.00225 wt%, based on the total weight of the consumable. For example, an inclusion level of 20% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.00001 wt% to about 0.003 wt%, based on the total weight of the consumable. For example, an inclusion level of 25% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.0000125 wt% to about 0.00375 wt%, based on the total weight of the consumable. For example, an inclusion level of 30% w / w for the composition, means that each C3 to C24 aliphatic ester may be present in the consumable from about 0.000015 wt% to about 0.0045 wt%, based on the total weight of the consumable.[000144] In some examples, the total amount of C3 to C24 aliphatic esters, which are preferably fatty acid esters, may be from about 15 pg / g to about 300 pg / g. In preferred examples, the total amount of C3 to C24 fatty acid esters may be about 20 pg / g to about 250 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.000075 wt% to about 0.0015 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumablemay comprise about 0.0001 wt% to about 0.00125 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00012 wt% to about 0.0024 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.00016 wt% to about 0.002 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.003 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.0002 wt% to about 0.0025 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.000225 wt% to about 0.0045 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.0003 wt% to about 0.00375 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0003 wt% to about 0.006 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.0004 wt% to about 0.005 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.000375 wt% to about 0.0075 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.0005 wt% to about 0.00625 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.00045 wt% to about 0.009 wt% of C3 to C24 aliphatic esters, based on the total weight of the consumable. In preferred examples, the consumable may comprise about 0.0006 wt% to about 0.0075 wt% of C3 to C24 fatty acid esters; the fatty acid esters may be as defined above.[000145] In some examples, the weight ratio of C3 to C24 aliphatic esters to C8 to C18 aromatic esters is from about 1:10 to about 60:1. In some examples, the weight ratio of C3 to C24 aliphatic esters to C8 to C18 aromatic esters is from about 1:10 to about 1:1 or from about 5:1 to about 60:1.[000146] In some examples, the weight ratio of C3 to C24 aliphatic esters which are fatty acid esters to C5 to C24 fatty acids is about 1:20 to about 2:1. In some examples, the weight ratio of C3 to C24 fatty acid esters to C5 to C24 fatty acids is about 1:20 to about 1:5. In other examples, the weight ratio of C3 to C24 fatty acid esters to C5 to C24 fatty acids is from about 1:1 to about2:1.Group 3: C4 to C18 Lactones[000147] In some examples, the additional compounds include at least one 04 to C18 lactone. The at least one 04 to 018 lactone may be defined by its molecular weight being from about 80 g / mol to about 350 g / mol.[000148] In some examples, the at least one 04 to 018 lactone is selected from gammalactones, delta-lactones, coumarins, pyranones, furanones, carotenoid or terpenoid lactones, furanocoumarins, furocoumarins, and unsaturated lactones. In some examples, the at least one 04 to 018 lactone is selected from valerolactone, undecan-4-olide, dihydroactinidiolide, delta-Decalactone, sclareolide, butyrolactone, but-2-en-4-olide, caprolactone, dl-pantolactone, gamma-octanoic lactone, gamma-nonalactone, alpha-levantanolide, 6-pentyloxan-2-one, gamma-decanolactone, (2,6,6-trimethyl-2-hydroxycyclohexylidene)acetic acid lactone, dodecalactone, loliolide, 5-methoxypsoralen, 6-methoxyfuro[2,3-h]chromen-2-one, maltol (3-Hydroxy-2-methyl-4H-pyran-4-one), 2,3-dihydro-3,5-dihydroxy-6-methyl-4(h)-pyran-4-one, ethyl maltol (2-Ethyl-3-hydroxy-4H-pyran-4-one), 3,4-dihydroisocoumarin, coumarin, 3,4-dihydrocoumarin, 6-methylcoumarin, 6-hydroxy-4-methylcoumarin, 7-hydroxycoumarin, 7-ethoxycoumarin, scopoletin, esculetin, 3-amino-4,7-dihydroxycoumarin, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, pantolactone, and combinations thereof.[000149] In some examples, the additional compounds comprise at least two 04 to C18 lactones, the 04 to 018 lactones being as defined above. In some examples, the at least two 04 to 018 lactones include an a,b-unsaturated lactone optionally selected from: (2, 6,6,6-trimethyl-2-hydroxycyclohexylylidene)acetic acid lactone, but-2-en-4-olide, dihydroactinidiolide, loliolide, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, 5-methoxypsoralen, coumarin, 6-methylcoumarin, 6-hydroxy-4-methylcoumarin, 7-ethoxycoumarin, 7-hydroxycoumarin, esculetin, 3-amino-4,7-dihydroxycoumarin, and scopoletin. In some examples, the at least two 04 to 018 lactones include scopoletin.[000150] In some examples, the at least two 04 to 018 lactones include butyrolactone. In some examples, the at least two 04 to 018 lactones include ethyl maltol. In some examples, the additional compounds include (2,6,6,6-trimethyl-2-hydroxycyclohexylylidene)acetic acid lactone, butyrolactone, scopoletin, and optionally ethyl maltol.[000151] In some examples, the 04 to 018 lactone includes a 04 to 018 alkyl lactone. The 04 to 018 alkyl lactone may be selected from valerolactone, un-decan-4-olide, butyrolactone, caprolactone, gamma-octanoic lactone, gamma-nonalactone, 6-pentyloxan-2-one, delta-decalactone, gamma-decanolactone, dodecalactone, and combinations thereof.[000152] In some examples the C4 to C18 lactone includes a C4 to C18 alkyl lactone as defined above and further includes ethyl maltol.[000153] In some examples, each C4 to C18 lactone is present in an amount of about 1 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, an inclusion level of 5% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.000005 wt% to about 0.0015 wt%, based on the total weight of the consumable. For example, an inclusion level of 8% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.000008 wt% to about 0.0024 wt%, based on the total weight of the consumable. For example, an inclusion level of 10% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.00001 wt% to about 0.003 wt%, based on the total weight of the consumable. For example, an inclusion level of 15% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.000015 wt% to about 0.0045 wt%, based on the total weight of the consumable. For example, an inclusion level of 20% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.00002 wt% to about 0.006 wt%, based on the total weight of the consumable. For example, an inclusion level of 25% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.000025 wt% to about 0.0075 wt%, based on the total weight of the consumable. For example, an inclusion level of 30% w / w for the composition, means that each C4 to C18 lactone may be present in the consumable from about 0.00003 wt% to about 0.009 wt%, based on the total weight of the consumable.[000154] In some examples, the total amount of C4 to C18 lactones may be from about 10 pg / g to about 500 pg / g. For example, when the C4 to C18 lactones include a C4 to C18 alkyl lactone as defined above. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.00005 wt% to about 0.0025 wt% of C4 to C18 lactones. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00008 wt% to about 0.004 wt% of C4 to C18 lactones. For example, at an inclusion level of 10% w / w of the composition, the consumable may includeabout 0.0001 wt% to about 0.005 wt% of C4 to C18 lactones. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.0075 wt% of C4 to C18 lactones. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0002 wt% to about 0.01 wt% of C4 to C18 lactones. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.00025 wt% to about 0.0125 wt% of C4 to C18 lactones. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.0003 wt% to about 0.015 wt% of C4 to C18 lactones.[000155] In other examples, the total amount of ethyl maltol may be about 1 pg / g to about 200 pg / g in the composition. For example, when the C4 to C18 lactone includes a C4 to C18 alkyl lactone as defined above and further includes ethyl maltol. At an inclusion level of 5% w / w of the composition, the consumable may therefore include about 0.00005 wt% to about 0.0025 wt% of C4 to C18 lactones, wherein about 0.000005 wt% to about 0.001 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 8% w / w of the composition, the consumable may therefore include about 0.00008 wt% to about 0.004 wt% of C4 to C18 lactones, wherein about 0.000008 wt% to about 0.0016 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 10% w / w of the composition, the consumable may therefore include about 0.0001 wt% to about 0.005 wt% of C4 to C18 lactones, wherein about 0.00001 wt% to about 0.002 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 15% w / w of the composition, the consumable may therefore include about 0.00015 wt% to about 0.0075 wt% of C4 to C18 lactones, wherein about 0.000015 wt% to about 0.003 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 20% w / w of the composition, the consumable may therefore include about 0.0002 wt% to about 0.01 wt% of C4 to C18 lactones, wherein about 0.00002 wt% to about 0.004 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 25% w / w of the composition, the consumable may therefore include about 0.00025 wt% to about 0.0125 wt% of C4 to C18 lactones, wherein about 0.000025 wt% to about 0.005 wt% is ethyl maltol, based on the total weight of the consumable. At an inclusion level of 30% w / w of the composition, the consumable may therefore include about 0.0003 wt% to about 0.015 wt% of C4 to C18 lactones, wherein about 0.00003 wt% to about 0.006 wt% is ethyl maltol, based on the total weight of the consumable.Group (4): Phenol and C7 to C18 Substituted Phenols[000156] In some examples, the additional compounds may further include phenol or the composition may be substantially free or free of phenol.[000157] In some examples, the additional compounds include at least one C7 to C18 substituted phenol. The at least one C7 to C18 substituted phenol may be defined by its molecular weight being from about 100 g / mol to about 250 g / mol.[000158] The C7 to C18 substituted phenols include one or more substituents which may be selected from alkyls, alkenyls, alkoxy groups, pyrrolidine, phenyls, acetals, hydroxyl groups (i.e. more than one hydroxyl group may be present), carboxyls (e.g. ketones, aldehydes, esters), and halogens (e.g. fluorine). In some examples, the C7 to C18 substituted phenol includes one or more substituents selected from alkyl groups, alkenyl groups, acetals, phenyls, alkoxy groups, esters, ketones, aldehydes, pyrrolidine, fluorine, and combinations thereof. In some examples, the C7 to C18 substituted phenol includes one or more substituents selected from alkyl groups, alkenyl groups, alkoxy groups, and combinations thereof. As noted above, aromatic aldehydes / acetals may simultaneously be C7 to C18 substituted phenols but if classified under one compound group, the skilled person will understand that the compound will not simultaneously be classified under another compound group. For example, if ethyl vanillin is considered an aromatic aldehyde and a C7 to C18 aromatic alcohol is present, then the composition will include another compound, e.g. 2,4-di-tert-butylphenol, as the C7 to C18 substituted phenol.[000159] In some examples, the composition is substantially free of polyphenols.[000160] In some examples, the composition further comprises a C7 to C18 substituted monophenol. The substituents are as defined above.[000161] In some examples, the at least one C7 to C18 substituted phenol is guiacol, syringol, or a derivative thereof. The term “derivative” being understood to refer to one or more additional substituents selected from the definition above.[000162] In some examples, the composition includes at least one C7 to C18 substituted phenol selected from: 2-methoxyphenol, 2-pyrrolidin-1 -ylphenol, 2,3-dimethoxyphenol, 3-cyclohexylphenol, 4-ethyl-2-methoxyphenol, 4-(2-hydroxyethyl)-2-methoxyphenol, 2,6-dimethoxy-4-methylphenol, biphenyl-2-ol, 4-Ethyl-2,6-dimethoxyphenol, 4-allyl-2,6-dimethoxyphenol, 2,4-di-tert-butylphenol, 2,6-dicyclohexylphenol, 2,6-di-tert-butyl-4-methylphenol, 2-ethoxy-5-(1-propenyl)phenol, 2-methoxy-4-(4-methyl-1 ,3-dioxolan-2-yl)phenol, 2,4-dihydroxy-6-methylbenzaldehyde, 4-Hydroxy-3-methoxybenzaldehyde, Methyl 3,4,5-trihydroxybenzoate, (3-hydroxyphenyl) benzoate, 1-(2-Hydroxy-4-methoxyphenyl)ethan-1-one, 1-(2,3-dihydroxy-4-methoxyphenyl)ethanone, 1-(4-Hydroxy-3,5-dimethoxyphenyl)ethan-1-one, 1-(2-hydroxy-4,5-dimethoxyphenyl)ethanone, coniferyl aldehyde, 1-(4-hydroxy-3-methoxyphenyl)propan-2-one, 2-hydroxy-4-methoxybenzaldehyde,ethyl vanillin, 2-fluoro-3-hydroxy-4-methoxybenzaldehyde, 1-(2-hydroxy-3-phenylphenyl)ethanone (2-hydroxy-3-phenylacetophenone), ethyl 4-hydroxy-3-methoxybenzoate, 4'-hydroxyacetophenone, p-cresol, 2,4-dimethylphenol, 3,4-dimethylphenol, 3,5-dimethylphenol, 2-ethylphenol, 4-ethylphenol, 2,6-dimethoxyphenol, 1-(2-hydroxy-5-methylphenyl)ethenone, 5-ethenyl-2-methoxy-phenol, and combinations thereof.[000163] In some examples, the composition includes at least one C7 to C18 substituted phenol selected from: 2-methoxyphenol, 2,3-dimethoxyphenol, 2,4-di-tert-butylphenol, 2-ethoxy-5-(1-propenyl)phenol, 2-methoxy-4-(4-methyl-1 ,3-dioxolan-2-yl)phenol, 4-Hydroxy-3-methoxybenzaldehyde, Methyl 3,4,5-trihydroxybenzoate, 2-hydroxy-4-methoxybenzaldehyde, ethyl vanillin, 4'-hydroxyacetophenone, and combinations thereof. In some examples, the composition includes at least one C7 to C18 substituted phenol selected from: 2-methoxyphenol, 2,3-dimethoxyphenol, 2,4-di-tert-butylphenol, 2-ethoxy-5-(1-propenyl)phenol, p-cresol, 2,4-dimethylphenol, 3,4-dimethylphenol, 3,5-dimethylphenol, 2-ethylphenol, 4-ethylphenol, 2,6-dimethoxyphenol, 1-(2-hydroxy-5-methylphenyl)ethenone, 5-ethenyl-2-methoxy-phenol, and combinations thereof.[000164] In some examples, each C7 to C18 substituted phenol is present in an amount of from about 0.1 pg / g to about 600 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.0000005 wt% to about 0.003 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.0000008 wt% to about 0.0048 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.000001 wt% to about 0.006 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.0000015 wt% to about 0.009 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.000002 wt% to about 0.012 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.0000025 wt% to about 0.015 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumablemay include about 0.000003 wt% to about 0.018 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable.[000165] In some examples, each C7 to C18 substituted phenol is present in an amount of from 0.1 pg / g to about 100 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.0000005 wt% to about 0.0005 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.0000008 wt% to about 0.0008 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.000001 wt% to about 0.001 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.0000015 wt% to about 0.0015 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.000002 wt% to about 0.002 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.0000025 wt% to about 0.0025 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.000003 wt% to about 0.003 wt% of each C7 to C18 substituted phenol, based on the total weight of the consumable.[000166] In some examples, the total amount of C7 to C18 substituted phenol is from about 10 to about 600 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.00005 wt% to about 0.003 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00008 wt% to about 0.0048 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumablemay include about 0.0001 wt% to about 0.006 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.009 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0002 wt% to about 0.012 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.00025 wt% to about 0.015 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.0003 wt% to about 0.018 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable.[000167] In some examples, the total amount of C7 to C18 substituted phenol is from about 10 to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 5% w / w of the composition, the consumable may include about 0.00005 wt% to about 0.0015 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 8% w / w of the composition, the consumable may include about 0.00008 wt% to about 0.0024 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may include about 0.0001 wt% to about 0.003 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 15% w / w of the composition, the consumable may include about 0.00015 wt% to about 0.0045 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 20% w / w of the composition, the consumable may include about 0.0002 wt% to about 0.006 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 25% w / w of the composition, the consumable may include about 0.00025 wt% to about 0.0075 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable. For example, at an inclusion level of 30% w / w of the composition, the consumable may include about 0.0003 wt% to about 0.009 wt% of C7 to C18 substituted phenol, based on the total weight of the consumable.[000168] In some examples, the composition may comprise one or more further compounds. The further compounds may be selected from norisoprenoids, bipyridine compounds, ethers,carboxylate esters, substituted furans, ketones, sesquiterpenes, terpene alcohols, and combinations thereof. Such compounds may be those defined below.[000169] In some examples, the composition may comprise a bipyridine compound, optionally which is 2,3’-dipyridyl or 4,4'-Methylenedipyridine. When present, the bipyridine compound may be included at an amount from about 0.1 to about 200 pg / g. In some examples, the bipyridine compound is present in an amount from about 10 to about 200 pg / g.[000170] In some examples the composition may comprise at least one norisoprenoid. In some examples the at least one norisoprenoid is selected from damascenone, damascene, ionone, megastigmatrienone, n-methylionone, solanone, 3-hydroxy-beta-damascone, 3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl), or a combination thereof. In some examples, the at least one norisoprenoid is selected from megastigmatrienone, damascenone, damascene, n-methylionone, solanone, 3-hydroxy-beta-damascone, and combinations thereof. In some examples, the at least one noroisoprenoid is megastigmatrienone and the composition may comprise one or more noroisoprenoid selected from: solanone, damascenone, damascene, n-methylionone, solanone, 4-hydroxy-beta-damascone, and combinations thereof. In some examples, the at least one noroisoprenoid is megastigmatrienone and the composition may comprise one or more noroisoprenoid selected from: solanone, damascene, n-methylionone, solanone, 4-hydroxy-beta-damascone, and combinations thereof.[000171] In some examples, the composition is substantially free of beta-ionone and / or beta-damascenone.[000172] In some examples, each norisoprenoid may be present in an amount of from about 0.1 to 350 pg / g. In some examples, each norisoprenoid may be present in an amount of from about 0.1 to about 200 pg / g. In some examples, the total amount of norisoprenoid is from about 20 pg / g to about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the total amount of norisoprenoid in the consumable may be about 0.002 wt% to about 0.05 wt%, based on the total weight of the consumable.[000173] In some examples, the composition further comprises at least one sesquiterpene. Sesquiterpenes are a class of terpenes that consist of three isoprene units and often have the molecular formula C15H24. Sesquiterpenes may be cyclic. In some examples, the at least one sesquiterpene in the composition of the present disclosure is a cyclic sesquiterpene. Thesesquiterpene may be defined by its molecular weight: from about 200 g / mol to about 300 g / mol.[000174] In some examples, the sesquiterpene may be selected from calamenene, alpha-muurolene, r-cadinene, viridiflorene, longifolene, nootkatone, beta-bisabolol, cedrol, nerolidol, santalol, beta-bisabolene, beta-cedrene, beta-humulene, alpha-cyperone, cyperotundone, 3,7-dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone, solavetivone, alantolactone, bergamontene, neophytadiene, guai-1(5)-en-11-ol:acetate, alpha-farnesene, and combinations thereof.[000175] In some examples, the at least one sesquiterpene is neophytadiene. In some examples, neophytadiene may be present in an amount of from about 20 pg / g to about 600 pg / g, based on the total weight of the composition.[000176] In some examples, the composition comprises neophytadiene and at least one further sesquiterpene selected from: calamenene, alpha-muurolene, r-cadinene, viridiflorene, longifolene, nootkatone, beta-bisabolol, cedrol, nerolidol, santalol, beta-bisabolene, beta-cedrene, beta-humulene, alpha-cyperone, cyperotundone, 3,7-dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone, solavetivone, alantolactone, bergamontene, guai-1(5)-en-11-okacetate, alpha-farnesene, and combinations thereof.[000177] In some examples, each sesquiterpene is present in the composition in an amount from about 0.5 pg / g to about 550 pg / g. In some examples, each sesquiterpene is present in an amount from about 2 pg / g to about 250 pg / g. In some examples, the total amount of sesquiterpene in the composition is from about 20 pg / g to about 600 pg / g. In some examples, the total amount of sesquiterpene in the composition is from about 20 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w for the composition, the consumable may include each sesquiterpene in an amount of from about 0.00005 wt% to about 0.055 wt%, or from about 0.0002 wt% to about 0.025 wt%. The total amount of sesquiterpene may be from about 0.0002 wt% to about 0.06 wt%, or from about 0.0002 to about 0.03 wt%, based on the total weight of the consumable.[000178] In some examples, the composition includes at least one norisoprenoid which is megastigmatrienone and at least one sesquiterpene which is neophytadiene. In some examples, the weight ratio of megastigmatrienone to neophytadiene is from about 1:20 to about 5:1. In some examples, the weight ratio of megastigmatrienone to neophytadiene is fromabout 1:10 to about 5:1. In some examples, the weight ratio of megastigmatrienone to neophytadiene is from about 1:2 to about 5:1.[000179] In some examples, the composition comprises at least one norisoprenoid which is megastigmatrienone, and the weight ratio of megastigmatrienone to the at least one C2 to C24 carboxylic acid as defined herein, is about 1 :2 to about 5:1. In some examples, the weight ratio of megastigmatrienone to the at least one C2 to C24 carboxylic acid as defined herein, is about 1:2 to about 1:1.[000180] The composition of the present disclosure may include at least one terpene alcohol. Terpene alcohols are a type of terpenoid; they are naturally occurring compounds found in various plants, fruits, and essential oils. Some examples include linalool (found in lavender), terpineol (found in lilacs) and geraniol (found in roses). Specifically, terpene alcohols are terpenes that include one or more alcohol / hydroxyl functional groups. In some examples, the terpene alcohol is defined by its molecular weight; the molecular weight of each terpene alcohol may be from about 120 g / mol to about 320 g / mol.[000181] In some examples, the terpene alcohol is selected from linalool, geranyl linalool, isophytol, menthol, dihydrolinalool, phytol, sclareol, 2-[5-methyl-5-vinyltetrahydro-2-furanyl]-2-propanol, a b 2,7,11 Cembratrienodiol 4,6 diol, labdenediol, nerolidol, and combinations thereof. In some examples, the terpene alcohol is selected from linalool, isophytol, menthol, phytol, sclareol, and combinations thereof. In some examples, the terpene alcohol includes an acyclic terpene alcohol such as linalool.[000182] In some examples, the terpene alcohol is an acyclic terpene alcohol. The acyclic terpene alcohol may be selected from linalool, geranyl linalool, isophytol, dihydrolinalool, phytol, nerolidol, and combinations thereof. In some examples, the acyclic terpene alcohol is linalool. In some examples, the acyclic terpene alcohol is geranyl linalool. In some examples, the composition further comprises a cyclic terpene alcohol selected from menthol and sclareol.[000183] In some examples, the terpene alcohol is a cyclic terpene alcohol selected from menthol, a b 2,7,11 Cembratrienodiol 4,6 diol, and sclareol.[000184] In some examples, each terpene alcohol is present in the composition an amount from about 0.1 pg / g to about 100 pg / g. In some examples, each terpene alcohol is present in the composition in an amount from about 1 pg / g to about 60 pg / g. In some examples, the total amount of terpene alcohol in the composition is from about 1 pg / g to about 150 pg / g. In some examples, the total amount of terpene alcohol in the composition is from about 5 pg / g to about 100 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly. In someexamples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w for the composition, the consumable may include each terpene alcohol in an amount of from about 0.00001 wt% to about 0.01 wt%, or from about 0.0001 wt% to about 0.006 wt%. The total amount of terpene alcohol may be from about 0.0001 wt% to about 0.015 wt%, based on the total weight of the consumable.[000185] In some examples, the composition further comprises one or more carboxylate esters. When present, these carboxylate esters may be in addition to the esters defined by group (2) above. The carboxylate esters may be defined by their molecular weight being from about 85 g / mol to about 400 g / mol.[000186] In some examples, the carboxylate ester is selected from: ethyl acetate; isopropyl formate; methyl methoxyacetate; methyl 2-methylbutyrate; propanoic acid, 2-hydroxy-, ethyl ester; ethyl isovalerate; mono-ethyl succinate; isoamyl isovalerate; 2-methylpentanoyl 2-methylpentanoate; triethyl citrate; 1, 2, 3-propanetriol,1 -acetate; 2-hydroxypropylacetate; 1,1-ethanediol, diacetate; dibutyl phthalate; acetic acid, methyl ester; bis(2-ethylhexyl) benzene-1,3-dicarboxylate; methyl phenylacetate; methyl nicotinate; proline, 2-methyl-5-oxo-, methyl ester; methyl pyruvate; ethyl pyruvate; methyl palmitate; ethyl palmitate; and combinations thereof.[000187] In some examples, the composition comprises at least two carboxylate esters in addition to the esters defined by group (2) above. In such examples, the carboxylate esters may be selected from: ethyl acetate, isopropyl formate, methyl meth oxy acetate, methyl 2-methyl butyrate, propanoic acid, 2-hydroxy-, ethyl ester, ethyl isovalerate, monoethyl succinate, triethyl citrate, 2-hydroxypropylacetate, 1,1 -ethanediol, diacetate, dibutyl phthalate, acetic acid, methyl ester, methyl pyruvate, Proline, 2-methyl-5-oxo-, methyl ester, methyl palmitate, ethyl palmitate, and combinations thereof.[000188] In some examples, each carboxylate ester is present in an amount of from 0.5 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, each carboxylate ester may be present in the consumable in an amount of about 0.0005 wt% to about 0.03 wt%, based on the total weight of the consumable. The total amount of carboxylate ester, when present, may be from about 10 pg / g to about 500 pg / g inthe composition, and when the composition is included at 10% w / w in the consumable, at about 0.001 wt% to about 0.05 wt%, based on the total weight of the consumable.[000189] In some examples, the composition further comprises one or more ethers. In some examples, the one or more ethers are defined by their molecular weight being from about 100 g / mol to about 250 g / mol. In some examples, the one or more ethers are hydroxy-ethers optionally selected from: 1-(1-prop-2-enoxypropan-2-yloxy)propan-2-ol, 1-[(1-methoxy-2-propanyl)oxy]-2-propanol, 1 ,1-oxydi-2-propanol, and combinations thereof. When present, the one or more ethers may be in the composition at an amount of from about 1 pg / g to about 50 pg / g.[000190] In some examples, the composition further comprises one or more ketone. The ketone is not limited but in some examples the composition comprises two or more ketones. Such ketones may include at least one cyclic unsaturated ketone, e.g. 2-cyclohexen-1-one, 4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-; 2-cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5-trimethyl-; 2-hydroxy-3-methyl-2-cyclopentenone; 2-cyclopenten-1-one, 2-hydroxy-, 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-, 2-cyclopenten-1-one, 2-ethyl-3-hydroxy, 2,6,6-Trimethyl-2-cyclohexene- 1,4-dione; furaneol; or combinations thereof, at least one acyclic unsaturated ketone, e.g. 6,8-nonadien-2-one, 8-methyl-5-(1 -methylethyl)-; geranyl acetone; 5,9,13-pentadecatrien-2-one, 6, 10, 14-trimethyl-; 2-pentadecanone, 6, 10, 14-trimethyl-; or combinations thereof, and / or at least one heteroaromatic ketone or aromatic ketone, e.g. dibenzylketone, 1-(5-methylpyridin-3-yl)ethanone; 1-pyridin-3-ylethanone; 2-acetylpyrrole; Ethanone, 1-(1 H-pyrrol-2-yl)-; 1-Propanone, 1-(4-methyl-2-pyridinyl)-; Ethanone, 1-(2-hydroxy-5-methylphenyl)-; Ethanone, 1-(4-methylphenyl)-; 6-Ethyl-3-hydroxy-2-methyl-4-pyrone;; or a combination thereof.[000191] In some examples, the composition further comprises one or more ketone selected from 4'-methylacetophenone, 4'-hydroxyacetophenone, 4'-methylvalerophenone, dibenzyl ketone, 1-(4-tert-butylphenyl)propan-2-one, 1-(2-hydroxy-3-phenylphenyl)ethanone (2-hydroxy-3-phenylacetophenone), 2-nonanone, 6,8-nonadien-2-one, 8-methyl-5-(1-methylethyl)-, geranylacetone, 9-hydroxy-4,7-megastigmadien-3-one, 5,9,13-pentadecatrien-2-one, 6, 10, 14-trimethyl-, 2-pentadecanone, 6, 10, 14-trimethyl-, pyrrolidin-2-one, n-methylpyrrolidin-2-one, ethyl levulinate, hexahydrofarnesyl acetone (6,10,14-Trimethyl-2-pentadecanone), acetoin, 1-(5-methylpyridin-3-yl)ethanone, acetyl pyrazine, 1-pyrazin-2-ylethanone, 1-pyridin-3-ylethanone, 2-acetylpyrrole, 1-methyl-2-acetylpyrrole, Isophorone, acetoxyacetone, hydroxyacetone, piperidine-2, 6-dione, 3,5,5-trimethylcyclohexane-1,2-dione, 2, 6, 6-trimethyl-2-cyclohexene- 1,4-dione, 2-hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one, 2-cyclohexen-1-one, 4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, 2-cyclohexen-1-one, 4-(3-hydroxybutyl)-3,5,5-trimethyl-, 2-hydroxy-3-methyl-2-cyclopentenone, methylcyclopentenolone, 2-cyclopenten-1-one, 3-ethyl-2-hydroxy-, 2-hydroxy-5-propan-2-ylcyclohepta-2,4,6-trien-1-one, dihydro-alpha-ionone, dihydro-beta-ionone, solanone, 1-(2-Hydroxy-4-methoxyphenyl)ethan-1-one, 1-(2,3-dihydroxy-4-methoxyphenyl)ethanone, (e)-beta-ionone, or a combination thereof. In some examples, the one or more ketone is selected from 4'-hydroxyacetophenone, 1-(4-tert-butylphenyl)propan-2-one, 6,8-nonadien-2-one, 8-methyl-5-(1-methylethyl)-, (e)-, geranylacetone, 5,9,13-pentadecatrien-2-one, 6,10,14-trimethyl-, hexahydrofarnesyl acetone (6,10,14-Trimethyl-2-pentadecanone), acetyl pyrazine, 2-acetylpyrrole, isophorone, 3,5,5-trimethylcyclohexane-1,2-dione, 2,6,6-trimethyl-2-cyclohexene-1, 4-dione, 2-cyclohexen-1-one, 4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, methyl cyclopentenolone, dihydro-beta-ionone, (e)-beta-ionone, or a combination thereof. In some examples, the one or more ketone is selected from 4'-methylacetophenone, 2-nonanone, ethyl levulinate, acetoin, 1-pyrazin-2-ylethanone, 2-hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one, 2-hydroxy-3-methyl-2-cyclopentenone, or a combination thereof.[000192] In some examples, the molecular weight of the ketone is from about 85 g / mol to about 300 g / mol.[000193] In some examples, the total amount of the one or more ketones is from about 20 pg / g to about 850 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the total amount of the one or more ketones may be about 0.002 wt% to about 0.085 wt%, based on the total weight of the consumable.[000194] In some examples, the total amount of the one or more ketones is from about 20 pg / g to about 350 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the total amount of the one or more ketones may be about 0.002 wt% to about 0.035 wt%, based on the total weight of the consumable.[000195] In some examples, the composition further comprises one or more furan derivatives. The furan derivatives, otherwise termed substituted furans, may each have a molecular weight of from about 90 g / mol to about 200 g / mol. In some examples, the composition is substantially free of furan derivatives as described herein.[000196] In some examples, the one or more furan derivatives are selected from furfuryl alcohol, furfural, 5-methyl furfural, ethanone, 1-(2-furanyl)-, 2-pentylfuran, 2-(propan-2-ylsulfanylmethyl)furan, 1-(furan-2-yl)pentan-1-one, furfuryl methyl ether, 2-acetylfuran, 2-acetyl-5-methylfuran, linalooloxide, 2-ethenyl-furan, 5-hydroxymethylfurfural, or a combination thereof. In some examples, the one or more furan derivatives include furfuryl alcohol. In some examples the one or more furan derivatives further comprise 5-methyl furfural, 2-pentyl furan, or a combination thereof.[000197] In some examples, the total amount of the one or more furan derivatives is from about 0.1 pg / g to about 50 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly, based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the total amount of the one or more furan derivatives may be about 0.00001 wt% to about 0.05 wt%, based on the total weight of the consumable.[000198] In some examples, the composition further includes at least one alkaloid selected from nicotine, myosmine, cotinine, caffeine, nicotyrine, N’propylnornicotine, and combinations thereof. In some examples, the composition further includes at least one norisoprenoid which is megastigmatrienone, and the weight ratio of megastigmatrienone to nicotine is from about 1:10 to about 1:1. In some examples, the weight ratio of megastigmatrienone to nicotine is from about 1 :5 to about 1:10.[000199] In some examples, the composition is nicotine-free.[000200] In some examples, the composition is substantially free of ethyl vanillin. In some examples, the composition is free of ethyl vanillin.[000201] In some examples, the composition comprises at least one C7 to C18 aromatic aldehyde; an aromatic aldehyde is an aromatic group which is substituted with at least one aldehyde group. The aromatic acetal / aldehyde may include one or more further substituents; such substituents are not typically limited. In some examples the one or more further substituents do not include hydroxyl groups. In some examples, the C7 to C18 aromatic aldehyde is defined by their molecular weight; the molecular weight of each C7 to C18 aromatic aldehyde may from about 100 g / mol to about 250 g / mol.[000202] The aldehyde group may be attached directly to the aromatic group, e.g. as in benzaldehyde or vanillin, or may be attached indirectly via an alkyl or alkenyl group as defined above. The aldehyde group may, for example, be attached via a linear alkyl group as inphenylacetaldehyde, via a branched alkyl group as in cyclamen aldehyde, or via an alkenyl group as in coniferyl aldehyde; the present disclosure is not limited in this respect. The aromatic group may also include one or more further substituents which are not typically limited. Examples include alkyl groups, alkenyl groups, hydroxyl groups, carboxyl groups other than aldehydes, alkoxy groups, acetals, and combinations thereof. The alkyl groups and alkenyl groups are as defined above.[000203] In some examples the at least one C7 to C18 aromatic aldehyde includes one or more substituents selected from alkyl groups, alkenyl groups, alkoxy groups, and combinations thereof. The skilled person will understand that when the aromatic group includes a hydroxyl group directly attached to the ring, the compound may also be a C7 to C18 substituted phenol according to the present disclosure. If classified under one compound group, here a C7 to C18 aromatic aldehyde, the skilled person will understand that the compound will not simultaneously be classified under another compound group. For example, if vanillin is considered an aromatic aldehyde, and the composition includes a C7 to C18 substituted phenol, then the composition will include another compound, e.g. 2-methoxyphenol, as the C7 to C18 substituted phenol.[000204] In some examples, the at least one C7 to C18 aromatic aldehyde is selected from benzaldehyde, phenylacetaldehyde, 3-methoxybenzaldehyde, cyclamen aldehyde, 2,4-dihydroxy-6-methylbenzaldehyde, vanillin, coniferyl aldehyde, 2-hydroxy-4-methoxybenzaldehyde, and combinations thereof.[000205] In some examples, the composition further comprises a piperidine derivative such as 1-ethyl-3-hydroxypiperidine, 4-(4-methylpiperidin-1 -yl)aniline, or a combination thereof.[000206] In some examples, the composition further comprises a pyranone derivative, such as 2h-pyran-2-one, 6-ethyl-5,6-dihydro-; 3-hydroxy-2-methyl-4h-pyran-4-one; 2-ethyl-3-hydroxy-4h-pyran-4-one; or a combination thereof. In some examples, the composition comprises 2h-pyran-2-one, 6-ethyl-5,6-dihydro-.Reaction Products[000207] The term "reaction product" means a product from a reaction between two materials. In accordance with some aspects described herein, there is provided a composition for a substance delivery system to provide a tobacco aroma, wherein the composition comprises one or more reaction products of two or more reactants, the reaction products being selected from:a. esters, the esters being an esterification reaction product of organic acid and alcohol reactants; and / orb. esters and / or alcohols, the esters and / or alcohols being a transesterification reaction product of ester and alcohol reactants;c. alcohols and / or acids, the alcohols and / or acids being a hydrolysis reaction product of ester and water reactants;d. acetals, the acetals being the acetalisation reaction product of aldehyde and alcohol reactants;e. acetals, the acetals being the acetalisation reaction product of ketone and alcohol reactants;or combinations of the reaction products.[000208] In some examples, the organic acid reactants are selected from C2 to C24 carboxylic acids and combinations thereof.[000209] In some examples, the organic acid reactants are selected from C2 to C24 keto carboxylic acids and combinations thereof. In some examples, the organic acid reactants are selected from C2 to C24 carboxy-aldehydes, C3 to C24 keto carboxylic acids and combinations thereof. In some examples, the organic acid reactants are selected from C2 to C18 carboxyaldehydes, C3 to C18 keto carboxylic acids and combinations thereof. In some examples, the organic acid reactants are selected from acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, isobutyric acid, butyric acid, methylbutyric acid, 2-methylbutyric acid, 3-methylpentanoic acid, isovaleric acid, valeric acid, hexanoic acid, hepatanoic acid, octanoic acid, nonanoic acid, methylvaleric acid, decanoic acid, glycolic acid, 2-butenedioic acid (Z), 2-butenedioic acid (E), succinic acid, glyceric acid, malic acid, pyroglutamic acid, trihydroxybutanoic acid, tetrahydroxypentanoic acid, 2-keto-L-gluconic acid, quinic acid, gluconic acid, galactaric acid, hexadecanoic acid, caffeic acid, linoleic acid, linolenic acid, glucuronic acid, chlorogenic acid, fumaric acid, maleic acid, oxalic acid, oxaloacetic acid, acetoacetic acid, beta-hydroxybutyric acid, alpha-ketoglutaric acid, alpha-ketobutyric acid, glyoxylic acid, formylacetic acid, oxobutanoic acid, oxoheptanoic acid, oxohexanoic acid, oxoocttanoic acid, formylbenzoic acid and combinations thereof.[000210] In some examples, the alcohol reactants are selected from terpene alcohols, C7 to C18 aromatic alcohols, phenol or C7 to C18 substituted phenols and combinations thereof. In some examples, the C7 to C18 substituted phenols are monophenols.[000211] In some examples, the alcohol reactants are primary alcohols, polyhydric alcohols or combinations thereof. In some examples, the primary alcohols are selected from ethanol, methanol or combinations thereof and the polyhydric alcohols are selected from glycerol, propylene glycol or combinations thereof.[000212] In some examples, the primary alcohols are selected from ethanol, methanol or combinations thereof and the polyhydric alcohols are selected from glycerol, propylene glycol, 2-methyl-1,3-propanediol or combinations thereof.[000213] In some examples, the alcohol reactant is glycerol. In some examples, the alcohol reactant is propylene glycol. In some examples, the alcohol reactant is 2-methyl-1,3-propanediol.[000214] In some examples, the ester reactants are selected from C3 to C24 aliphatic esters, C8 to C18 aromatic esters and combinations thereof.[000215] In some examples, the aldehyde reactants are selected from C3 to C24 aliphatic, and aromatic aldehydes and combinations thereof.[000216] In some examples, the ketone reactants are selected from C3 to C24 aliphatic and aromatic ketones, and combinations thereof.[000217] In some examples, the composition has a pH of less than 7. In some examples, the optionally wherein the composition has a pH of about 4 to about 5.[000218] The definitions provided for each of these groups of compounds in the present disclosure applies mutatis mutandis.Plant Extracts[000219] In some examples, one or more of the compounds are obtained by extraction from a natural source, e.g. a tobacco material. Also provided herein is a method for forming the composition, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.[000220] The present disclosure is not, however, limited to obtaining one or more compounds via an extraction method. The present disclosure includes the formulation of a partially or totally synthetic or artificial composition. In some examples, at least one of the compounds may be asynthetic compound. In this manner, the composition may include one or more compounds which are naturally derived, e.g. from a tobacco source, and one or more compounds which are synthetic (e.g. obtained commercially or otherwise synthesised).[000221] In some examples, the total number of chemical compounds present in the composition is less than about 800, such as less than about 600, or less than about 500. By total number of chemical compounds is meant the number of different chemical compounds present at a detectable level by e.g. GC-MS.[000222] In some examples, the total content of any one of the tobacco-specific nitrosamines (TSNAs) in the composition, namely N-nitrosonornicotine (NNN), N’-nitrosoanatabine (NAT), N-nitrosoanabasine (NAB) and nicotine-derived nitrosamine ketone (NNK), is less than about 4 pg / g, or less than about 3 pg / g. This may be an indication that at least one compound is obtained from a tobacco extract.[000223] In some examples, the composition may include formaldehyde and / or acetaldehyde. This may be an indication that at least one compound is obtained from a tobacco extract. The amount of formaldehyde and / or acetaldehyde is less than about 4 pg / g.[000224] In some examples, the composition may include at least one plant material, optionally wherein the plant material is a tobacco extract. The tobacco extract may include one or more of the compounds defined above for the composition. The disclosures made herein in relation to the compounds thus apply equally to a tobacco extract comprising one or more of said compounds. In other examples, one or more of said compounds may be added to the tobacco extract to form a composition of the present disclosure. In some examples, the composition is a tobacco extract.[000225] When present or used to obtain one or more compounds of the composition, any tobacco extract may be used. In some examples, the tobacco extract may be an extract of Virginia tobacco, Burley tobacco, Oriental tobacco, Dark tobacco, or a combination thereof. In some examples, the tobacco extract comprises an extract of Virginia tobacco. The tobacco may be cured; in some examples, the tobacco is cured. Cured tobacco may be flue-cured, aircured and / or sun-cured. In some examples, the tobacco extract comprises an extract of flue-cured Virginia tobacco.[000226] In some examples, the tobacco from which one or more compounds may be extracted (referred to herein as raw tobacco) may include tobacco leaf. In some examples, the tobacco leaf may be defined by its nicotine content. In some examples, the nicotine content of the tobacco leaf may be from about 0.5 to about 8.0 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 0.8 to about 7.5wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 1.5 to about 7.5 wt%, based on the total weight of the leaf.[000227] In some examples, the tobacco leaf may be defined by its sugar content. Exemplary nicotine and sugar contents for flue-cured Virginia tobacco are about 0.9 to about 5.5 wt% nicotine and about 4 to about 25 wt% sugar. Exemplary nicotine and sugar contents for aircured Burley tobacco are about 1.5 to about 6.5 wt% nicotine and less than about 1 to about 2 wt% sugar. Exemplary nicotine and sugar contents for sun-cured Oriental tobacco are about 0.5 to about 3.0 wt% nicotine and about 8 to about 12 wt% sugar. Exemplary nicotine and sugar contents for fire-cured dark tobacco are about 2.5 to about 6 wt% nicotine and less than about 1 to about 2 wt% sugar.[000228] In some examples, the tobacco extract is obtained from cured Virginia tobacco, cured Burley tobacco, cured Oriental tobacco, cured Dark tobacco, ora combination thereof. In some examples, the tobacco extract is obtained from flue-cured Virginia tobacco, air-cured Burley tobacco, sun-cured Oriental tobacco, fire-cured Dark tobacco, or a combination thereof. The solvent extraction method disclosed herein for forming the composition is not particularly limited. It may be a simultaneous distillation extraction method, a supercritical fluid extraction method or another extraction method known in the art. Other extraction methods are also known including maceration or percolation or hot reflux or Soxhlet extraction, or microwave extraction. The method may also include further steps such as filtration, fractionation, pyrolysis, adsorption, distillation and / or purification. Extraction methods are provided in WO 2026 / 021165 A1 , US 2026 / 0053181 A1 , WO 2026 / 026620 A1 , WO 2026 / 045589 A1 , and WO 2026 / 045587 A1 which are herein incorporated by reference for such methods.[000229] Hot reflux and microwave extraction are described in WO 2026 / 045589 A1 and WO 2026 / 045587 A1 (Shenzhen Smoore Technology LTD), which are herein incorporated by reference for such methods. For example, a hot reflux extraction method is disclosed using an SF-2L small-scale reflux apparatus. In this method, tobacco leaves are placed in a roundbottom flask which is heated by an electric heating mantle. Evaporated ethanol and water are passed into a condenser and refluxed. The extraction temperature is 95°C and the extraction time is 120 minutes. After extraction, a filtrate is collected and the extract is concentrated using a rotary evaporator. Further examples of hot reflux extraction can be found in WO 2026 / 045587 A1.[000230] Simultaneous distillation extraction is a technique in which the steps of isolation and extraction of certain compounds from a sample can be achieved simultaneously. In some example, a simultaneous distillation extraction (SDE) process can be used for forming tobacco extracts in which process comprises (i) providing a tobacco material, (ii) subjecting the tobaccomaterial to steam distillation, and (iii) extracting one or more volatile compounds of interest from the tobacco material with a solvent, wherein the distillation step (ii) and extraction step (iii) are carried out simultaneously. The method may comprise mixing a quantity of tobacco (e.g. ground tobacco) with water. This solution may have a pH of from about 5 to about 7, such as from about 5.5 to about 6.5. Glass beads may be added to prevent bumping. The solution may then be heated, for example, to a temperature of from about 100°C to about 130°C.[000231] The distillation step (ii) and extraction step (iii) being carried out simultaneously means that in some examples, the SDE method may be carried out in a single step. In some examples, an additional distillation and / or extraction step is excluded. In some examples, the SDE method is carried out in a single apparatus with no additional processing prior to removal of the extracted product from the apparatus.[000232] In some examples the solvent used for extraction is a non-polar solvent. In some examples the solvent used for extraction is a polar solvent. As used herein, the term “polar” refers to a solvent having a dielectric constant of greater than or equal to 15. As used herein, the term “non-polar” refers to a solvent having a dielectric constant of less than 15.[000233] In some examples, the solvent is immiscible with water. In some examples, the solvent comprises an organic solvent. The term “organic” is understood in the art; it is typically considered to be a solvent comprising carbon. In some examples, the solvent is selected from: n-butanol, cyclohexane, dichloromethane, ethyl acetate, heptane, hexane, methyl-t-butyl ether, 2-butanone, pentane, diisopropyl ether, diethyl ether, and mixtures thereof. The use of a mixture of pentane and ether is non-toxic and may be easily replaced by ethanol after extraction of the volatile compounds of interest has been achieved.[000234] In some examples, further processing of the extracted product may be carried out. The further processing may comprise a purifying step which comprises replacing the solvent used for extraction with another solvent suitable for use in a composition as described herein. In some examples, such a purifying step comprises replacing the solvent used for extraction with ethanol.[000235] In some examples a supercritical fluid extraction (SFE) process used for forming tobacco extracts is employed. The process may comprise contacting tobacco with an extraction solvent under supercritical conditions. In some examples, the extraction solvent comprises, or is, supercritical carbon dioxide. In some examples, no co-solvent is present.[000236] In some examples, the SFE process is performed at a pressure of from about 50 to about 500 bar. In some examples, the temperature during extraction may range from about 25°C to about 90°C. In some examples, supercritical extraction is performed using a flow rateof extraction solvent of from about 0.5 to about 5 kg / hr. In some examples, the pressure is varied during the SFE process, for example to collect fractions having varying volatility. In such examples, a lower pressure (e.g. about 50 to about 200 bar) may be used for a first period of time, followed by a higher pressure (e.g. from about 200 to about 500 bar) for a second period of time. The first period of time may be from about 0.5 to about 2 hours. The second period of time may be from about 0.5 to about 2 hours. In some examples, the two fractions or extracts are combined. In some examples the two fractions or extracts are collected separately and not combined. In some examples, only the extract from the second extraction is retained and / or used.[000237] In some examples the supercritical conditions comprise a pressure of from about 50 to about 500 bar, such as from about 100 to about 400 bar or from about 100 to about 300 bar. In some examples, the supercritical conditions comprise an extraction temperature of from about 25°C to about 90°C, such as from about 30°C to about 70°C, or from about 40°C to about 60°C. In some examples, the extraction process may be performed from about 0.5 to about 5 hours, such as from about 1 to about 4 hours, from about 2 to about 3 hours, or about 2.5 hours. In some examples, the supercritical extraction may be performed using a flow rate of extraction solvent (e.g. carbon dioxide) of from about 0.5, 0.8, or 1 kg / hr to about 2, 3 or 5 kg / hr. In some examples, supercritical extraction is performed using a flow rate of extraction solvent (e.g. carbon dioxide) of from about 0.1 to about 5 kg / hr, such as from about 0.8 to about 3 kg / hr, from about 1 to about 3 kg / hr, or about 1 kg / hr. The skilled person will understand that these pressure, temperature, time and flow rate conditions may be combined with one another.[000238] In some examples, the SFE process involves placing ground tobacco in a container (e.g., 260 g of ground tobacco in a 1 L container) and using supercritical carbon dioxide as an extraction solvent at 1 kg / h and ethanol as a co-solvent (30%). The pressure of the system is set to 250 bar and the temperature maintained at 75 degrees. The extracts are collected for a period of 2 hours.Tobacco Particles[000239] In some examples, the composition may further comprise a plurality of solid tobacco particles. In some examples, the solid tobacco particles remain as distinct entities within the composition, such that the composition can be considered to be in the form of a heterogeneous mixture. For example, the solid tobacco particles may be at least partially suspended in the composition. As used herein, the term “at least partially suspended” means that the solid tobacco particles are distributed within the composition (e.g. a liquid composition), wherein the distribution of said particles within the formulation is not necessarily even. For example, thespatial distribution of the particles may be biased towards one portion of the composition. In some examples, the suspension of the particles may be enhanced by agitation, for example shaking or inversion, such as when comprised in an article and / or in a non-combustible aerosol provision system, including in use.[000240] In some examples the solid tobacco particles are visible, for example to the naked eye. It will be understood that the term “visible” as used herein means that the solid tobacco particles can be seen, e.g. when present in a composition according to the present disclosure, such as by a user. Thus, the presence of the solid tobacco particles in the composition of the present disclosure can be readily apparent to a user (e.g. of a substance provision system), such as by the presence of distinct, visible particles in said composition. By “the naked eye”, the term will be understood to mean that the solid tobacco particles can be seen e.g. by a user without magnification or other visual enhancement. In various examples, the solid tobacco particles are visible under ambient conditions, for example normal temperature (e.g. from about 15 °C to about 25 °C) and pressure (e.g. about 1 atm). In various examples, the tobacco particles may be visible in one or more stages of use but not all. For example, the tobacco particles may be visible in the composition as such. In further examples, the tobacco particles may be visible when the composition is comprised in an article. For example, the article may be partially or completely transparent such that the presence of the tobacco particles in the formulation in the article may be determined by a user by viewing the article. In some examples, the article may comprise at least a transparent portion, wherein the transparent portion may be configured so that the solid tobacco particles are visible to the naked eye, e.g. to a user of the article. In further examples, the tobacco particles may be visible when the composition is comprised in a substance delivery system. For example, the article and substance delivery system may each comprise at least a transparent portion wherein said transparent portions are arranged such that the tobacco particles are visible to the naked eye, e.g. to a user of the substance delivery system.[000241] The size of the solid tobacco particles is not necessarily limited. In some examples, the solid tobacco particles have a size of at least about 50 pm, at least about 0.1 mm or at least about 0.5 mm. In some examples, the solid tobacco particles have a size of up to about 15 mm, up to about 10 mm or up to about 2 mm. In further examples, the solid tobacco particles have a size of from about 50 pm to about 15 mm, from about 0.1 mm to about 10 mm or from about 0.5 mm to about 2 mm. The particle size may be determined by sieving. For example, a recited lower particle size limit means that the particles will not pass through a sieve with a mesh size of said limit, and an upper particle size limit means that the particles will pass through a sieve with a mesh size of said limit. Thus, a particle size of at least 50 pm means that the particles are retained on a sieve with a 50 pm mesh. In another example, a particlesize of up to about 15 mm means that the particles are not retained on a sieve (i.e. the particles pass through the sieve) with a 15 mm mesh.[000242] In some examples, at least about 80%, at least about 90%, at least about 95% or at least about 99% by weight of the solid tobacco particles have a size according to any of the foregoing examples.[000243] The tobacco material from which the tobacco particles according to the present disclosure are obtained or obtainable from is not necessarily limited. For example, the tobacco material may be as described in any of the examples of tobacco / tobacco material described herein. In some examples, the tobacco material from which the tobacco particles are obtained or obtainable from may include tobacco leaf. In further examples the tobacco leaf may be defined by its nicotine and / or sugar content as described herein.[000244] In some examples, the tobacco particles are obtained or obtainable by grinding a tobacco material, such as tobacco leaf. The means by which the tobacco material may be ground is not limited and a person of skill in the art of the present disclosure will be able to select suitable apparatus and / or methods for grinding a tobacco material such as tobacco leaf as part of their common general knowledge. In some examples, the tobacco particles are obtained or obtainable by mill grinding a tobacco material. For instance, using a cutting mill, examples of which are commercially available and known to a person of skill in the art. For instance, a FRITSCH PULVERISETTE 19 cutting mill. In some examples, tobacco particles are obtained or obtainable by grinding, such as mill grinding, a tobacco material and sieving the ground tobacco material, e.g. to obtain a particle size such as those disclosed herein. In some examples the sieving may be integrated into the grinding process, e.g. the grinding apparatus such as a cutting mill may comprise a sieve.[000245] In some examples, the tobacco material from which the tobacco particles are obtained may have been processed. In some examples, the tobacco particles may be obtained or obtainable from a tobacco material that has been extracted with at least one solvent. For example, a waste or by-product of an extraction process such as disclosed in further detail herein. In advantageous examples, the tobacco material may have been ground, e.g. to form solid tobacco particles, prior to the extraction process such that the solid tobacco particles may be used directly after the extraction process in the composition of the present disclosure.Substance Delivery System[000246] In another aspect of the present disclosure, there is provided a non-combustible substance delivery system comprising the composition, consumable or container or package described herein. As used herein, the term “delivery system” is intended to encompass systems that deliver at least one substance to a user.[000247] The substance delivery system may be a non-combustible aerosol provision system, or an aerosol-free delivery system.[000248] A non-combustible aerosol provision system is a system that releases compounds from an aerosol-generating material without combusting the aerosol-generating material, such as electronic cigarettes, tobacco heating products, and hybrid systems to generate aerosol using a combination of aerosol-generating materials. An aerosol-free delivery system is a system that delivers the at least one substance to a user orally, nasally, Transdermally or in another way without forming an aerosol, including, but not limited to, lozenges, gums, patches, articles comprising inhalable powders, and oral products such as oral tobacco which includes snus or moist snuff, wherein the at least one substance may or may not comprise nicotine.[000249] According to the present disclosure, a “non-combustible” aerosol provision system is one where a constituent aerosol-generating material of the aerosol provision system (or component thereof) is not combusted or burned in order to facilitate delivery of at least one substance to a user. The aerosol provision system may also be referenced herein as an aerosol delivery system. In some examples, the delivery system is a non-combustible aerosol provision system, such as a powered non-combustible aerosol provision system. In some / examples, the non-combustible aerosol provision system is an electronic cigarette, also known as a vaping device or electronic nicotine delivery system (END), although it is noted that the presence of nicotine in the aerosol-generating material is not a requirement.[000250] In some examples, the non-combustible aerosol provision system is an aerosolgenerating material heating system, also known as a heat-not-burn system. An example of such a system is a tobacco heating system.[000251] In some examples, the non-combustible aerosol provision system is a hybrid system to generate aerosol using a combination of aerosol-generating materials, one or a plurality of which may be heated. Each of the aerosol-generating materials may be, for example, in the form of a solid, liquid or gel and may or may not contain nicotine. In some examples, the hybrid system comprises a liquid or gel aerosol-generating material and a solid aerosol-generating material. The solid aerosol-generating material may comprise, for example, tobacco or a nontobacco product. Typically, the non-combustible aerosol provision system may comprise anon-combustible aerosol provision device and an article for use with or as the non-combustible aerosol provision device, which is also referred to as a consumable for use with the non-combustible aerosol provision device. The consumable being as defined herein. In some examples, the disclosure relates to consumables comprising aerosol-generating material and configured to be used with non-combustible aerosol provision devices. These consumables are sometimes referred to as articles throughout the disclosure.[000252] In some examples, the non-combustible aerosol provision system, such as a non-combustible aerosol provision device thereof, may comprise a power source and a controller. The power source may, for example, be an electric power source or an exothermic power source. In some examples, the exothermic power source comprises a carbon substrate which may be energised so as to distribute power in the form of heat to an aerosol-generating material or to a heat transfer material in proximity to the exothermic power source.[000253] In some examples, the non-combustible aerosol provision system may comprise an area for receiving the consumable, an aerosol generator, an aerosol generation area, a housing, a mouthpiece, a filter and / or an aerosol-modifying agent. In some examples, the consumable for use with the non-combustible aerosol provision device may comprise aerosolgenerating material, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generator, an aerosol generation area, a housing, a wrapper, a filter, a mouthpiece, and / or an aerosol-modifying agent.[000254] In some examples, there is provided a substance delivery system that is an aerosol-free delivery system as defined above.[000255] In some examples, the substance to be delivered may be an aerosol-generating material or a material that is not intended to be aerosolised. As appropriate, either material may comprise, in addition to the composition of the present disclosure, one or more active constituents, one or more flavours, one or more aerosol-former materials and / or one or more functional materials. More information is set out herein.Consumable, Aerosolisable Formulation and Aerosol Generating Material[000256] In some examples there is provided a consumable comprising the composition as defined herein, a substrate material, optionally wherein the substrate material comprises an aerosol-former material, a carrier material, or a combination thereof. A consumable is an article part or all of which is intended to be consumed during use by a user. In some examples the consumable comprises aerosol-generating material as the substrate material and is therefore an aerosolisable formulation or aerosol-generating system. In some examples, the consumable is a material that is not intended to be aerosolised.[000257] The terms aerosolisable formulation, aerosolisable material, and aerosol-generating material, are used interchangeably herein. Hence, there is provided an aerosolisable formulation comprising the composition as defined herein, an aerosol-former material and optionally nicotine. In some examples the formulation comprises the composition as defined herein, an aerosol-former material and nicotine.[000258] In some examples the formulation comprises the composition in an amount of at least about 1% by weight, such as at least about 5 wt% by weight, preferably at least about 10 wt% by weight. The composition may be present in the formulation in an amount of no greater than about 25% by weight, such as no greater than about 20% by weight, preferably no greater than about 15 wt% by weight. In some examples the composition may be present in the formulation in an amount of from about 1% by weight to about 25% by weight, such as from about 5 wt% by weight to about 20% by weight, preferably from about 10% by weight to about 15% by weight.[000259] The aerosolisable formulation may take various forms, provided that the formulation is capable of generating aerosol, for example when heated, irradiated or energized in any other way, including a semi-solid (such as a gel), a liquid or a solid, which may or may not contain an active substance and / or flavourants as defined herein. The aerosol-generating material may comprise one or more active substances and / or flavours, one or more aerosol-former materials, and optionally one or more other functional material.[000260] In some examples, the aerosolisable formulation is a liquid. In some examples the formulation is a liquid and comprises about 1% to about 25% by weight of the composition, about 50 to about 99% by weight of the aerosol-former material, and optionally nicotine, such as about 5 wt% by weight to about 20% by weight of the composition, about 60% to about 98% by weight of the aerosol-former material, and optionally nicotine, preferably about 10% by weight to about 15% by weight of the composition, about 70% to about 95% by weight of the aerosol-former material, and optionally nicotine.[000261] Nicotine may be provided in any suitable amount depending on the desired dosage when the formulation is aerosolised and inhaled by the user. Nicotine may be included in the composition even if it is already present in the composition. In some examples nicotine is present in an amount of no greater than about 6 wt% based on the total weight of the formulation. In some examples nicotine is present in an amount of from about 0.1 to about 6 wt% based on the total weight of the formulation, such as from about 0.5 to about 6 wt% based on the total weight of the formulation, preferably about 0.5 to about 5 wt% based on the total weight of the formulation.[000262] In some examples the aerosolisable formulation is a liquid and may comprise about 1% to about 25% by weight of the composition, where the composition is defined according to the examples above, about 50 to about 99 wt% of the aerosol-former material, and about 0.1 to about 6 wt% of nicotine.[000263] In some examples the formulation may contain one or more acids in addition to nicotine (as the active agent). In some examples, the one or more acids may be one or more organic acids. In some examples, the one or more acids may be one or more organic acids selected from the group consisting of benzoic acid, levulinic acid, malic acid, maleic acid, fumaric acid, citric acid, lactic acid, acetic acid, succinic acid, and mixtures thereof. When included in the formulation in combination with nicotine, the one or more acids may provide a formulation in which the nicotine is at least partially in protonated (such as monoprotonated and / or diprotonated) form.[000264] In some examples, the aerosolisable formulation / aerosol-generating material may be an extruded material or in the form of strands or strips. In some examples there is provided an aerosol generating material / system comprising the composition as defined herein, an aerosol former material, one or more binders, and optionally a botanical material. Optionally a filler may also be present. Optionally, a solvent, such as water, is also present and one or more other components of the aerosol-generating material may or may not be soluble in the solvent.[000265] The aerosol-generating material may comprise or be in the form of an aerosolgenerating film. The aerosol-generating film may comprise a binder, such as a gelling agent, and an aerosol former. Optionally, a substance to be delivered and / or filler may also be present. The aerosol-generating film may have a thickness of about 0.015 mm to about 1 mm. For example, the thickness may be in the range of about 0.05 mm, 0.1 mm or 0.15 mm to about 0.5 mm or 0.3 mm. The aerosol-generating film may be continuous. For example, the film may comprise or be a continuous sheet of material. The sheet may be in the form of a wrapper; it may be gathered to form a gathered sheet or it may be shredded to form a shredded sheet. The shredded sheet may comprise one or more strands or strips of aerosol-generating material.[000266] The aerosol-generating film may be discontinuous. For example, the aerosolgenerating film may comprise one or more discrete portions or regions of aerosol-generating material, such as dots, stripes or lines, which may be supported on a support. In such examples, the support may be planar or non-planar.[000267] The aerosol-generating film may be formed by combining a binder, such as a gelling agent, with a solvent, such as water, an aerosol-former and one or more other components,such as one or more substances to be delivered, to form a slurry and then heating the slurry to volatilise at least some of the solvent to form the aerosol-generating film. The slurry may be heated to remove at least about 60 wt%, 70 wt%, 80 wt%, 85 wt% or 90 wt% of the solvent.[000268] The aerosol-generating material may comprise or be an “amorphous solid”. In some examples, the aerosol-generating materiel comprises an aerosol-generating film that is an amorphous solid. The amorphous solid may be a “monolithic solid”. The amorphous solid may be substantially non-fibrous. In some examples, the amorphous solid may be a dried gel. The amorphous solid is a solid material that may retain some fluid, such as liquid, within it. In some examples, the amorphous solid may, for example, comprise from about 50wt%, 60wt% or 70wt% of amorphous solid, to about 90wt%, 95wt% or 100wt% of amorphous solid.[000269] In some examples, the binder consists of one or more gelling agent(s). Suitably, the aerosolisable formulation or aerosol generating system comprises from about 2 wt% to about 80 wt% binder(s), for example from about 5 wt%, 7 wt%, 10 wt%, 15 wt%, 17 wt%, 20 wt%, or 25 wt% to about 70 wt%, 60 wt%, 50 wt%, 45 wt%, 40 wt%, 35 wt% or 30 wt% of one or more binders (all calculated on a dry weight basis). For example, the aerosolisable formulation or aerosol generating system may comprise about 5-70 wt%, 7-60 wt%, 10-50 wt%, 15-45 wt%, 17-40 wt%, 20-35 wt% or 25-30 wt% of the binder(s).[000270] In some examples, the one or more binders comprises one or more gelling agent(s). In some examples, the one or more binders consist of one or more gelling agent(s). In some examples, the gelling agent comprises a hydrocolloid.[000271] In some examples, the one or more binders comprises (or is) one or more compounds selected from polysaccharide gelling agents, such as alginate, pectin, starch or a derivative thereof, cellulose or a derivative thereof, pullulan, carrageenan, agar and agarose; gelatin; gums, such as xanthan gum, guar gum and acacia gum; silica or silicone compounds, such as PDMS and sodium silicate; clays, such as kaolin; and polyvinyl alcohol.[000272] In some examples the one or more binders comprises (or is) one or more polysaccharide gelling agents. In some examples, the polysaccharide gelling agent is selected from alginate, pectin, starch or a derivative thereof, or cellulose or a derivative thereof. In some examples the polysaccharide gelling agent is selected from alginate and a cellulose derivative.[000273] In some examples, the one or more binders is a polysaccharide gelling agent, optionally wherein the polysaccharide gelling agent is selected from alginate and a cellulose derivative. In some examples, the polysaccharide gelling agent is alginate. In some examples, the alginate is sodium alginate.[000274] In some examples, the polysaccharide gelling agent is a cellulose derivative. Without wishing to be bound by theory, it is believed that such gelling agents do not react with calcium ions to form crosslinks. In some examples the binder is not crosslinked. The absence of crosslinks in the gelling agent may facilitate quicker delivery of the composition (and any optional additional active substances and / or flavours) from the aerosolisable formulation or aerosol generating system. Examples of cellulosic binders (also referred to herein as cellulosic gelling agents or cellulose derivatives) include, but are not limited to, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples the cellulose or derivative thereof is selected from hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples, the cellulose derivative is CMC. For example, in some examples, the binder comprises (or is) one or more of alginate, pectin, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, pullulan, xanthan gum, guar gum, carrageenan, agarose, acacia gum, fumed silica, PDMS, sodium silicate, kaolin and polyvinyl alcohol.[000275] In some examples, the binder comprises (or is) one or more of hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, guar gum, acacia gum, alginate and / or pectin. In some cases, the binder comprises (or is) alginate and / or pectin, and may be combined with a setting agent (such as a calcium source) during formation of the aerosolisable formulation or aerosol generating system. In some cases, the binder may comprise a calcium-crosslinked alginate and / or a calcium-crosslinked pectin. In some examples, the binder comprises (or is) alginate, optionally wherein the alginate is present in the aerosolisable formulation in an amount of from about 5-70 wt%, 7-60 wt%, 10-50 wt%, or 15-45 wt%, of the aerosolisable formulation or aerosol generating system (calculated on a dry weight basis). In some examples, alginate is the only binder present in the aerosolisable formulation / aerosol generating system. In other examples, the binder comprises alginate and at least one further binder, such as pectin. In particular examples, the binder is carboxymethylcellulose, optionally wherein the carboxymethylcellulose (CMC) is present in an amount of about 2-80 wt%, for example about 5-70 wt%, 10-60 wt%, 15-50 wt%, 17-45 wt%, 20-40 wt% or about 30 wt%. In some examples, CMC is the only binder present in the aerosolisable formulation / aerosol generating system.[000276] The aerosolisable formulation or aerosol generating material may further comprise a filler. Use of a filler may help to reduce tackiness of the aerosolisable formulation / aerosolgenerating material, for example if high levels of aerosol-former material are present. Suitably, the aerosolisable formulation / aerosol generating material comprises from about 2 wt% to about 60 wt% binder and any optional filler. In some examples, filler is present in an amount of less than about 50 wt% of a filler, such as from about 1 wt% to 50 wt%, or 5 wt% to 40 wt%, or 5 wt% to 30 wt%, or 10 wt% to 20 wt%. In other examples, filler is present in an amount of less than 20 wt%, suitably less than 10 wt% or less than 5 wt%. In some cases, the aerosolisable formulation comprises less than 1 wt% of a filler, and in some cases, comprises no filler. The filler, if present, may comprise one or more inorganic filler materials, such as calcium carbonate, perlite, vermiculite, diatomaceous earth, colloidal silica, magnesium oxide, magnesium sulphate, magnesium carbonate, and suitable inorganic sorbents, such as molecular sieves. The filler may comprise one or more organic filler materials such as wood pulp; tobacco pulp; hemp fibre; starch and starch derivatives, such as maltodextrin; chitosan; and cellulose and cellulose derivatives, such as ground cellulose, microcrystalline cellulose and nanocrystalline cellulose. In particular cases, the aerosolisable formulation comprises no calcium carbonate such as chalk.[000277] In particular examples which include filler, the filler is fibrous. For example, the filler may be a fibrous organic filler material such as wood pulp, tobacco pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous organic filler material may be wood pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous filler is wood pulp. Without wishing to be bound by theory, it is believed that including fibrous filler in an aerosolisable formulation may increase the tensile strength of the material. This may be particularly advantageous in examples wherein the aerosolisable formulation or aerosol generating material is provided as a sheet, such as when a sheet circumscribes a rod of aerosolisable or aerosol generating material.[000278] The aerosol-former material may comprise one or more constituents capable of forming an aerosol. In some examples, the aerosol-former material may comprise one or more of glycerol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3-butylene glycol, erythritol, meso-Erythritol, ethyl vanillate, ethyl laurate, a diethyl suberate, triethyl citrate, triacetin, a diacetin mixture, benzyl benzoate, benzyl phenyl acetate, tributyrin, lauryl acetate, lauric acid, myristic acid, and propylene carbonate. In heated products, the aerosol-former material can be present in an amount of greater than 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15% by weight of the aerosol-generating material.[000279] The consumable may comprise one or more further constituents. In particular, one or more further constituents may be selected from one or more active agents, and / or one or more functional constituents. In some examples, it may be desirable for the composition to comprise only some of the chemical markers disclosed herein, and this composition combinedor used with a known active or flavourant, such as menthol or CBD, in a consumable to create a cigarette-like experience with an added sensation or effect.[000280] The active agent as used herein may be a physiologically active material, which is a material intended to achieve or enhance a physiological response. The active agent may, for example, be selected from nutraceuticals, nootropics, psychoactives. The active substance may be naturally occurring or synthetically obtained. The active agent may comprise for example nicotine, caffeine, taurine, theine, vitamins such as B6 or B12 or C, melatonin, cannabinoids, or constituents, derivatives, or combinations thereof. The active substance may comprise one or more constituents, derivatives or extracts of tobacco, cannabis or another botanical. In some examples, the active substance is a legally permissible recreational drug. In some examples, the active agent comprises nicotine. In some examples, the active agent comprises caffeine, melatonin, or vitamin B12.[000281] In some examples, the active agent may comprise one or more constituents, derivatives or extracts of cannabis, such as one or more cannabinoids or terpenes. Cannabinoids are a class of natural or synthetic chemical compounds that act on cannabinoid receptors (i.e., CB1 and CB2) in cells that repress neurotransmitter release in the brain. Cannabinoids are cyclic molecules exhibiting particular properties such as the ability to cross the blood-brain barrier with ease. Cannabinoids may be naturally occurring (phytocannabinoids) from plants such as cannabis, (endocannabinoids) from animals, or artificially manufactured (synthetic cannabinoids). Cannabis species express at least 85 different phytocannabinoids, and these may be divided into subclasses, including cannabigerols, cannabichromenes, cannabidiols, tetrahydrocannabinols, cannabinols and cannabinodiols, and other cannabinoids.[000282] In some examples, the at least one cannabinoid may be selected from cannabigerol (CBG), cannabigerolic acid (CBGA), cannabichromene (CBC), cannabichromenic acid (CBCA), cannabidiol (CBD), cannabidolic acid (CBDA), tetrahydrocannabinol (THC), including its isomers A6a,10a-tetrahydrocannabinol (A6a,10a-THC), A6a(7)-tetrahydrocannabinol (A6a(7)-THC), A8-tetrahydrocannabinol (A8-THC), A9-tetrahydrocannabinol (A9-THC), A10-tetrahydrocannabinol (A10-THC), A9, 11 -tetrahydrocannabinol (A9,11-THC), tetrahydrocannabinolic acid (THCA), cannabinol (CBN), cannabinolic acid (CBNA), and cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM) and combinations thereof. According to one example, the at least one cannabinoid may be selected from cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN) and combinations thereof.[000283] Naturally derived cannabinoids are generally present in their carboxylated form. In this regard, cannabidiol (CBD) and cannabidolic acid (CBDA) are the respective decarboxylated and carboxylated forms.[000284] The cannabinoid referred to herein may be present in either the carboxylated or decarboxylated form. Exemplary carboxylated cannabinoid in this regard include cannabigerolic acid (CBGA), cannabichromenic acid (CBCA), cannabinolic acid (CBNA), tetrahydrocannabinolic acid (THCA), cannabidolic acid (CBDA) and combinations thereof.[000285] As noted herein, the active substance may comprise or be derived from one or more botanicals or constituents, derivatives or extracts thereof. As used herein, the term “botanical” includes any material derived from plants including, but not limited to, extracts, leaves, bark, fibres, stems, roots, seeds, flowers, fruits, pollen, husk, shells or the like. Alternatively, the material may comprise an active compound naturally existing in a botanical, obtained synthetically. The material may be in the form of liquid, gas, solid, powder, dust, crushed particles, an extrudate, granules, pellets, shreds, strips, sheets, or the like. Example botanicals are tobacco, eucalyptus, star anise, hemp, cocoa, cannabis, fennel, lemongrass, peppermint, spearmint, rooibos (Aspalathus linearis), chamomile, flax, ginger, ginkgo biloba, hazel, hibiscus, laurel, licorice (liquorice), matcha, mate, orange skin, papaya, rose, sage, tea such as green tea or black tea, thyme, clove, cinnamon, coffee, aniseed (anise), basil, bay leaves, cardamom, coriander, cumin, nutmeg, oregano, paprika, rosemary, saffron, lavender, lemon peel, mint, juniper, elderflower, vanilla, Wintergreen, beefsteak plant, curcuma, turmeric, sandalwood, cilantro, bergamot, orange blossom, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, geranium, mulberry, ginseng, theanine, theacrine, maca, ashwagandha, damiana, guarana, chlorophyll, baobab or any combination thereof. The mint may be chosen from the following mint varieties: Mentha Arventis, Mentha c.v., Mentha niliaca, Mentha piperita, Mentha piperita citrata c.v., Mentha piperita c.v, Mentha spicata crispa, Mentha cardifolia, Memtha longifolia, Mentha suaveolens variegata, Mentha pulegium, Mentha spicata c.v. and Mentha suaveolens.[000286] In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is tobacco. In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from eucalyptus, star anise, cocoa and hemp. In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from rooibos and fennel. In some examples, the consumable may include a botanical material in addition to any plant material, e.g. tobacco extract, present in the composition. In someexamples, this may be advantageous to include other flavourants and / or aroma compounds and / or active agents in the second plant material.[000287] When nicotine is present in the formulation, it may be present in protonated and / or un-protonated form. In some examples, the formulation comprises nicotine in unprotonated form and nicotine in monoprotonated form. It may also be that small amounts of diprotonated nicotine are present. In one example the formulation comprises nicotine in unprotonated form, nicotine in monoprotonated form and nicotine in diprotonated form. As will be understood by one skilled in the art, the protonated form of nicotine may be prepared by reacting unprotonated nicotine with an acid. The acid(s) are one or more suitable acids, such as organic acids. In some examples, the acid is a carboxylic acid. The carboxylic acid may be any suitable carboxylic acid. In some examples, the acid is a mono-carboxylic acid. In some examples, the acid is selected from the group comprising of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, isobutyric acid, butyric acid, methylbutyric acid, 2-methylbutyric acid, 3-methylpentanoic acid, isovaleric acid, valeric acid, hexanoic acid, hepatanoic acid, octanoic acid, nonanoic acid, methylvaleric acid, decanoic acid, glycolic acid, 2-butenedioic acid (Z), 2-butenedioic acid (E), succinic acid, glyceric acid, malic acid, pyroglutamic acid, trihydroxybutanoic acid, tetrahydroxypentanoic acid, 2-keto-L-gluconicacid, quinic acid, gluconic acid, galactaric acid, hexadecanoic acid, caffeic acid, linoleic acid, linolenic acid, glucuronic acid, chlorogenic acid, fumaric acid, maleic acid, oxalic acid, oxaloacetic acid, acetoacetic acid, beta-hydroxybutyric acid, alpha-ketoglutaric acid, alphaketobutyric acid and mixtures thereof.[000288] In some examples, the one or more acids are selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoicacid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof.[000289] In some examples, the one or more acids consist of benzoic acid and one more organic acids selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof. In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of acetic acid, heptanoic acid, isobutyric acid, isovaleric acid, methylbutyric acid, 3-methylpentanoic acid, methylvaleric acid, phenylacetic acid, valeric acid, butyric acid, decanoic acid and combinations thereof. In some examples, the one or more organic acids are selected from benzoic acid, levulinic acid, lactic acid and combinations thereof. In some examples, the one or more organic acids are selected from benzoic acid,levulinic acid and combination thereof. In some examples, the one or more organic acids are selected from benzoic acid, lactic acid and combination thereof. In some examples, the one or more organic acids are a combination of benzoic acid, levulinic acid and lactic acid. In some examples, the one or more organic acids are a combination of benzoic acid and levulinic acid. In some examples, the one or more organic acids are a combination of benzoic acid and lactic acid. In some examples, the organic acid is benzoic acid. In some examples, the organic acid is levulinic acid. In alternative examples, the aerosolisable formulation may be free of inorganic acids and their corresponding salts. For example, the aerosolisable formulation may be free of phosphoric acids.[000290] Where present, the amount of organic acid present may vary. The formulation may comprise from about 0.01% to about 10% by weight of organic acid, present as one or more organic acids, based on the total weight of the formulation. In some examples, the formulation comprises at least about 0.01%, at least about 0.1 %, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or at least about 10% organic acid by weight, based on the total weight of the formulation. In some preferred examples, the formulation comprises from about 0.01 % to about 5% by weight of organic acid. For example, the formulation comprises an organic acid in an amount of from about 0.1% to about 2.5% by weight of the formulation. In the case where a salt of an organic acid is added (e.g., citric acid anhydrate), the percent by weight is calculated based on the weight of the free acid, not including any counter-ion which may be present.[000291] In some examples, the total content of the one or more organic acids is of from 0.7 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.7 to 1.3 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.8 to 1.3 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.8 to 1.2 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.9 to 1.2 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.9 to 1.1 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.8 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.9 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 1.0 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from1.1 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 1.2 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 1.3 to 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 1.3 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 1.2 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 1.1 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 1.0 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 0.9 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 0.8 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is of from 0.6 to 0.7 mole equivalents based on the nicotine, when present.[000292] In some examples, the total content of the one or more organic acids is 1.4 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is 1.0 mole equivalents based on the nicotine, when present. In some examples, the total content of the one or more organic acids is 0.6 mole equivalents based on the nicotine, when present.[000293] In some examples, the further constituent comprises a flavour. As used herein, the terms "flavour" and "flavourant" refer to materials which, where local regulations permit, may be used to create a desired taste, aroma, or other somatosensory sensation in a product for adult consumers. They may include naturally occurring flavour materials, botanicals, extracts of botanicals, synthetically obtained materials, or combinations thereof (e.g., tobacco, cannabis, licorice (liquorice), hydrangea, eugenol, Japanese white bark magnolia leaf, chamomile, fenugreek, clove, maple, matcha, menthol, Japanese mint, aniseed (anise), cinnamon, turmeric, Indian spices, Asian spices, herb, Wintergreen, cherry, berry, red berry, cranberry, peach, apple, orange, mango, clementine, lemon, lime, tropical fruit, papaya, rhubarb, grape, durian, dragon fruit, cucumber, blueberry, mulberry, citrus fruits, Drambuie, bourbon, scotch, whiskey, gin, tequila, rum, spearmint, peppermint, lavender, aloe Vera, cardamom, celery, cascarilla, nutmeg, sandalwood, bergamot, geranium, khat, naswar, betel, shisha, pine, honey essence, rose oil, vanilla, lemon oil, orange oil, orange blossom, cherry blossom, cassia, caraway, cognac, jasmine, ylang-ylang, sage, fennel, wasabi, piment, ginger, coriander, coffee, hemp, a mint oil from any species of the genus Mentha, eucalyptus, star anise, cocoa, lemongrass, rooibos (Aspalathus linearis), flax, ginkgo biloba, hazel, hibiscus,laurel, mate, orange skin, rose, tea such as green tea or black tea, thyme, juniper, elderflower, basil, bay leaves, cumin, oregano, paprika, rosemary, saffron, lemon peel, mint, beefsteak plant, curcuma, cilantro, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, limonene, thymol, camphene), flavour enhancers, bitterness receptor site blockers, sensorial receptor site activators or stimulators, sugars and / or sugar substitutes (e.g., sucralose, acesulfame potassium, aspartame, saccharine, cyclamates, lactose, sucrose, glucose, fructose, sorbitol, or mannitol), and other additives such as charcoal, chlorophyll, minerals, botanicals, or breath freshening agents. They may be imitation, synthetic or natural ingredients or blends thereof. They may be in any suitable form, for example, liquid such as an oil, solid such as a powder, or gas.[000294] The flavour may be added to the consumable as part of a so-called “flavour block”, where one or more flavours are blended together and then added to the substrate material.[000295] In some examples, the flavour comprises menthol, spearmint and / or peppermint. In some examples, the flavour comprises flavour components of cucumber, blueberry, citrus fruits and / or redberry. In some examples, the flavour comprises eugenol. In some examples, the flavour comprises flavour components extracted from tobacco. In some examples, the flavour comprises flavour components extracted from cannabis.[000296] In some examples, the flavour may comprise a sensate, which is intended to achieve a somatosensory sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect. A suitable heat effect agent may be, but is not limited to, vanillyl ethyl ether and a suitable cooling agent may be, but not limited to eucalyptol (if not already present in the composition), WS-3.[000297] Where present, a flavouring agent may be included in the formulation in an amount up to about 10% by weight, such as up to about 5% by weight, such as up to about 1% by weight of the formulation. In some examples, a flavouring agent is present in an amount of from about 0.01% to about 5% by weight, preferably in an amount of from about 0.1% to about 2.5% by weight of the formulation, and more preferably in an amount of from about 0.25% to about 1% by weight of the formulation.[000298] The one or more other functional constituents may comprise one or more of colouring agents, pH regulators, preservatives, stabilizers, and / or antioxidants. A colouring agent may be employed in amounts sufficient to provide the desired physical attributes to the product. The colouring agent may, for example, alter the visual appearance of the formulation andfurther, may colour-match the formulation to other components of the aerosolisable formulation or other components of a consumable comprising the formulation. In some examples, the colouring agent may be included so as to confer the aerosolisable formulation with a brown appearance.[000299] When the consumable comprises aerosol-generating material, the consumable may further comprise one or more other components, such as an aerosol-generating section, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generation area, a housing, a wrapper, a mouthpiece, a filter and / or an aerosolmodifying agent.[000300] A consumable may also comprise an aerosol generator, such as a heater, that emits heat to cause the aerosol-generating material to generate aerosol in use. The heater may, for example, comprise combustible material, a material heatable by electrical conduction, or a susceptor. The aerosol-generating section and / or the aerosol-generating material may comprise a cavity for receiving an aerosol-generator, such as a blade or a pin, of a noncombustible aerosol provision device. A susceptor is a material that is heatable by penetration with a varying magnetic field, such as an alternating magnetic field. The susceptor may be an electrically-conductive material, so that penetration thereof with a varying magnetic field causes induction heating of the material. The material may be a magnetic material, so that penetration thereof with a varying magnetic field causes magnetic hysteresis heating of the heating material. The susceptor may be both electrically-conductive and magnetic, so that the susceptor is heatable by both mechanisms. A device or a consumable may comprise the susceptor. For example, the aerosol-generating section of a consumable may comprise aerosol-generating material and a susceptor.[000301] A consumable may be in the form of a rod and may comprise a downstream mouthend and an upstream end.[000302] Consumables are often named according to their length: "regular" (typically in the range 68-75 mm, e.g. from about 68 mm to 25 about 72 mm), "short" or "mini" (68 mm or less), "king-size" (typically in the range 75-91 mm, e.g. from about 79 mm to about 88 mm), "long" or "super-king" (typically in the range 91-105 mm, e.g. from about 94 mm to about 101 mm) and "ultra-long" (typically in the range from about 110 mm to about 121 mm). Typical heating product consumable circumferences are: "regular" (about 23-25 mm), "wide" (greater than 25 mm), "slim" (about 22-23 mm), "demi-slim" (about 19-22 mm), "super-slim" (about 16-19 mm), and "micro-slim" (less than about 16 mm). Accordingly, for example, a consumable in demi-slim size will have a length of about 75 mm and a circumference of about 21 mm. Aconsumable in a king-size, super-slim format will have a length of about 83 mm and a circumference of about 17 mm, for example.[000303] Articles may include an aerosol-generating material and a downstream portion downstream of the aerosol-generating material, and each format may be produced with downstream portions of different lengths. The downstream portion length will usually be from about 30 mm to 50 mm. A tipping paper connects the downstream portion to the aerosol generating material and will usually have a greater length than the downstream portion, for example from 3 to 10 mm longer, such that the tipping paper covers the downstream portion and overlaps the aerosol generating material, for instance in the form of a rod, to connect the downstream portion to the rod.[000304] The consumable may comprise aerosol-generating material that is wrapped in a wrapper. The wrapper may, for example, be a paper or a paper-backed foil wrapper. The wrapper can be permeable, partially permeable or impermeable to gas.[000305] An aerosol-modifying agent is a substance, typically located downstream of the aerosol generation area, that is configured to modify the aerosol generated, for example by changing the taste, flavour, acidity or another characteristic of the aerosol. The aerosolmodifying agent may be provided in an aerosol-modifying agent release component, that is operable to selectively release the aerosol-modifying agent. The aerosol-modifying agent may, for example, be an additive or a sorbent. The aerosol-modifying agent may, for example, comprise one or more of a flavourant, a colourant, water, and a carbon adsorbent. The aerosol-modifying agent may, for example, be a solid, a liquid, or a gel. The aerosol-modifying agent may be in powder, thread or granule form. The aerosol-modifying agent may be free from filtration material.[000306] An aerosol generator is an apparatus configured to cause aerosol to be generated from the aerosol-generating material. In some examples, the aerosol generator is a heater configured to subject the aerosol-generating material to heat energy, so as to release one or more volatiles from the aerosol-generating material to form an aerosol. In some examples, the aerosol generator is configured to cause an aerosol to be generated from the aerosolgenerating material without heating. For example, the aerosol generator may be configured to subject the aerosol-generating material to one or more of vibration, increased pressure, or electrostatic energy. The aerosol generator may comprise a projection that is configured to subject the aerosol-generating material to heat energy, such as a blade or pin heater. The projection may be configured for insertion into the aerosol-generating section of a consumable. The aerosol generator may be configured to heat the aerosol-generating material to a temperature of up to about 500 °C, about 450 °C, or about 400 ° C or about 350 °C.[000307] Exemplary aerosol generator technologies include: for heater technologies: a resistive heater, an infrared heater, an induction heater, a laser heater, a plasma heater, a microfluidic heater, a convection heater, allotrope of carbon heater, carbon foam heater, a radio-frequency heater, an electro-resistive heater, a halogen heater; for non-heating technology: vibration vaporiser, surface acoustic wave vaporiser, increased pressure vaporiser, electrostatic energy vaporiser, an ultrasonic vaporiser.Containers and Packages[000308] In a further aspect there is provided a container or package comprising the composition or consumable as defined herein. In some examples, there is provided a pouched oral product comprising a saliva permeable pouch. In other examples, there is provided a cartridge for an aerosol provision system.[000309] The pouched oral product is configured for oral use which means that the composition is provided in a form such that during use, saliva in the mouth of the user causes one or more of the components of the composition (e.g., flavouring agents and / or active ingredients) to pass into the mouth of the user. In some examples, the composition is adapted to deliver components to a user through mucous membranes in the user's mouth, the user's digestive system, or both, and, in some instances, said component is an active ingredient (including, but not limited to, for example, nicotine, a stimulant, vitamin, an amino acid, a botanical, or combinations thereof) that can be absorbed through the mucous membranes in the mouth or absorbed through the digestive tract when the product is used.[000310] The pouched oral product may comprise a particulate filler component. As used herein, the term "particulate" refers to a material in the form of a plurality of individual particles. Particulate fillers may fulfil multiple functions, such as enhancing certain organoleptic properties such as texture and mouthfeel, enhancing cohesiveness or compressibility of the product, and the like. Generally, the filler is a porous particulate material and often is cellulose-based. For example, suitable fillers are any non-tobacco plant material or derivative thereof, including cellulose materials derived from such sources. Examples of cellulosic non-tobacco plant material include cereal grains (e.g., maize, oat, barley, rye, buckwheat, and the like), sugar beet (e.g., FIBREX® brand filler available from International Fiber Corporation), bran fiber, and mixtures thereof. Non-limiting examples of derivatives of non-tobacco plant material include starches (e.g., from potato, wheat, rice, corn), natural cellulose, and modified cellulosic materials. Additional examples of potential fillers include maltodextrin, dextrose, calcium carbonate, calcium phosphate, lactose, mannitol, xylitol, and sorbitol. Combinations of fillers can also be used.[000311] In some examples, the particulate filler comprises a starch, a cellulose material, or both. "Starch" as used herein may refer to pure starch from any source, modified starch, or starch derivatives. Starch is present, typically in granular form, in almost all green plants and in various types of plant tissues and organs (e.g., seeds, leaves, rhizomes, roots, tubers, shoots, fruits, grains, and stems). Starch can vary in composition, as well as in granular shape and size. Often, starch from different sources has different chemical and physical characteristics. A specific starch can be selected for inclusion in the mixture based on the ability of the starch material to impart a specific organoleptic property to composition. Starches derived from various sources can be used. For example, major sources of starch include cereal grains (e.g., rice, wheat, and maize) and root vegetables (e.g., potatoes and cassava). Other examples of sources of starch include acorns, arrowroot, arracacha, bananas, barley, beans (e.g., favas, lentils, mung beans, peas, chickpeas), breadfruit, buckwheat, canna, chestnuts, colacasia, katakuri, kudzu, malanga, millet, oats, oca, Polynesian arrowroot, sago, sorghum, sweetpotato, quinoa, rye, tapioca, taro, tobacco, water chestnuts, and yams. Certain starches are modified starches. A modified starch has undergone one or more structural modifications, often designed to alter its high heat properties. Some starches have been developed by genetic modifications and are considered to be "modified" starches. Other starches are obtained and subsequently modified. For example, modified starches can be starches that have been subjected to chemical reactions, such as esterification, etherification, oxidation, depolymerization (thinning) by acid catalysis or oxidation in the presence of base, bleaching, transglycosylation and depolymerization (e.g., dextrinization in the presence of a catalyst), cross-linking, enzyme treatment, acetylation, hydroxypropylation, and / or partial hydrolysis. Other starches are modified by heat treatments, such as pregelatinization, dextrinization, and / or cold-water swelling processes. Certain modified starches include monostarch phosphate, distarch glycerol, distarch phosphate esterified with sodium trimetaphosphate, phosphate distarch phosphate, acetylated distarch phosphate, starch acetate esterified with acetic anhydride, starch acetate esterified with vinyl acetate, acetylated distarch adipate, acetylated distarch glycerol, hydroxypropyl starch, hydroxypropyl distarch glycerol, starch sodium octenyl succinate.[000312] In some examples, the particulate filler comprises a cellulose material. One nonlimiting example of a suitable cellulose material for use in the products described herein is microcrystalline cellulose ("MCC"). The MCC may be synthetic or semi-synthetic, or it may be obtained entirely from natural celluloses. The MCC may be selected from the group consisting of AVICEL® grades PH-100, PH-102, PH-103, PH-105, PH-112, PH-113, PH-200, PH-300, PH-302, VIVACEL® grades 101, 102, 12, 20 and EMOCEL® grades 50M and 90M, and the like, and mixtures thereof.[000313] The filler component may further comprise a cellulose derivative or a combination of such derivatives. In some examples, the cellulose derivative is a cellulose ether (including carboxyalkyl ethers), meaning a cellulose polymer with the hydrogen of one or more hydroxyl groups in the cellulose structure replaced with an alkyl, hydroxyalkyl, or aryl group. Nonlimiting examples of such cellulose derivatives include methylcellulose, hydroxypropylcellulose ("HPC"), hydroxypropylmethylcellulose ("HPMC"), hydroxyethyl cellulose, and carboxymethylcellulose ("CMC"). In some examples, the composition comprises from about 0.1% to about 5% of HPC or other cellulose derivative by weight, e.g., about 1% to about 3% HPC or other cellulose derivative by weight, based on the total weight of the composition.[000314] In some examples, a particulate filler can be characterized as substantially spherical, such as cellulose spheres. By “substantially spherical” is meant at least a portion of the particulate filler component is in the shape of a sphere and / or is “sphere-like’ in shape. As such, “substantially spherical” encompasses slightly elongated (e.g., oval) shapes, slightly flattened shapes, and the like. Substantially spherical particulate filler components are intended to be distinguished from conventional particulate filler components (e.g., commercially available “fillers” or “particulate fillers” that are not explicitly designed as “spherical”). Such conventional particulate filler components typically substantially comprise particles with rather irregular shapes. In some cases, at least some (e.g., including a majority) of such conventional particulate filler components comprise one or more edges (e.g., jagged edges) that are typically not observable on substantially spherical particulate filler components as employed in the context of the present disclosure. Further, the uniformity of the particle shapes and sizes of a substantially spherical filler component is generally much greater than that of a conventional particulate filler component.[000315] In some examples, the substantially spherical filler component comprises MCC. In some examples, the substantially spherical filler component comprises solid (although porous) MCC spheres. In some examples, the substantially spherical filler component comprises hollow MCC spheres. In some examples, the center / core of such hollow MCC spheres may be unfilled; in some examples, the center / core of such hollow MCC spheres may be filled with one or more additional components (e.g., flavorants, fillers, active ingredients, etc.). Examples of suitable MCC spheres include, but are not limited to, Vivapur® MCC spheres from JRS Pharma, available, e.g., with particle sizes of 100-200 pm (Vivapur® 100), 200-355 pm (Vivapur® 200), 355-500 pm (Vivapur® 350), 500-710 pm (Vivapur® 500), 710-1000 pm (Vivapur®700), and 1000-1400 pm (Vivapur® 1000). Further examples of suitable MCC spheres include, but are not limited to, Celphere™ MCC spheres from Asahi Kasei Corporation, available, e.g., with particle sizes of 75-212 pm (Celphere™ SCP-100), 106-212pm (Celphere™ CP-102), 150-300 pm (Celphere™ CP-203), 300-500 pm (Celphere™ CP-305), and 500-710 pm (Celphere™ CP-507).[000316] The quantity of the particulate filler (e.g., MCC) may vary. The amount of filler component on a wet weight basis can vary but is typically up to about 75 percent of the total product by weight. A typical range of filler component can be from about 10 to about 75 percent, for example, from about 10, about 15, about 20, about 25, or about 30, to about 35, about 40, about 45, about 50, about 55, about 60, about 65, about 70, or about 75 weight percent (e.g., about 15 to about 60 weight percent, or about 25 to about 45 weight percent) on a wet weight basis. In some examples, the amount of particulate filler component is at least about 10 percent by weight, such as at least about 20 percent, or at least about 25 percent, or at least about 30 percent, or at least about 35 percent, or at least about 40 percent, based on the total weight of the product.[000317] The water content of the product, prior to use by a consumer, may vary according to the desired properties. Typically, the oral product is less than about 60 percent by weight of water, and generally is from about 1 to about 60% by weight of water, for example, from about 5 to about 55, about 10 to about 50, about 20 to about 45, or about 25 to about 40 percent water by weight, including water amounts of at least about 5% by weight, at least about 10% by weight, at least about 15% by weight, and at least about 20% by weight, based on the total weight of the product.Process and Aerosol / Aerosolised Formulation[000318] In another aspect there is provided a process for forming an aerosol, the process comprising providing a consumable as defined herein, wherein the consumable comprises aerosol-former material, and aerosolising the consumable. The process may alternatively comprise providing the aerosol generating system as defined herein or the aerosol provision system defined herein and aerosolising the formulation or consumable in the system.[000319] In another aspect, there is provided an aerosolised formulation formed from a noncombustible aerosol provision device, wherein the aerosolised formulation comprises one or more of the compounds defined herein.[000320] In some examples, the aerosolised formulation may comprise acetic acid.Uses[000321] In accordance with some aspects of the present disclosure, there is provided use of a composition to modify the tobacco flavour of a consumable in a substance delivery system, wherein the composition comprises one or more compounds as defined herein (a) to (d).[000322] In some examples; the composition and substance delivery system is as defined in any of the above paragraphs. In this respect, the skilled person will appreciate that the disclosure relating to the compositions, consumable and substance delivery system applies mutatis mutandis to the uses disclosed herein. The use of the composition to modify the tobacco flavour is, in some examples, relative to the consumable without the composition. In some examples, the composition increases the tobacco flavour of the consumable. In some examples, the composition increases the tobacco flavour intensity of the consumable.[000323] In accordance with some aspects of the present disclosure, there is provided the use of a composition as defined herein to modify the irritation of a consumable in a substance delivery system. The use of the composition to modify the irritation is, in some examples, relative to the consumable without the composition. In some examples, the composition increases the irritation of the consumable. In some examples, the composition increases the irritation intensity of the consumable.[000324] In accordance with some aspects of the present disclosure, there is provided the use of a composition as defined herein to modify the taste of a consumable in a substance delivery system. The use of the composition to modify the taste is, in some examples, relative to the consumable without the composition. In some examples, the composition increases the tobacco taste of the consumable. In some examples, the composition increases the tobacco taste intensity of the consumable.[000325] In some examples; the composition and substance delivery system is as defined in any of the above paragraphs. In this respect, the skilled person will appreciate that the disclosure relating to the compositions, consumable and substance delivery system applies mutatis mutandis to the uses disclosed herein.[000326] In some examples, the composition of the present disclosure includes one or more compounds listed above for taste modification. Such compounds may be termed taste markers.[000327] The present invention will now be described with reference to the following nonlimiting examples.EXAMPLESExample 1[000328] Nine different tobacco extracts were formed. The extracts were formed from different blends of flue-cured Virginia tobacco, air-cured Burley tobacco, sun-cured Oriental tobacco, and fire-cured Dark tobacco, using a combination of solvent extraction methods. Each of these extracts was analysed to determine the compounds therein; analysis was performed using GC-MS. Specifically, compounds and their amounts could be identified based on GC-MS spectra as compared to reference MS libraries and reference compounds.[000329] Once the compounds and their amounts had been identified for each of the different tobacco extracts, the compounds were classified according to their chemical group (e.g. aliphatic ester and the like). In total, over 300 chemical compounds were identified across the tobacco extracts analysed. Once classified into groups, the molecular weight of each compound was identified from literature sources and the compounds were assigned a flavour profile contribution if appropriate. As a result of this grouping and flavour profile assignment, the inventors identified the combination of chemical groups as defined in the appended claims which provide a ‘FMC’-like flavour experience when used in a composition for a substance delivery system.[000330] Table 1 below summarises several of the chemical groups, exemplary compounds thereof and the flavour profile contribution.Table 1 : Chemical Groups, Exemplary Compounds, Flavour Profile ContributionChemical Group Exemplary Compounds Flavour Profile Contribution Carboxylic acid Acetic acid Creamy / Sweet / Green / Spicy / Savoury / FruitySaturated fatty acid 2-methylbutanoic acidpentanoic acid, 3-methyl- pentanoic acid, 3-methyl- valeric aciddecanoic aciddodecanoic acidoctanoic acidpelargonic acidtetradecanoic acidpalmitic acidstearic acidUnsaturated fatty acid pentadecanoic acid9,12,15-octadecatrienoic acid, (z,z,z)- linolenic acidelaidic acidAromatic carboxylic acid (3,4-dimethoxyphenyl) acetic acidbenzoic acidphenylacetic acid[000331] Tables 2a to 2c provide more detailed information on the grouping and levels of flavour compounds present in the seven tobacco extracts analysed. Some compounds fall into multiple classes and may therefore be listed twice. The term “derivative” is used interchangeably herein with “substituted”.Table 2a - Tobacco Extractsl & 2Level in tobacco Level in tobacco Compounds MW Classextract 1 (pg / g) extract 2 (pg / g) ethyl octanoate 172.26 Aliphatic ester 4ethyl decanoate 186.29 Aliphatic ester 1ethyl tetradecanoate 256.42 Aliphatic ester 2methyl palmitate 270.45 Aliphatic ester 19ethyl palmitate 284.48 Aliphatic ester 29ethyl linolenate 306.49 Aliphatic ester 62ethyl linoleate 308.5 Aliphatic ester 23ethyl stearate 312.53 Aliphatic ester 5methyl linolenate 292.47 Aliphatic ester 4 -docosahexaenoic acid342.49 Aliphatic ester 20 21 methyl esterbenzyl alcohol 108.14 Aromatic alcohol 11 benzenemethanol, alpha- 122.16 Aromatic alcohol 3 - methyl- 2-phenylethanol 122.17 Aromatic alcohol 11 1 -phenylpropane-1 ,2-diol 152.19 Aromatic Alcohol 6 1-phenyl-2-butanol 150.22 Aromatic alcohol 0.5 ethyl phenylacetate 164.19 Aromatic ester 1phenylethyl isovalerate 192.26 Aromatic ester 0.3benzyl benzoate 212.25 Aromatic ester 1phenethyl phenylacetate 240.3 Aromatic ester 1scopoletin 192.17 Aromatic ester 34 70 methyl 4-fluoro-3- 170.15 Aromatic ester - 3 methoxybenzoate2,5-diacetoxytoluene 194.2 Aromatic ester - 7 2,6- 196.2 Aromatic ester - 7 dimethoxyphenylacetate2-chloroethyl benzoate 170.61 Aromatic ester - 16 dibutyl phthalate 278.34 Aromatic ester - 10 ethyl acetate 88.11 Carboxylate ester - 0.7 methyl methoxyacetate 104.11 Carboxylate ester 3 2-hydroxypropylacetate 104.1 Carboxylate ester 17 dibutyl phthalate 278.34 Carboxylate ester 10Aromatic carboxylicbenzoic acid 122.12 13 - acidacetic acid 60.05 Carboxylic acid 46Aromatic carboxylicphenylacetic acid 136.15 4 28 acid2-methylbutanoic acid 102.13 Saturated fatty acid 4 6 pentanoic acid, 3-methyl- 102.13 Saturated fatty acid 3palmitic acid 256.42 Saturated fatty acid 89 -9,12,15-octadecatrienoic Unsaturated fatty278.43 75 - acid, (z,z,z)- acidvaleric acid 102.13 Saturated fatty acid 3 tetradecanoic acid 228.37 Saturated fatty acid 7Unsaturated fatty242.4 - 8 pentadecanoic acid acidpalmitic acid 256.42 Saturated fatty acid 141 stearic acid 284.48 Saturated fatty acid 7Unsaturated fatty278.43 - 72 linolenic acid acidUnsaturated fatty282.46 - 36 elaidic acid acidCarboxylic214.32 - 1 hexanoyl hexanoate anhydridesclareolide 310.5 Lactone 15 - butyrolactone 86.09 Lactone 3 3 (2,6,6-trimethyl-2-hydroxycyclohexylidene)ac 180.24 Lactone 6 - etic acid lactonemaltol (3-Hydroxy-2- 126.11 Lactone 4 - methyl-4H-pyran-4-one)ethyl maltol (2-Ethyl-3- 144.16 Lactone 55 - hydroxy-4H-pyran-4-one)scopoletin 192.17 Lactone 34 70 sclareolide 310.5 Lactone 15but-2-en-4-olide 100.1 Lactone 3 dl-pantolactone 132.16 Lactone 5 alpha-leva ntanolide 166.22 Lactone 11 (2,6,6-trimethyl-2-hydroxycyclohexylidene)ac 180.24 Lactone - 18 etic acid lactone5-methoxypsoralen 216.19 Lactone 2 2-methoxyphenol 124.14 Phenol derivative 82,3-dimethoxyphenol 154.16 Phenol derivative 54-ethyl-2-methoxyphenol 166.21 Phenol derivative 0.9 -4-Ethyl-2,6- di 182.22 Phenol derivative 2 - methoxyphenol2,4-di-tert-butylphenol 206.3 Phenol derivative 34-Hydroxy-3- - methoxybenzaldehyde 152.15 Phenol derivative 151-(4-Hydroxy-3,5- dimethoxyphenyl)ethan-1 - 196.18 Phenol derivative 0.5 - one2- pyrrol id i n- 1 -ylphenol 151.19 Phenol derivative 0.5 3-cyclohexylphenol 162.23 Phenol derivative 52 4-(2-hydroxyethyl)-2- 168.18 Phenol derivative - 1 methoxyphenol2,6-dimethoxy-4- - methylphenol 168.19 Phenol derivative 7 2,6-dicyclohexylphenol 218.32 Phenol derivative - 10 2,4-dihydroxy-6- 152.15 Phenol derivative - 1 methylbenzaldehydeMethyl 3,4,5- 170.15 Phenol derivative - trihydroxybenzoate 3 1-(2-Hydroxy-4- - methoxyphenyl)ethan-1 - 166.17 Phenol derivative 4 onephenol 94.11 Phenolic compound 2 2, 3, 5-tri methylpyrazine 122.16 Pyrazine derivative 7pyrazine, 2,6-diethyl- 136.19 Pyrazine derivative 42, 3,5,6- - 136.19 Pyrazine derivative 8 tetramethylpyrazine- 2,5-dimethyl pyrazine 108.14 Pyrazine derivative 8- isopropenylpyrazine 120.15 Pyrazine derivative 0.4- acetylpyrazine 122.12 Pyrazine derivative 81-(5-methylpyridin-3- - 135.17 Pyridine derivative 0.9 yl)ethanone3-phenylpyridine 155.19 Pyridine derivative 0.9 1 -pyridin-3-ylethanone 121.14 Pyridine derivative 3- 2-(3-pyridinyl)-2-pyrroline 132.16 Pyridine derivative 76Table 2b - Tobacco Extracts 3 & 4Level inLevel in tobacco Compounds MW Class tobacco extractextract 4 (pg / g) 3 (pg / g)ethyl octanoate 172.26 Aliphatic ester 4ethyl decanoate 186.29 Aliphatic ester 2ethyl tetradecanoate 256.42 Aliphatic ester 5methyl palmitate 270.45 Aliphatic ester 7 5 ethyl palmitate 284.48 Aliphatic ester 17 2 methyl linoleate 292.46 Aliphatic ester 11ethyl linolenate 306.49 Aliphatic ester 31ethyl linoleate 308.5 Aliphatic ester 10ethyl stearate 312.53 Aliphatic ester 3docosahexaenoic acid342.49 Aliphatic ester - 38 methyl esterbenzyl alcohol 108.14 Aromatic alcohol 52 - 1 -phenylethanol 122.17 Aromatic alcohol 1 - 2-phenylethanol 122.17 Aromatic alcohol - 16 1 -phenylpropane-1 ,2-diol 152.19 Aromatic Alcohol - 6 ethyl phenylacetate 164.19 Aromatic ester 2 - 2,5-diacetoxytoluene 194.2 Aromatic ester - 132,6- 196.2 Aromatic ester - 11 dimethoxyphenylacetatemethyl biphenyl-4- 198.22 Aromatic ester - 2 carboxylatedibutyl phthalate 278.34 Aromatic ester 8 5 Methyl 3,4,5- 170.15 Aromatic ester - 2 trihydroxybenzoate(3-hydroxyphenyl)214.22 Aromatic ester - 15 benzoateethyl acetate 88.11 Carboxylate ester 8 0.8 ethyl isovalerate 130.19 Carboxylate ester 0.8mono-ethyl succinate 146.14 Carboxylate ester - 1triethyl citrate 276.29 Carboxylate ester 0.42-hydroxypropylacetate 104.1 Carboxylate ester 24 dibutyl phthalate 278.34 Carboxylate ester 8 5Aromatic carboxylic136.15 - 57 phenylacetic acid acid2-methylbutanoic acid 102.13 Saturated fatty acid 0.5 13 3-methylvaleric acid 102.13 Saturated fatty acid 39 valeric acid 102.13 Saturated fatty acid 0.4pelargonic acid 158.24 Saturated fatty acid 3 tetradecanoic acid 228.37 Saturated fatty acid 21 pentadecanoic acid 242.4 Saturated fatty acid 12 palmitic acid 256.42 Saturated fatty acid 31 206 linolenic acid 278.43 Unsaturated fatty acid 28 97 elaidic acid 282.46 Unsaturated fatty acid 45 hexanoyl hexanoate 214.32 Carboxylic anhydride 3 butyrolactone 86.09 Lactone 1 3 but-2-en-4-olide 100.1 Lactone 2 dl-pantolactone 132.16 Lactone 7 (2,6,6-trimethyl-2-hydroxycyclohexylidene)ac 180.24 Lactone 2 20 etic acid lactoneloliolide 196.22 Lactone 14 5-methoxypsoralen 216.19 Lactone 4 6-methoxyfuro[2,3- 218.2 Lactone - 2 hlchromen-2-one2 , 3-d ihyd ro-3 , 5-d ihyd roxy- 144.13 Lactone - 12 6-methyl-4(h)-pyran-4-oneethyl maltol (2-Ethyl-3- 144.16 Lactone 175 - hydroxy-4H-pyran-4-one)7-ethoxycoumarin 190.2 Lactone 1 scopoletin 192.17 Lactone 24 105Phenol 94.11 Phenolic compound - 32,5-dimethyl pyrazine 108.14 Pyrazine derivative 1acetyl pyrazine 122.12 Pyrazine derivative 4n-phenylpyridine-3- 198.22 Pyridine derivative - 1 carboxamide1-(5-methylpyridin-3- 135.17 Pyridine derivative - 1 yl)ethanonethionicotinic acid 139.15 Pyridine derivative 6 3-phenylpyridine 155.19 Pyridine derivative 1 2-(pyridin-2- 168.21 Pyridine derivative - 2 ylmethyl)pyridine3-methyl-2-phenylpyridine 169.22 Pyridine derivative 0.52-(3-pyridinyl)-2-pyrroline 132.16 Pyridine derivative - 187Table 2c -Tobacco Extracts 5, 6 & 7Level in Level in Level in tobacco tobacco tobacco Compounds MW Classextract 5 extract 6 extract 7 (pg / g) (pg / g) (pg / g) ethyl tetradecanoate 256.42 Aliphatic ester 6methyl palmitate 270.45 Aliphatic ester 2 22 pentadecanoic acid,270.45 Aliphatic ester - 1 - ethyl esterethyl palmitate 284.48 Aliphatic ester 7 38methyl linoleate 292.46 Aliphatic ester 2 35ethyl linolenate 306.49 Aliphatic ester 14 108ethyl linoleate 308.5 Aliphatic ester 3 40ethyl stearate 312.53 Aliphatic ester 3 5benzyl alcohol 108.14 Aromatic alcohol 0.7 1 -phenylethanol 122.17 Aromatic alcohol 1methyl benzoate 136.15 Aromatic ester - - 11 ethyl phenylacetate 164.19 Aromatic ester - 2 - isobutyl benzoate 164.2 Aromatic ester - - 8benzyl benzoate 212.25 Aromatic ester - 4 -phenethyl phenylacetate 240.3 Aromatic ester 2 diethylene glycol302.31 Aromatic ester - - 8 dibenzoate2-hydroxyethyl benzoate 152.15 Aromatic ester 3 dibutyl phthalate 278.34 Aromatic ester 116-hydroxy-4- 176.17 Aromatic ester - 14 - methylcoumarin(3-hydroxyphenyl)214.22 Aromatic ester - - 0.3 benzoateethyl acetate 88.11 Carboxylate ester 1 3isopropyl formate 102.13 Carboxylate ester 2triethyl citrate 276.29 Carboxylate ester 0.71 ,2,3-propanetriol,1- 134.14 Carboxylate Ester - - 14 acetate2-hydroxypropylacetate 104.1 Carboxylate ester - - 12 1 ,1-ethanediol, diacetate 132.16 Carboxylate ester 3 - - dibutyl phthalate 278.34 Carboxylate ester 11 - - Aromatic carboxylic122.12 - - 253 benzoic acid acid2-methylbutanoic acid 102.13 Saturated fatty acid 43-methylvaleric acid 102.13 Saturated fatty acid 10palmitic acid 256.42 Saturated fatty acid 3 49Unsaturated fatty278.43 - 91 - linolenic acid acidCarboxylic142.18 - - 0.5 isovaleric anhydride anhydrideCarboxylic214.32 - - 0.3 hexanoyl hexanoate anhydridebutyrolactone 86.09 Lactone 3 16-pentyloxan-2-one 170.25 Lactone 1 gamma-decanolactone 170.25 Lactone - - 1 (2,6,6-trimethyl-2- hydroxycyclohexylidene) 180.24 Lactone 3 7 -acetic acid lactonedodecalactone 186.29 Lactone 4ethyl maltol (2-Ethyl-3- - hydroxy-4H-pyran-4-one) 144.16 Lactone 2 152coumarin 146.15 Lactone 13,4-dihydrocoumarin 148.16 Lactone 36-hydroxy-4- - - methylcoumarin 176.17 Lactone 14scopoletin 192.17 Lactone 3 142, 3, 5-tri methylpyrazine 122.16 Pyrazine derivative 102,5-dimethyl pyrazine 108.14 Pyrazine derivative 1 67acetyl pyrazine 122.12 Pyrazine derivative 102,3-diethylpyrazine 136.19 Pyrazine derivative 0.31 -pyrazin-2-ylethanone 122.13 Pyrazine derivative 2253-(2,3-dihydro-1 h-pyrrol- - -5-yl)pyridine 146.19 Pyridine derivative 18Example 2[000332] An investigation was conducted to provide a sensory analysis of eliquids comprising organic acids and aerosol former materials. Due to the liability of certain organic acids derivable from tobacco aroma compositions, the invention sought to reduce the impact of said acids on the sensory properties of the eliquid. A further aim of the investigation was to determine ways in which migration of liable acids could be reduced without adversely affecting eliquid sensorial characteristics.[000333] According to the present invention, it was found that sensory properties of eliquids could be maintained at a consistent level by forming acetals from (i) carboxylic acids, such as keto acids or carboxy-aldehydes, and (ii) polyhydric alcohols, such as glycerol. Moreover, it was observed that loss of acid was mitigated by forming said acetal compounds.[000334] Figures 1 and 2 illustrate embodiments of the invention. Levulinic acid (150mg) was premixed with 15g of a polyhydric alcohol (Figure 1 = glycerol; Figure 2 = glycerol and propylene glycol in a 50:50 weight ratio). The consumable formulations were heated (Fisherbrand Isotemp) for 2 hours at70°C and with stirring at 1500rpm. Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquidchromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 10 times (10k dilution) using a solvent (water / methanol, 8:2) for characterisation. Characterisation was used for qualitative and quantitative purposes.[000335] Where levulinic acid was combined with glycerol only, the concentration of levulinic acid in the consumable was reduced (6.4 pg / mL vs 9.4 pg / mL) and theoretical conversion to acetals (3-(5-hydroxy-2-methyl-1,3-dioxan-2-yl)propanoic acid and 3-(4-(hydroxymethyl)-2-methyl-1,3-dioxolan-2-yl)propanoic acid) was increased (49.2% vs 18.4%) relative to corresponding consumables comprising a mixture of glycerol and propylene glycol. Theoretical conversion was determined based upon the levulinic acid concentration at T= 0 (i.e. at the point of formulation; (i) levulinic acid concentration in glycerol = 12.6 pg / mL; (ii) levulinic acid concentration in glycerol / propylene glycol = 11.5 pg / mL) and the levulinic acid concentration quantitatively determined after heating.[000336] The concentration of levulinic acid in the consumable reduced on storage (6.5 pg / mL vs 3.8 pg / mL) and theoretical conversion to acetals (3-(5-hydroxy-2-methyl-1,3-dioxan-2-yl)propanoic acid and 3-(4-(hydroxymethyl)-2-methyl-1,3-dioxolan-2-yl)propanoic acid) increased (48.6% vs 70.1%) after storage. Theoretical conversion was determined based upon the levulinic acid concentration at T=0 (i.e. at the point of formulation; levulinic acid concentration = 12.6 pg / mL) and the levulinic acid concentration quantitatively determined after storage.[000337] Figure 5 illustrates an eliquid prepared without premixing the organic acid (levulinic acid) and glycerol. The eliquid consisted essentially of glycerol and propylene glycol in a 50:50 weight ratio, 10mg / ml nicotine, levulinic acid and menthol. The consumable formulations were stored for 7 days at room temperature (approx. 20°C). Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 1 time (1k dilution) using a solvent (water / methanol, 8:2) for characterisation. Characterisation was used for qualitative and quantitative purposes.[000338] Levulinic acid concentration was found to decrease after storage, relative to the levulinic acid concentration at T=0, i.e. at the point of formulation (levulinic concentration at T=0 - 11.5 pg / mL; levulinic concentration after storage - 11.3 pg / mL; reduction of 1.4%). No acetal derivatives of levulinic acid or glycerol were qualitatively observed (LCD = 0.5ppm).Example 3[000339] Further investigation of acetal formation was carried out in accordance with the present invention. 4-formylbenzoic acid was mixed with 15g of a polyhydric alcohol (i.e. glycerol) and characterised at TO (cf. Figure 6; 6A = 0.1% 4-formylbenzoic acid in glycerol; 6B = 0.1% 4-formylbenzoic acid in solvent). Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulation was diluted 1 time (1k dilution) using the polyhydric alcohol and additionally a solvent (water / ethanol, 5:5) for characterisation.[000340] The consumable formulations were stirred using magnetic stirrer at 1500 rpm and reacted for 2 hours and 20 hours at 80°C. Spectroscopic characterisation of the consumable formulations are illustrated in Figure 7 (2hrs) and Figure 8 (20hrs). The concentration of 4-formylbenzoic acid (7A I 8A; EIC = 149.0245) in the consumable reduced on storage and theoretical conversion to acetals (2-(4-carboxyphenyl)-1,3-dioxolane-4-methanol and 2-(4-carboxyphenyl)-1,3-dioxan-5-ol) (cf. 7B I 8B; EIC = 223.0611) increased after storage. Yield was higher after an extended mixing step (20h; cf. Fig 8) relative to a shorter period (2h; cf. Fig. 7). Theoretical conversion was determined based upon the 4-formylbenzoic acid concentration at T=0 in the solvent.[000341] Glyoxylic acid was mixed with 15g of a polyhydric alcohol (i.e. glycerol). The consumable formulations were stirred using magnetic stirrer at 1500 rpm and reacted for 2 hours at 80°C. Spectroscopic characterisation of the consumable formulation is illustrated in Figure 9. Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 1 times (1k dilution) using a solvent (water / ethanol, 5:5) for characterisation. Characterisation was used for qualitative and quantitative purposes.[000342] The concentration of glyoxylic acid (9A; EIC = 72.9932) in the consumable reduced on storage and theoretical conversion to acetals ((2-carboxy-1,3-dioxolan-4-yl) methanol and 2-carboxy-1,3-dioxan-5-ol) (cf. 9B; EIC = 147.0299) increased after storage (cf Fig. 9). Theoretical conversion was determined based upon the glyoxylic acid concentration at T=0 in the solvent.[000343] Figures 10 and 11 illustrate an embodiment of the invention, where pyruvic acid (150mg) was premixed with 15g of a polyhydric alcohol (i.e. glycerol) and characterised at TO (cf. Fig 10; 10A = 1% pyruvic acid in solvent; 10B = 1% pyruvic acid in glycerol; 10C = 10% pyruvic acid in glycerol). Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 1 time (1k dilution) and 10 times (10k dilution) using the polyhydric alcohol and additionally a solvent (water / ethanol, 5:5) for characterisation.[000344] The consumable formulations were stirred using magnetic stirrer at 1500 rpm and reacted for 20 hours at 80°C. The concentration of pyruvic acid in the consumable reduced on storage (cf. 11 A; EIC = 87.0082) and theoretical conversion to acetals (4-(hydroxymethyl)-2-methyl-1 ,3-dioxolane-2-carboxylic acid and 5-hydroxy-2-methyl-1 ,3-dioxane-2-carboxylic acid) (cf. 11 B = 1% pyruvic acid in glycerol, EIC = 161.0453; 11C = 10% pyruvic acid in glycerol, EIC = 161.0453) increased after storage. Theoretical conversion was determined based upon the pyruvic acid concentration at T=0 in the solvent.[000345] Figures 12 and 13 illustrate an embodiment of the invention, where pyruvic acid (150mg) was premixed with 15g of a polyhydric alcohol (i.e. 2-methyl-1,3-propanediol) and characterised at TO (cf. Fig 12; 12A = 1% pyruvic acid in solvent; 12B = 1% pyruvic acid in 2-methyl-1,3-propanediol; 12C = 10% pyruvic acid in 2-methyl-1,3-propanediol). Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 1 time (1k dilution) and 10 times (10k dilution) using the polyhydric alcohol and additionally a solvent (water / ethanol, 5:5) for characterisation.[000346] The consumable formulations were stirred using magnetic stirrer at 1500 rpm and reacted for 20 hours at 80°C. The concentration of pyruvic acid in the consumable reduced on storage (cf. 13A; EIC = 87.0082) and theoretical conversion to an acetal (2-(5-methyl-1,3-dioxan-2-yl)propanoic acid) (cf. 13B = 1% pyruvic acid in 2-methyl-1,3-propanediol, EIC = 159.0665; 13C = 10% pyruvic acid in 2-methyl-1,3-propanediol, EIC = 159.0664) increased after storage. Theoretical conversion was determined based upon the pyruvic acid concentration at T=0 in the solvent.[000347] Figures 14 and 15 illustrate an embodiment of the invention, where a-ketoglutaric acid (150mg) was premixed with 15g of a polyhydric alcohol (i.e. 2-methyl-1,3-propanediol)and characterised at TO (cf. Fig 14; 14A = 1% a-ketoglutaric acid in solvent; 14B = 1% a-ketoglutaric acid in 2-methyl-1,3-propanediol; 14C = 10% a-ketoglutaric acid in 2-methyl-1,3-propanediol). Characterisation of the formulation was undertaken using liquid chromatography (Agilent Infinity 1290 series) coupled to quadrupole time-of-flight mass spectrometer (Bruker timsTOF Pro) and liquid chromatography (Agilent Infinity 1290 series) coupled to triple quadrupole (Sceix triple quadrupoles 6500+) mass spectrometer. The consumable formulations were diluted 1 time (1k dilution) and 10 times (10k dilution) using the polyhydric alcohol and additionally a solvent (water / ethanol, 5:5) for characterisation.[000348] The consumable formulations were stirred using magnetic stirrer at 1500 rpm and reacted for 20 hours at 80°C. The concentration of a-ketoglutaric acid in the consumable reduced on storage (cf. 15A; EIC = 145.0143) and theoretical conversion to acetals (4-(2-hydroxy-5-methyl-1 ,3-dioxan-2-yl)-2-oxobutanoic acid, 4-(2-hydroxy-5-methyl-1 ,3-dioxan-2-yl)-4-oxobutanoic acid and 2-(2-carboxyethyl)-5-methyl-1,3-dioxane-2-carboxylicacid) (cf. 15B = 1% a-ketoglutaric acid in 2-methyl-1,3-propanediol, EIC = 217.0717; 15C = 10% a-ketoglutaric acid in 2-methyl-1,3-propanediol, EIC = 217.0717) increased after storage. Theoretical conversion was determined based upon the a-ketoglutaric acid concentration at T=0 in the solvent.[000349] This information demonstrates the formation of acetals in different pre-mixture compositions comprising polyols and carboxylic acids derivable from tobacco aroma compositions described herein.Example 4[000350] Further analysis was carried out to supplement the observations in the previous Examples.[000351] Four sample e-liquids were tested in non-combustible aerosol provision systems according to the present disclosure. The same device was used for all four samples.[000352] The objective of this Example was to determine whether any differences between the four sample e-liquids could be determined, with a focus on FMC-like tase and overall satisfaction score.[000353] The methodology of this test was sequential monadic testing (product placement with rotation). In this case, participants (n=355) were provided with the non-combustible aerosol provision systems containing the sample e-liquid and asked to use the products as they would normally as part of their daily routine for 2 days.[000354] Following placement, participants completed a sensorial evaluation by being asked a series of questions about the samples. The key drivers of an FMC-like taste that were evaluated included the tobacco taste likeability, aroma likeability, authenticity, smoothness of taste, aftertaste and sweetness.[000355] The key drivers of overall satisfaction that were evaluated include the drivers of the FMC-like taste, and additionally include physiological factors, such as the immediacy and sufficiency of the physiological response to the e-liquid, and sensorial factors, including irritation, chest sensation, smoothness of vapour and mouth drying, each of which contribute to the overall FMC experience and thus contribute to an overall satisfaction.[000356] Table 3 below details each sample tested.Table 3Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) (Meq)1 Extract 210% 16 160 / 40 PG / VG2 Extract 210% 14 160 / 40 PG / VG3 Extract 410% 16 160 / 40 PG / VG4 Extract 48.5% 14 160 / 40 PG / VG[000357] Two comparative examples were also provided to participants and evaluated.[000358] This first comparative example is a commercially available tobacco-flavour e-liquid, which was chosen due to its popularity with smokers in the UK market.[000359] The second comparative example is a tobacco stick for use in a heated tobacco device, which was chosen due to its similarity with factory made cigarette, such as similarity in FMC-like taste and overall FMC-like experience.[000360] The results of the comparative analysis are provided in Table 4 below:Table 4Sample No. FMC-Like taste FMC-Like taste OSSvs Comparative vs Comparative vs Comparative Example 1 Example 2 Example 11 — —2 — — —3 + — —4 — —Key: “+” indicates improvement versus comparative example“ — ” indicates parity versus comparative example[000361] It can be seen that sample 3 has a superior FMC-like taste compared to comparative example 1 and has an equivalent scoring of the FMC-like taste when compared to comparative example 2, indicating that the presently disclosed extracts advantageously provide an FMC-like experience, such as FMC-like taste, to the consumer.[000362] The four samples were further tested as indicated above, however participants were divided between a full flavour (FF) solus and none-full flavour (NFF) solus. Full flavour cigarettes typically have a stronger, sometimes described as harsher or more intense, taste, whereas non-full flavour cigarettes are typically described as having a smoother taste[000363] Results of the comparative analysis are provided below in Table 5.Table 5Sample FMC-Like taste FMC-Like taste OSS (FF Solus) No. (FF Solus) (NFF Solus)vs Comparativevs Comparative vs Comparative Example 2 Example 2 Example 21 —2 — — —3 — — —4 —Key: “+” indicates improvement versus comparative example“ — ” indicates parity versus comparative example[000364] It can be seen that samples 2 and 3 achieve an equivalent scoring of FMC-like taste in both the FF and NFF groups when compared to comparative example 2. Furthermore, the overall satisfaction score of samples 1-4 achieves an equivalent scoring to the FF group when compared to comparative example 2.[000365] Accordingly, it can be seen that a full flavour user has a similar overall satisfaction when using the disclosed samples 1-4 or when using the second comparative example. This advantageously demonstrates that, amongst a population full flavour users, the disclosed blends are able to provide just as effective experience as a commercially available product which more closely resembles an FMC.Example 5[000366] To further supplement the observations in the previous Examples, sample e-liquids were tested in a non-combustible aerosol provision system. The same device was used for all samples.[000367] The methodology of this test was sequential monadic product placement with block rotation. In this case, participants (n=300) were FMC users who were provided with a noncombustible aerosol provision system containing the sample e-liquid back-to-back and asked to use the products as they would normally as part of their daily routine for 2 days.[000368] A comparative example was also analysed - comparative example 2, as described above.[000369] Following placement, participants completed a sensorial evaluation and participants were scored on; Whether the e-liquid had an FMC-like taste and / or experience comparable with comparative example 2. Participants were asked a series of questions about the sample and the samples were assigned a mean score on a 7-point scale. The following drivers of FMC authentic taste were assessed: (1) Tobacco- taste likability; (2) aftertaste likeability; (3) aroma likeability; (4) taste intensity; (5) taste amount; and (6) taste consistency. (1)-(6) are listed in order of their importance for FMC authentic taste, with (1) being the most important and (6) being the least important.[000370] The samples being assessed are detailed in the table below.Table 6Sample No. E-Liquid Liquid Nicotine Benzoic Acid Level (mg / mL) and Lactic acid (Meq)5 Extract 210% 16 160 / 40 PG / VG6 Extract 210% 20 160 / 40 PG / VG[000371] The results of the sensorial evaluation are provided in the table below.Table 7Sample TobaccoAftertaste Aroma Taste Taste Taste taste likability Likeability intensity amount consistency likabilityComparative 5.0 4.9 4.6 4.9 4.9 5.2 Example 2Sample 6 4.8 4.7 4.6 4.7 4.8 4.9Sample 5 4.9 4.8 4.8 4.6 4.8 4.8** indicates significant difference at 95% confidence interval[000372] As can be seen, the top 5 drivers of FMC-like authenticity in both samples 5 and 6 are not significantly different from comparative example 2, indicating said samples provide an overall FMC-like experience.Example 6[000373] Further analysis was carried out to supplement the observations in the previous Examples.[000374] Four sample e-liquids were tested in non-combustible aerosol provision systems according to the present disclosure. The same device was used for all four samples.[000375] The methodology of this test was sequential monadic testing (product placement with rotation). In this case, participants (n=355) were provided with the non-combustible aerosol provision systems containing the sample e-liquid and asked to use the products as they would normally as part of their daily routine for 2 days.[000376] Following placement, participants completed a sensorial evaluation by being asked a series of questions about the samples. In particular, the sensorial factors evaluated which contribute to the overall FMC experience included irritation, chest sensation, smoothness of vapour and mouth drying. Participants assessed whether the factors were just right (“JR”), too much or not enough (e.g. too sweet, not sweet enough or just right).[000377] Table 8 below details each sample tested.Table 8Sample No. E-Liquid Liquid Nicotine Benzoic AcidLevel (mg / mL) (Meq)1 Extract 210% 16 160 / 40 PG / VG2 Extract 210% 14 160 / 40 PG / VG3 Extract 410% 16 160 / 40 PG / VG4 Extract 48.5% 14 160 / 40 PG / VG[000378] Two comparative examples were also analysed.[000379] The first comparative example (“comparative example 1”) is a commercially available tobacco-flavour e-liquid, which was chosen due to its popularity with smokers in the UK market.[000380] The second comparative example (“comparative example 2”) is a tobacco stick for use in a heated tobacco device, which was chosen due to its similarity with factory made cigarette (FMC), such as similarity in FMC-like taste and overall FMC-like experience.[000381] The results of the comparative analysis are provided in Table 9 and 10 below.Table 9: Sensation analysis vs comparative example 1Sample No. Irritation (JR) Chest Sensation Smooth Vapour Mouth Drying (JR)(JR) (JR)vs Comparative vs Comparative Example 1 vs Comparative vs Comparative Example 1 Example 1 Example 11 — — —2 — — — —3 — — — —4 — — — —Table 10: Sensation analysis vs comparative example 2Sample No. Irritation (JR) Chest Sensation Smooth Vapour Mouth Drying (JR)(JR) (JR)vs Comparative vs Comparative Example 2 vs Comparative vs Comparative Example 2 Example 2 Example 21 —2 — — — —3 —4 — —Key: “+” indicates improvement versus comparative example (90% Confidence Interval) “ — ” indicates parity versus comparative example (90% Confidence Interval)[000382] All samples provide multiple FMC-like sensations, including irritation, smooth vapour and mouth drying that is at least equivalent to the FMC-like sensations provided by comparative example 1.[000383] Additionally, all samples advantageously provide a level of irritation that is at least equivalent to comparative example 2, thus providing an e-liquid which more closely provides an overall FMC-like experience.Example 7[000384] Four sample e-liquids were tested in a non-combustible aerosol provision system. The same device was used for each sample. The objective of this Example was to determine whether any differences between the four sample e-liquids could be determined, with a focus on irritation and overall FMC experience.[000385] The methodology of this test was sequential monadic testing in which the participants (n=12) evaluated multiple samples one at a time, completing the full sensory attributes for each sample before moving on to the next. A rating was given between 1 and 10, 1 being the lowest and 10 being the highest. The results are shown below; “NSD” means no significant difference versus the benchmark.[000386] A comparative example was also analysed (“comparative example 1”), which is a commercially available tobacco-flavour e-liquid, which was chosen due to its popularity with smokers in the UK market. In this case, comparative example 1 contained 18.6 mg nicotine.[000387] Table 11 below details each sample tested.Table 11Sample No. E-Liquid Tobacco liquid Nicotine Level Benzoic Acid extract (TLE) (mg / ml) (Meq) inclusion (%)1 Extract 2 8 18.6 160 / 40 PG / VG2 Extract 2 10 16.0 160 / 40 PG / VG3 Extract 2 10 14.0 160 / 40 PG / VG4 Extract 4 7 18.6 160 / 40 PG / VG5 Extract 4 10 16.0 160 / 40 PG / VG6 Extract 4 8.5 14.0 160 / 40 PG / VG[000388] Sample 1 of Table 11 was set as the benchmark against which irritation was evaluated amongst the samples containing extract 2.[000389] Sample 4 of Table 11 was set as the benchmark against which irritation was evaluated amongst the samples containing extract 4.[000390] The results of the comparative analysis are provided below in Tables 12 and 13.Table 12Sample No. Irritation Close to FMC Experience1 3.6 5.32 NSD vs sample 1 NSD vs sample 13 NSD vs sample 1 NSD vs sample 1Comparative example 1 (18.6 mg nicotine) 2.2 2.0[000391] Comparative analysis reveals that sample 1 (Extract 2 with 18.6mg / ml nicotine and 8% tobacco liquid extract (TLE) inclusion) has a statistically equivalent irritation and FMC experience in comparison to samples 2 and 3. However, comparative example 1 demonstrated decreased irritation and FMC experience versus the benchmark (sample 1). Accordingly, sample 1 delivers an improved FMC-like experience, including in respect of irritation, versus a commercially available tobacco-flavour e-liquid.Table 13Sample No. Irritation Close to FMC Experience4 4.0 5.35 3.2 NSD vs sample 46 3.4 NSD vs sample 4Comparative example 1 (18.6 mg nicotine) 2.2 2.0[000392] Comparative analysis reveals that sample 4 (Extract 4 with 18.6 mg / ml of nicotine and 7% TLE inclusion) has improved irritation in comparison to samples 5 and 6, advantageously demonstrating that increased irritation can be effected by increasing nicotine and / or reducing TLE %.[000393] Furthermore, comparative example 1 demonstrated decreased irritation versus the benchmark (sample 4) and samples 5 and 6. Accordingly, samples 4-6 deliver an improved FMC-like experience in respect of irritation, versus a commercially available tobacco-flavour e-liquid. Sample 4 was also shown to deliver an overall closer FMC experience versus comparative example 1.[000394] Participants were further tasked with identifying the location of irritation according to a check-all-that-apply (“CATA”) approach. In particular, participants were asked to indicate whether irritation was detected in the mouth, nose, tongue, chest, throat and / or other for each of samples 1-6 and comparative example 1.[000395] The results are shown in Figures 16 & 17.[000396] It was found that for Extract 2, as nicotine level was increased from 14.0 mg / ml to 18.6 mg / ml, directionally more irritation was perceived on the tongue.[000397] It was found that for Extract 4, as nicotine level was increased from 14.0 mg / ml to 18.6 mg / ml, directionally more irritation was perceived on the mouth.Example 8[000398] To further supplement the observations in the previous Examples, sample e-liquids were tested in a non-combustible aerosol provision system as defined herein. The same device was used for all samples.[000399] The methodology of this test was sequential monadic product placement with block rotation. In this case, participants (n=300) were FMC users who were provided with aerosol provision systems containing the sample e-liquid back-back and asked to use the products as they would normally as part of their daily routine for 2 days.[000400] A comparative example was also analysed - comparative example 2, as described above.[000401] Following placement, participants completed a sensorial evaluation and participants were scored on; Whether the e-liquid had an FMC-like taste and / or experience comparable with comparative example 2.[000402] Participants were asked a series of questions about the sample. The following drivers of FMC authentic sensation were assessed: (1) smooth taste; (2) irritation; (3)mouth drying; (4) sweetness; (5) bitterness; and (6) warmth of vapour. Participants assigned driver (1) was assigned a mean score on a 7-point scale. Participants assessed whether drivers (2)-(6) werejust right (“JR”), too much or not enough (e.g. too sweet, not sweet enough or just right) and the percentage of each calculated.[000403] The samples being assessed are detailed in the table below.Table 14Sample No. E-Liquid Liquid Nicotine Benzoic Acid Level (mg / mL) and Lactic acid (Meq)5 Extract 210% 16 160 / 40 PG / VG6 Extract 210% 20 160 / 40 PG / VG[000404] The results of the sensorial evaluation are provided in the table below.Table 15Sample Smooth Irritation Mouth Sweetness Bitterness Warmth of taste (7 pt (% JR) drying (% (% JR) (% JR) vapour (% scale) JR) JR)Comparative 4.2 67 65 69 71 82 Example 2Sample 6 4.3 63 74 67 67 80Sample 5 4.4 68 70 64 77 78* indicates significant difference at 95% confidence interval[000405] As can be seen, each of the drivers of FMC-like sensation authenticity in both samples 5 and 6 are not significantly different from comparative example 2, indicating said samples provide an overall FMC-like experience.Example 9:Overview[000406] A non-targeted GCMS study was performed to analyse tobacco extracts 2 and 4 to identify the compounds present using chromatogram deconvolution and El library matching.[000407] A list of compounds of interest was searched for in the untargeted results and the concentration of said compounds was calculated over three replicates.[000408] The concentration of compounds of interest were calculated over a period of 12 months, with values generated at T = 0, 1, 3, 6, 9 and / or 12 months.[000409] Tobacco extract was stored at:• 25(±2)°C at 60(±5) % relative humidity (“Ambient” or “AMB”), or• 5(±3)°C (“Cold”).Materials and Methods[000410] 300 pL of a tobacco extract sample was weighed into a 50 mL centrifuge tube. 10 mL of ethyl acetate was added to each sample which was then spiked with 100 pL of an internal standard (ISTD) solution. The ISTD was 1,4-dibromobenzene. Samples were shaken at 300 rpm for approximately 2 hours on a platform shaker.[000411] Aliquots of each sample were transferred into 2 mL GC autosampler vials for analysis. Samples were analyzed via GCMS operating in Scan mode using a Restek Rxi 5ms column (30m x 0.25mm x 0.25pm).[000412] Agilent Unknowns Analysis software was used to process all samples using chromatogram deconvolution to find compounds whose spectra were then compared against an in house PCDL and NIST 20 for identification.[000413] Semiquantitative concentration results were obtained from the relative response of ID / d compounds compared to the ISTD 1-4, dibromobenzene (approximate concentration of 500 ng / mL).Results[000414] Results are provided below in respect of extract 2 and extract 4that were analysed as above.Stability of Flavour Compounds[000415] A number of flavour compounds was determined to be present in extract 4. These flavour compounds are indicated in the table below, and an exemplary concentration range for each flavour compound is indicated.Table 16Class Exemplary Extract 4 concentration range Flavour Compound (pg / g) (ug / g) Linolenic acid 4.283 C5 to C24 fatty acid 1-500Palmitic acid (n-hexadecanoic7.340 C5 to C24 fatty acid 1-500acid)[000416] GCMS Scan Flavour Analysis of the first tobacco extract was carried out over a period of 12 months with concentrations of each compound of interest calculated at T = 0, 1, 3, 6, 9 and / or 12 months under ambient or cold conditions.[000417] A concentration was also calculated after a 1 month accelerated period in which the extract was stored at 40(±2)°C at 75(±5) % relative humidity (“accel”).[000418] The concentration over time is provided in Table 17 below, where a V” indicates that the concentrations falls within the exemplary range indicated above .Table 17Flavour AMB ACC AMB COL COL AMB COL AMB i COL Compound T=0 EL T=1 D D T= 9 D T=12 : D (pg / g) T=1 T=6 T=9 : T=12T=1 Linolenic NA acid Palmiticacid[000419] As indicated by Table 16 and 17 above, each of the flavour compounds shown maintain a concentration within the exemplary acceptable range over a period of at least T=12 months.[000420] A number of flavour compounds was determined to be present in a extract 2. These flavour compounds are indicated in the table below, and an exemplary concentration range for each flavour compound is indicated.Table 18Class Exemplary Flavour compound Extract 2 concentration range (pg / g) (ug / g) Linolenic acid 7.866 C5 to C24 fatty acid 1-500Palmitic acid (n- 12.407 C5 to C24 fatty acid 1-500hexadecanoic acid)Myristic acid C5 to C24 fatty acid 1-500(tetradecanoic acid) 0.9735 [000421] GCMS Scan Flavour Analysis of the extract 2 was carried out over a period of 12 months with concentrations of each compound of interest calculated at T = 0, 1, 3, 6, 9 and / or 12 months under ambient or cold conditions.[000422] A concentration was also calculated after a 1 month accelerated period in which the extract was stored at 40(±2)°C at 75(±5) % relative humidity (“accel”).0 [000423] The concentration over time is provided in Table 19 below, where a V” indicates that the concentrations falls within the exemplary range indicated above.Table 19Flavour AMB ACC AMB COLD AMB § COLD AMB COLD AMB COLD AMB COLD compoun T=0 EL T=1 T=1 T=3 § T=3 T=6 T=6 T=9 T=9 T=12 T=12T=1LinolenicacidPalmiticacidMyristic a NA NAcid[000424] As indicated by Table 18 and 19 above, each of the flavour compounds shown 5 maintain a concentration within the exemplary acceptable range over a period of at least T=12 months.Example 10[000425] A difference between e-liquids obtained from tobacco liquid extracts compared to synthetic tobacco is the presence of naturally occurring acids in the tobacco extract. To understand the chemical and sensorial behaviour of such acids and identify alternatives to acids presently included in synthetic tobacco e-liquids (lactic acid and benzoic acid), a study was performed to determine the binding affinities of acids found naturally in tobacco to their cognate receptor, TRPV1. The reference compounds used in this study were benzoic acid and lactic acid. These molecules were selected as benchmarks to contextualize and compare the binding affinities obtained for the compounds of interest.[000426] The test compounds were: heptanoic acid, 3-methylpentanoic acid, 2-methylvaleric acid, levulinic acid, 2-methylbutyric acid, isovaleric acid, valeric acid, isobutyric acid, and butyric acid.[000427] The affinity values considered throughout the analysis are the binding affinity scores (kcal / mol) obtained from compound-receptor interaction analyses derived from molecular docking simulations. These values represent the predicted strength of interaction between each ligand (test or reference compound) to the simulated molecular receptor.[000428] It will be appreciated by one skilled in the art that each of the compounds may be capable of binding to suitable receptors to act as the required agonist, antagonist or inhibitor. When a potential modulator interacts with a receptor then the interaction will have a given binding energy. The binding energy may be determined based on the follow equation:[000429] More specifically, the modulator and receptor involves several molecular interactions (e.g., van der Waals, electrostatic, hydrogen bonds, hydrophobic, and others) and physicalchemical complementarity among the receptor and the modulator. The protein structure file (receptor) may be retrieved from the Protein Data Bank and was described using electron microscopy model. The details are as follows: TRPV1: PDB: 7LR0,httpsV / w^^ DOI: 10.2210 / pdb7lr0 / pdb. The receptors hydrogen atoms may be added, according to appropriate hybridization geometry, to those atoms based on built-in modules to add partial charges, protonation states followed by bond orders assignment and set up rotatable bonds of the receptors.[000430] Active site pockets of a protein molecule are the sites where the potential modulators bind to a protein. To perform these experiments, one may use one simulation box thatdeterminates the searching area for the modulators. This theoretical procedure may be performed using the TRPV1 grid-box size with dimensions of x=20 A, y= 20 A, z=20 A and a center coordinates of X=106.82 A, Y= 82.40 A, Z = 90.48 A.[000431] Gibbs free energy of binding (FEB in Kcal / mol) for complexes structures of a receptor - modulator may be calculated using a scoring function which approximates the chemical potentials (AGbind). The docking free energy of binding (FEBd0Ck) is defined by AGbindvalues for all docked poses of the formed complexes (protein- modulators) and include the internal steric energy of a given protein and modulators which can be expressed as the sum of individual molecular mechanics terms of standard-chemical potentials.[000432] A more negative value of FEB (kcal / mol) implies a higher affinity between the receptor and the different types of modulator substrates. The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is AGbind> 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity, otherwise they are categorized having medium to high docking affinity.[000433] The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is AGbind s 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity.[000434] In summary, the FEB threshold is 0 kcal / mol. FEB values higher than 0 means an absence of affinity for the receptor. If FEB is lower than 0 kcal / mol, there was affinity for receptors. Lowest FEB values means a better affinity for receptor.[000435] The A affinity represents the difference in binding affinity between a test compound and a reference compound. This value is calculated relative to each reference compound (benzoic acid and lactic acid). For each receptor, the A affinity is computed as the absolute value of the difference between the docking affinity of a target compound and the dockingaffinity of the reference compound, according to the following expression:By way of example:Butyric acid (test compound): affinity = -4.477 kcal / molBenzoic acid (reference): affinity = -6.169 kcal / mol6,169 — (“4,477") 1,692;[000436] This A affinity calculation was performed for both reference compounds, across all test compounds. The results of the affinity analysis are provided in Table 20 below.[000437] In Table 20, the affinity value of each acid for its receptor (kcal / mol) is described by whether it was more negative (i.e., a higher affinity) or less negative (i.e. , a lower affinity) than the affinity value calculated for benzoic acid as a reference.[000438] In Table 20, the compounds have been ranked in order of their A affinity, wherein 1 represents the smallest A affinity and 12 represents the largest A affinity, versus benzoic acid as a reference.Table 20Compound Affinity value A affinity(kcal / mol) compared rankingto referenceHeptanoic acid More negative 13-Methylpentanoic acid Less negative 22-Methylvaleric acid Less negative 3Levulinic acid Less negative 42-Methylbutyric acid Less negative 6Isovaleric acid Less negative 7Valeric acid Less negative 8Isobutyric acid Less negative 9Lactic acid Less negative 10Butyric acid Less negative 11[000439] It can be seen how all acids tested were comparable in terms of A affinity to either benzoic acid or lactic acid.Example 11[000440] Following the results of the binding affinity study, the test acid compounds were analysed for their transfer efficiency from e-liquid to aerosol.[000441] Acids were measured in e-liquid and aerosol sample types using Gas Chromatography coupled with Mass Spectrometry (GC-MS) and were compared based on how much was proportionally detected in terms of w / w (mass balance). E-liquid measurements were a direct calculation. For aerosol measurements, using a smoking machine, the amount of e-liquid vaped was determined based on the mass of the remaining e-liquid. Accordingly, the acids were measured in the residual e-liquid, initial e-liquid and in the emission captured in a filter pad used in a smoking machine.[000442] To measure the acids in the e-liquid, 10 mg of e-liquid was weighed into a vial- and 990 mL of isopropanol added. 10 pL of Naphthalene_d8 at 10000 ppm was then added and the solution vortexed for 15 seconds, checking for complete homogenisation. The solution was then injected into the GC-MS.[000443] To measure the acids in an aerosol sample, the e-liquid was vaped using a smoking machine (LM4) aligned with the angle to 15° and connect to an e-liquid device set to the holder, which contains a filter pad (e.g. a Cambridge filter (ml)). The smoking machine was programmed with the following specifications: 70 puffs, 3 seconds puff duration, 55 mL puff volume, 30 sec puff interval.[000444] The analyzed extract is generated from the smoking of 70 puffs and 15°. The smoking analysis is carried out in a linear smoking machine with one impinger containing 10 mL of extractive solution and 45 mm filter pad. Each sample was analyzed in at least 3 replicates. The filter pads used in the smoking process were conditioned for 48 hours at 25°C and a maximum relative humidity of 60%.[000445] After smoking using the smoking machine, the filter pad was transferred to a 125 mL Erlenmeyer flask and 10 mL of extractive solution added. The samples were shaken in an orbital shaker at 250rpm for 30 minute. The samples were filtered with an aliquot of each sample into a 2mL vial, which was then injected into the GC-MS.[000446] The concentration of each acid in the aerosol can thus be calculated as follows:Concentration (mg / mL)=((Aa / Ai-l)x C) / DAa = analyte area;Ai = Internal standard area;I = Standard curve intercept;C = Internal Standard concentrationD = Slope[000447] Accordingly, the transfer efficiency can be calculated based on how much was proportionally detected in terms of w / w in the e-liquid versus the aerosol.[000448] The results of this study are set out in Table 21 below.Table 21Compound Transfer efficiencyHeptanoic acid 93%Benzoic acid (reference) 100%3-Methylpentanoic acid 85%2-Methylvaleric acid 86%Levulinic acid 81%2-Methylbutyric acid 85%Isovaleric acid 93%Valeric acid 80%Isobutyric acid 81%Lactic acid 97%Butyric acid 83%[000449] It can be seen how the transfer efficiency of each of the acids is close to 100%. Hence, a further study was performed to determine and compare the sensorial contributions of the acids in the FMC-like space.[000450] Sensory attribute models are obtained from data collected through structured sensory evaluations, in which a trained panel quantifies the intensity of specific attributes (such as mouthful...

Claims

CLAIMS1). A composition for use in a non-combustible substance delivery system to provide a tobacco aroma, the composition comprising a combination of fatty acids selected from the following groups:(a) one C14 to C18 saturated fatty acid and one C16 to C20 unsaturated fatty acids;(b) three C3 to C18 saturated fatty acids; or(c) at least three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid;wherein the composition has a pH of about 4 to about 7.6.2). The composition according to claim 1, wherein the composition further comprises acetic acid, C7 to C24 aromatic carboxylic acids and combinations thereof; preferably wherein the composition further comprises a combination of acetic acid and C7 to C24 aromatic carboxylic acids.3). The composition according to claim 1 or claim 2, wherein the composition comprises no more than four aromatic carboxylic acids.4). The composition according to any one of claims 1 to 3, wherein the composition comprises a combination of fatty acids consisting of three C3 to C18 saturated fatty acids and at least one C3 to C18 unsaturated fatty acid.5). The composition according to any one of claims 1 to 3, wherein the composition comprises a combination of fatty acids consisting of three C3 to C18 unsaturated fatty acids and nine C3 to C18 saturated fatty acids.6). The composition according to any one of claims 1 to 5, wherein the composition comprises no more than four unsaturated fatty acids.7). The composition according to any one of claims 1 to 6, wherein the composition comprises unsaturated fatty acids, if present, in an amount of from about 1 pg / g to about 400 pg / g; preferably in an amount of from about 10 pg / g to about 200 pg / g.). The composition according to any one of claims 1 to 7, wherein the composition comprises saturated fatty acids in an amount of from about 1 pg / g to about 500 pg / g; preferably in an amount of from about 10 pg / g to about 400 pg / g.). The composition according to any one of claims 4 to 8, wherein the weight ratio of the unsaturated fatty acids to the saturated fatty acids, if both present in the combination of fatty acids, is of from about 2.0: 1.0 to about 1.0:2.5; preferably about 1.0: 1.0 to about 1.0:2.2; more preferably from about 1.0: 1.7 to about 1.0 to 2.2.0). A composition for a non-combustible substance delivery system to provide a tobacco aroma, wherein the composition comprises one or more reaction products of two or more reactants, the reaction products being selected from:(a) esters, the esters being an esterification reaction product of organic acid and alcohol reactants; and / or(b) esters and / or alcohols, the esters and / or alcohols being a transesterification reaction product of ester and alcohol reactants;(c) alcohols and / or acids, the alcohols and / or acids being a hydrolysis reaction product of ester and water reactants;(d) acetals, the acetals being the acetalisation reaction product of aldehyde and alcohol reactants;(e) acetals, the acetals being the acetalisation reaction product of ketone and alcohol reactants;or combinations of the reaction products.1). The composition according to claim 10, wherein the organic acid reactants are selected from C2 to C24 carboxylic acids and combinations thereof.2). The composition according to claim 10 or claim 11, wherein the alcohol reactants are selected from terpene alcohols, C7 to C18 aromatic alcohols, phenol or C7 to C18 substituted phenols and combinations thereof, optionally wherein the C7 to C18 substituted phenols are monophenols.3). The composition according to any one of claims 10 to 12, wherein the alcohol reactants are primary alcohols, polyhydric alcohols or combinations thereof; preferably whereinthe primary alcohols are selected from ethanol, methanol or combinations thereof and the polyhydric alcohols are selected from glycerol, propylene glycol or combinations thereof.14). The composition according to any one of claims 10 to 13, wherein the ester reactants are selected from C3 to C24 aliphatic esters, C8 to C18 aromatic esters and combinations thereof.15). The composition according to any one of claims 10 to 14, wherein the aldehyde reactants are selected from C3 to C24 aliphatic, and aromatic aldehydes and combinations thereof.16). The composition according to any one of claims 10 to 15, wherein the ketone reactants are selected from C3 to C24 aliphatic and aromatic ketones, and combinations thereof.17). The composition according to any one of claims 10 to 16, wherein the composition has a pH of less than 7; optionally wherein the composition has a pH of about 4 to about 5.18). The composition according to any one of claims 10 to 17, wherein the composition is obtained by extracting one or more reactants or compounds from a tobacco source.19). A method for forming the composition any one of claims 1 to 18, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the reactants or compounds from the tobacco into the solvent.20). A consumable comprising the composition according to any one of claims 1 to 18, and a substrate material, optionally wherein the substrate material comprises a carrier material, a porous material, or a combination thereof.21). A container or package containing the composition according to any preceding claim 1 to 18, preferably wherein the container or package is a pouched oral product comprising a saliva permeable pouch, or a cartridge for an aerosol provision system.22). A substance delivery system comprising the consumable of claim 20, or the container or package of claim 21.23). The substance delivery system according to claim 22, wherein the system is a noncombustible aerosol provision system, or an aerosol-free delivery system.24). An aerosolisable formulation comprising:(a) a carrier; and(b) a composition as defined in accordance with claims 1 to 18. ). An aerosolised formulation comprising:(a) a carrier; and(b) a composition in accordance with claims 1 to 18.